Synthesis and properties of gold(III) pincer complexes with sulfur ligands by Currie, Lucy
 Synthesis and Properties of 
Gold(III) Pincer Complexes with 
Sulfur Ligands 
 
Lucy A Currie 
 
 
 
A thesis submitted in partial fulfilment of the requirements for the 
degree of Doctor of Philosophy  
University of East Anglia 
School of Chemistry 
 
 
 
June 2018 
 
This copy of the thesis has been supplied on condition that anyone who consults it is 
understood to recognise that its copyright rests with the author and that use of any information 
derived therefrom must be in accordance with current UK Copyright Law. In addition, any 
quotation or extract must include full attribution 
  
i 
 
Abstract 
This thesis investigates the synthesis of gold(III) pincer complexes and their functionalisation 
and reactivity with sulfur based ligands. The first chapter gives a brief introduction to gold 
chemistry, focusing on C^N^C gold(III) pincer complexes. The synthesis of these complexes 
and their subsequent functionalisation is described, emphasising their impact on our 
understanding of gold(III) chemistry.   
Chapter Two investigates the synthesis of a series of C^N^C gold(III) thiolate complexes. 
These complexes are photoluminescent and show either red or green emission. The emission 
properties are investigated in the solid state and solution. Analysis of crystal polymorphs with 
different emission properties show the potential for intermolecular interactions to affect the 
emission pathway. We identify two separate emission pathways resulting in the different 
emissions observed.  
Chapter Three explores the potential mechanisms of reductive elimination from C^N^C 
gold(III) complexes. Two different methodologies have been developed that trigger either C–
S or C–C bond formation from a series of gold(III) complexes (chloride, thiolate, aryl and 
alkyl). The investigations are extended to further gold(III) heteroatom species and their 
reactivity is compared. 
Chapter Four investigates reactions of gold(III) complexes with two different transmetallating 
agents: organozinc halides and silyl boronic acids. Use of these transmetallating agents, to the 
best of our knowledge, is unexplored with gold(III) systems. Zinc aryl halides transmetallate 
Au–Cl and Au–S bonds affording gold(III) aryls in one step under mild conditions. The use of 
a silyl boronic acid in the transmetallation of Au–O bonds produces a gold(III) silyl complex.  
Chapter Five investigates the synthesis and anticancer properties of a series of C^N^C 
gold(III) NHC complexes. We investigate the potential influence of systemic alterations to 
both the pincer system and NHC upon the anticancer properties and DNA intercalation. In 
addition, the reactivity of these complexes with thiols is probed. 
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Introduction  
1.1 Why are we interested in gold? 
The noble character of gold(0) had led to the preconception that gold is unreactive. It has long 
been considered a stable and inert metal, which is in part due to its redox potentials. The 
discovery that gold salts, particularly of gold(I), were active catalysts has revived an interest 
in understanding the nature of gold species.1 Subsequently, this has led to the application of 
gold in catalysis, anticancer agents and photoluminescent materials.  
The organometallic chemistry of gold is less well developed if compared to platinum, 
palladium and iridium, its neighbours in the periodic table. This can be exemplified by the 
recent isolation of the first gold(III) alkene complex in 2013,2 compared to the isoelectronic, 
platinum(II) equivalent, Zeise’s salt, which was reported in 1827 (Figure 1.1).3 Gold(III) is 
frequently compared to platinum(II) as they are isoelectronic. Whilst this is useful in 
highlighting the development of gold chemistry the two metals differ in their reactivity, such 
as the oxidative addition of aryl halide bonds is more facile for Pt(0) than Au(I) and their 
properties differ, such as electronegativity and their respective bond strengths. 
 
Figure 1.1. A gold(III) alkene complex and Zeise’s salt. 
1.2 Relativistic effects 
The slow development of gold chemistry is related to the perceived inertness. This is due to 
relativistic effects that influence the atomic properties of gold. Relativistic effects occur in late 
transition metals due to high speed electrons moving close to a heavy nucleus.4 Gold has 
higher relativistic effects than its neighbours in the periodic table and is responsible for the 
difference in properties.5 One of these properties is electronegativity, gold is the most 
electronegative metallic element, with a similar electronegativity to carbon and hydrogen.6 
Relativistic effects cause the contraction of penetrating orbitals, resulting in stabilisation of 
the 6s and 6p orbitals.7 This contraction of 6s and 6p orbitals increases the shielding of the 
nuclear charge and therefore results in the expansion of orbitals with higher angular 
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momentum and less penetrating radial distribution functions such as the 5d orbitals (Figure 
1.2). Relativistic effects also result in increased spin orbit splitting also known as spin orbit 
coupling, which affects the photoluminescent properties of gold complexes (see section 2.1).  
 
Figure 1.2. The effects upon the energy levels with and without relativistic effects of the 
valence shells in gold.8 
The relativistic effect is also responsible for the yellow colour and lowered reactivity of gold, 
and consequently the prevalence of gold(0) found in nature.7 The golden colour of the metal 
results from a transition from the filled 5d band to the Fermi level which requires the 
absorption of blue and green light and reflection of red and yellow light to give the distinctive 
golden colour.9  
1.3 Common oxidation states 
The stability of gold(0) is indicated by the positive electropotentials (Figure 1.3).6 The 
favourable reduction potentials from gold(III) to both gold(I) and gold(0) make the synthesis 
of stable gold(III) complexes more difficult, with reduction products frequently observed. The 
comparative ease of reduction of gold(III) is evident when compared to the reduction of 
platinum(II) (Pt2+/Pt0 = 1.19 V) to which it’s reactivity is most frequently compared.  
 
Figure 1.3. The electropotentials of gold ions in 1 M aqueous acid solutions at 25 °C.6 
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Organometallic gold chemistry is dominated by gold in oxidation states +1 and +3, due to the 
favourable valence electron arrangements d10 and d8 respectively. Gold(I) complexes 
predominantly adopt a linear geometry, though there are some interesting nonlinear examples 
discussed in Section 3.2. Whereas gold(III) complexes adopt a square planar geometry around 
the metal centre, typical of 2nd and 3rd row d8 transition metal complexes.  The development 
of organometallic gold(III) chemistry has been slower than that of gold(I), mainly due to 
favourable reduction pathways of gold(III) to gold(I). There is significant interest in gold(III) 
because it is isoelectronic with iridium(I) and platinum(II), both of which have been 
extensively used in photoluminescent, catalytic and anticancer applications. Many cross-
coupling catalyses involve oxidative addition and reductive elimination steps which require 
access of both gold(I) and (III) oxidation states, recent advances in understanding the 
fundamental catalytic steps have identified conditions under which this transition more 
facile.10 
Gold(II) is less stable than gold(I) and (III), due to the d9 electron configuration with one 
electron in the dx2−y2  orbital and therefore it often disproportionates to a mixed valence 
gold(I)/(III) complex.14 Disproportionation of the naked ions is favourable and the process has 
been demonstrated to release 300 kcalmol-1.11 In fact many early complexes identified as 
gold(II) have now been identified as mixed gold(I)/(III) complexes. Numerous gold(II) 
complexes are dinuclear and are stabilised by the formation of a gold-gold bond. These 
complexes can be synthesised by the oxidative addition of halides to dinuclear gold(I) 
complexes and frequently contain bridging ligands. Recently the first complex containing an 
unsupported gold(II)-gold(II) bond was synthesised and isolated,12 and subsequently a further 
stable example using a C^N^C pincer ligand was synthesised by Bochmann et al..13  
Unusually for a metal it is possible to form the auride, an Au- anion. It was initially discovered 
as an alkali metal salt, such as in RbAu and CsAu.14 The formation is possible due to the 
unusual relativistic effects of gold. 
1.4 Organometallic gold complexes  
Recent advances in organometallic gold chemistry have highlighted the importance of the 
ligand system utilised. Bulky N-heterocyclic carbene (NHC) ligands were used in the 
stabilisation of gold(I) hydrides by Sadighi et al.,15 whereas Bochmann et al. demonstrated 
that the C^N^C pincer systems (based on a pyridine diphenyl ligand system) were vital in 
stabilising the first gold(III) hydride.13a Alternatively, Bourissou at al. have shown that the 
hemilabile P^N chelate systems enabled facile oxidative addition of aryl halides to gold(I), a 
reaction that until recently was unobserved for gold(I) systems.16 This is in contrast the 
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plethora of platinum based cross coupling reactions where oxidative addition of aryl halides 
are frequently observed. As the understanding of organometallic gold systems is improving it 
is challenging the initial preconception of gold’s inertness. 
1.4.1 Cyclometallated gold(III) complexes  
The most successful approach to stabilise gold(III) complexes from reduction is the use of 
cyclometallating ligands.17 These ligands contribute to the stabilisation through the chelate 
effect and a shift in redox potentials.6 There are many bidente and tridente cyclometallated 
gold(III) complexes supported by a range of ligands. Figure 1.4 shows a selection of C and N 
based ligands, where C is an aryl ligand.18 Cyclometallation reactions conditions are strongly 
ligand dependant, and various methodologies have been developed.18 One approach is direct 
auration; this is often a two-step process where first the ligand is mixed with a gold(III) salt 
to form an Au–N adduct which is then heated or subjected to microwave conditions to induce 
C–H activation and cyclisation. This method was used in the synthesis of the three complexes 
on the left of Figure 1.4, to form a 5 membered cycle using C^N,19 or C^C^N ligands,20 or a 
6 membered cycle using a C^N ligand.21 Alternatively, transmetallation of a mercurated 
species is another common route in the formation of Au-C bonds, such as in the case of C^N^C 
ligands (see Scheme 1.1), this is followed by C–H activation to form the second Au–C bond. 
Finally, silver(I) salts can assist cyclometallation through chloride abstraction, forming a 
reactive site and insoluble silver chloride; this method was used in the synthesis of a C^N^N 
complex (right Figure 1.4).18,22 
 
Figure 1.4. Examples of cyclometallated gold(III) complexes (anions omitted). 
1.4.2 Gold(III) complexes using a C^N^C pincer ligand 
The work in this thesis focuses on the use of pincer ligands based on C^N^C biscyclometalated 
gold(III) complex using dianionic 2,6-diaryl-substituted pyridine ligands that give neutral, 
highly stable complexes.17 This system is by far the most widely explored in relation to 
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gold(III) chemistry due to the stability of the complexes formed. However, there are other 
biscyclometalated systems using substituted phenyl pyridine ligands: either dianionic 3,5-
diaryl-substituted phenyl pyridine ligands that give neutral, highly stable N^C^C gold(III) 
complexes or monoanionic C^N^N and N^C^N, which give less stable cationic gold(III) 
species.  
The 2,6-diphenylpyridine gold(III) complex, was first synthesised by Che et al.23 and further 
developed by Yam et al to give the modified system (C^Npy^C)AuCl (2),24 where the addition 
of tert-butyl groups improved solubility. Further derivatives have been synthesised by 
Bochmann et al. through substitution of the central pyridine for either a pyrazine25 to give 
(C^Npz^C)AuCl (1) or a p-OMe-pyridine26 to give (C^Npy-OMe^C)AuCl (39) (Scheme 1.1). The 
syntheses of these complexes were similar, firstly the 2,6-diphenylpyridine or 2,6-
diphenylpyrazine based ligand was synthesised with a Suzuki-Miyaura coupling between the 
2,6-dichloropyridine (or its 4-subsituted pyridine derivatives) and 4-tert-butylphenylboronic 
acid. Then the ligand was mercurated using a suitable mercury salt (Hg(OAc)2/EtOH for the 
pyridine and p-OMe-pyridine ligands and Hg(OAcF)2/HOAc
F for the pyrazine ligand). Finally, 
transmetallation of the mercury species by KAuCl4 and subsequent C-H activation gave the 
corresponding C^N^C gold complexes 1, 2 and 39.  
 
Scheme 1.1. The synthesis of C^N^C gold(III) complexes; (i) Suzuki cross coupling (X = N: 
2 molar equivalents Na2CO3, 0.6 mol% Pd(PPh3)2Cl2 in MeCN/H2O refluxed for 48 h; X = 
CH: 2 mol% Pd(PPh3)4, 2 molar equivalents K3PO4 refluxed in iPrOH for 12 h; X = C-OMe: 
0.6 molar equivalents K3PO4, 5 mol% Pd(PPh3)4
 in iPrOH refluxed for 48 h); (ii) 
mercuriation (X = N: Hg(OAcF)2/HOAc
F refluxed for 48 h; X = CH, C-OMe: 
Hg(OAc)2/EtOH refluxed for 72 h) (iii) transmetallation (X = N: KAuCl4 in MeCN/H2O 
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(1:1) was refluxed for 72 h; X = CH: KAuCl4 in MeCN, refluxed  for 24 h; X = C-OMe: 
KAuCl4 in MeCN/H2O (3:2) refluxed for 72 h). 
Bochmann at al. demonstrated that the gold(III) hydroxide stabilised by the C^Npy^C pincer 
system (centre of Scheme 1.2) was a versatile starting material and key in the synthesis of 
many gold(III) derivatives and several highly reactive species.27 It was synthesised through 
the reaction of (C^Npy^C)AuCl (2) with CsOH⸱H2O in a THF/toluene/H2O mixture. It has 
been shown to react with a range of functionalities, including C–H and N–H bonds, and 
boronic acids resulting in the range of (C^Npy^C) gold(III) complexes such as gold(III) aryls 
and acetylides (Scheme 1.2).  
 
Scheme 1.2. The versatility of the C^N^CAu-OH complex. 
The (C^Npy^C)Au–OH complex has also been used in the synthesis of gold(III) hydroperoxide 
and gold(III) peroxide, both of which have been postulated as intermediates in heterogeneous 
gold-catalysed oxidations.28 The hydroperoxide and hydroxide underwent dehydration 
reactions in dry conditions (Scheme 1.3). The dehydration of the hydroxide complexes to give 
a bridging µ-oxide was of significant interest because the crystal obtained had an Au–O–Au 
bond angle of 113.5°. This angle is close to a tetrahedral angle of 109.5° indicating that there 
is no π-bonding in the Au–O bond. 
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Scheme 1.3. The hydration and dehydration equilibria and oxygen abstraction of gold(III) 
oxygen containing complexes. 
Further understanding of the Au–O bond was developed by Bochann et al. based on the 
observation that ethylene could insert into an Au–O bond in the (C^Npy^C)Au–OAcF complex 
(Scheme 1.4).2 This reaction helped demonstrate the bond strengths in gold(III) complexes, 
with the Au–C bond being stronger than the Au–O bond.6 This particular reactivity has been 
further investigated and developed by Tilset et al. into a catalytic system where it was shown 
that acetylene inserted into an Au–O bond of a C^N chelated gold(III) trifluoroacetate 
complex to give a functionalised acetylene.29 
 
Scheme 1.4. The ethylene insertion into an Au–O bond.  
The first reported gold(III) hydride was synthesised by Bochmann et al. through the reaction 
of superhydride (LiHBEt3) with the (C^N
py^C)Au–OH complex (Scheme 1.5), which further 
highlights the versatility of the hydroxide species as a starting material.13a This gold(III) 
hydride was both air and moisture stable, indicating the covalent nature of the Au–H bond. 
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However, upon treatment with dimethylallene it underwent a 1,2 insertion to produce a 
gold(III) vinyl complex (Scheme 1.5). Synthesis of subsequent gold(III) hydrides supported 
by a range of C^N^C ligand systems used 0.5 M solution of lithium aluminium hydride in 
tetrahydrofuran as a hydride source (Scheme 1.5).26 The use of azobisisobutyronitrile (AIBN) 
extended the scope of the insertion reactions and enhanced the rate.26,30 The insertion was 
shown to go via an outer sphere mechanism involving radical formation which is responsible 
for the stereo- and regiospecific formation on the Z-vinyl isomers in the case of alkyne 
insertion.  
 
Scheme 1.5. Synthesis and reactivity of gold(III) hydrides. 
Oxygen abstraction from (C^N^C)Au–OH complex by phosphines (PAr3) also gave the 
gold(III) hydride complex.28 This indicates that the bond energy of the Au–H bond is greater 
than that of the Au–O bond.6 The same methodology was used to form a gold(III) alkyl 
complex from the alkoxide.31 In addition, the reaction of the (C^N^C)Au–H with 
(C^N^C)Au–OH forms a unsupported gold(II) dimer with an Au–Au bond.13a 
Finally, the C^N^C pincer ligand has been vital in the isolation of stable gold(III) π complexes 
of alkenes and alkynes by Bochmann et al. (Figure 1.5). Two different synthetic approaches 
have been used to obtain gold(III) olefin complexes, either starting with (C^Npy^C)Au–OH in 
the presence of an olefin and [H(OEt2)2]
+X-, X = H2N(B(C6F5)3)2 or B(3,5-C6H3(CF3)2)4 at -40 
°C or from (C^Npy^C)Au–OAcF in the presence of an olefin and B(C6F5)3 at -40 °C.
2 All 
alkenes: ethylene, cyclopentene and norbornene, coordinated η2 and the solids of the 
complexes were stable at room temperature under a nitrogen atmosphere. The 1H NMR 
spectrum showed a downfield shift in the signal corresponding to the coordinated ethylene (δ 
= 6.29 ppm) in comparison to free ethylene (δ = 5.38 ppm), which contrasted the ethylene 
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gold(I) and platinum(II) species where an upfield shift was observed for the coordinated 
ethylene signal. This indicated that the π-electron donation from the alkene to the gold(III) is 
not compensated by back-bonding. DFT calculations estimated a rotational barrier of 2.4 kJ 
mol-1, further indicating a low back-bonding contribution from gold(III).  
Synthesis of a gold(III) alkyne used a similar protocol to that of the alkene complexes. First, 
(C^N^C)Au–OAcF was reacted with B(C6F5)3 to form an ion pair [(C^N^C)Au⸱⸱⸱Y] (Y = 
AcFOB(C6F5)3), followed by addition of an internal alkyne (
tBuC≡CMe, AdC≡CAd Ad = 
adamntyl) yields a π-alkyne complex (Figure 1.5).32 Only small shifts in the 13C NMR spectra 
were observed compared to the free alkyne, which was similar to the alkene complex. Charge-
decomposition analysis showed the bonding was almost entirely dependent on the π donation 
of the alkyne to the gold, indicating again the limited π-donation from gold(III).  
 
Figure 1.5, Gold(III) π complexes.  
Together, these complexes demonstrate the ability of the C^N^C ligand system to form stabile 
gold(III) complexes in a range of conditions. Furthermore, C^N^C pincer ligands play a vital 
role in stabilising the hydride and π complex, facilitating their isolation and studies into their 
properties. These complexes also reveal further characteristics of C^N^C gold(III) complexes 
such as the high covalent nature of the Au–H and Au–C bonds resulting from the high 
electronegativity of gold, the order of bond strengths Au-H > Au-C ≥ Au-O and lack of π 
back-bonding.  These particularly contrast platinum(II) complexes, against which gold(III) 
complexes are frequently compared.   
Further modification of square planar C^N^C gold(III) systems have applications in 
photoluminescent materials and as anticancer agents. The stability of this system also allows 
investigations into the study of fundamental steps of cross coupling catalysis. These 
applications will be discussed in the following chapters.  
References 
(1) Raubenheimer, H. G.; Schmidbaur, H. J. Chem. Educ. 2014, 91, 2024. 
(2) Savjani, N.; Rosca, D. A.; Schormann, M.; Bochmann, M. Angew. Chem.-Int. Ed. 
2013, 52, 874. 
Chapter One 
 
11 
 
(3) (a) Zeise, W. C. Poggendorf's Ann. Phys. Chem. 1827, 9, 632. (b) Seyferth, D. 
Organometallics 2001, 20, 2. 
(4) (a) Pitzer, K. S. Acc. Chem. Res. 1979, 12, 272. (b) Pyykko, P. Angew. Chem.-Int. Ed. 
2002, 41, 3573. 
(5) Pyykko, P. Angew. Chem.-Int. Ed. 2004, 43, 4412. 
(6) Rosca, D. A.; Wright, J. A.; Bochmann, M. Dalton Trans. 2015, 44, 20785. 
(7) Pyykko, P.; Desclaux, J. P. Acc. Chem. Res. 1979, 12, 276. 
(8) Yam, V. W. W.; Cheng, E. C. C. Chem. Soc. Rev. 2008, 37, 1806. 
(9) Gimeno, M. C.; Laguna, A. Gold Bull. 2003, 36, 83. 
(10) Joost, M.; Amgoune, A.; Bourissou, D. Angew. Chem.-Int. Ed. 2015, 54, 15022. 
(11) Barakat, K. A.; Cundari, T. R.; Rabaa, H.; Omary, M. A. J. Phys. Chem. B 2006, 110, 
14645. 
(12) Zopes, D.; Hegemann, C.; Tyrra, W.; Mathur, S. Chem. Commun. 2012, 48, 8805. 
(13) (a) Rosca, D. A.; Smith, D. A.; Hughes, D. L.; Bochmann, M. Angew. Chem.-Int. Ed. 
2012, 51, 10643. (b) Dann, T.; Rosca, D. A.; Wright, J. A.; Wildgoose, G. G.; 
Bochmann, M. Chem. Commun. 2013, 49, 10169. 
(14) Jansen, M. Chem. Soc. Rev. 2008, 37, 1824. 
(15) Tsui, E. Y.; Muller, P.; Sadighi, J. P. Angew. Chem.-Int. Ed. 2008, 47, 8937. 
(16) Zeineddine, A.; Estevez, L.; Mallet-Ladeira, S.; Miqueu, K.; Amgoune, A.; 
Bourissou, D. Nat. Commun. 2017, 8, 8. 
(17) Kumar, R.; Nevado, C. Angew. Chem.-Int. Edit. 2017, 56, 1994. 
(18) Henderson, W. Adv. Organomet. Chem. 2006, 54, 207. 
(19) Constable, E. C.; Leese, T. A. J. Organomet. Chem. 1989, 363, 419. 
(20) Kumar, R.; Linden, A.; Nevado, C. Angew. Chem.-Int. Ed. 2015, 54, 14287. 
(21) Nonoyama, M.; Nakajima, K.; Nonoyama, K. Polyhedron 1997, 16, 4039. 
(22) Liu, H. Q.; Cheung, T. C.; Peng, S. M.; Che, C. M. J. Chem. Soc.-Chem. Commun. 
1995, 1787. 
(23) Wong, K. H.; Cheung, K. K.; Chan, M. C. W.; Che, C. M. Organometallics 1998, 17, 
3505. 
(24) Wong, K. M. C.; Hung, L. L.; Lam, W. H.; Zhu, N. Y.; Yam, V. W. W. J. Am. Chem. 
Soc. 2007, 129, 4350. 
(25) Fernandez-Cestau, J.; Bertrand, B.; Blaya, M.; Jones, G. A.; Penfold, T. J.; 
Bochmann, M. Chem. Commun. 2015, 51, 16629. 
(26) Pintus, A.; Rocchigiani, L.; Fernandez-Cestau, J.; Budzelaar, P. H. M.; Bochmann, 
M. Angew. Chem.-Int. Ed. 2016, 55, 12321. 
(27) Rosca, D. A.; Smith, D. A.; Bochmann, M. Chem. Commun. 2012, 48, 7247. 
Chapter One 
 
12 
 
(28) Roşca, D.-A.; Wright, J. A.; Hughes, D. L.; Bochmann, M. Nat. Commun. 2013, 4, 
2167. 
(29) (a) Langseth, E.; Nova, A.; Tråseth, E. A.; Rise, F.; Øien, S.; Heyn, R. H.; Tilset, M. 
J. Am. Chem. Soc. 2014, 136, 10104. (b) Holmsen, M. S. M.; Nova, A.; Balcells, D.; 
Langseth, E.; Øien-Odegaard, S.; Heyn, R. H.; Tilset, M.; Laurenczy, G. ACS Catal. 
2017, 7, 5023. 
(30) Pintus, A.; Bochmann, M. RSC Adv. 2018, 8, 2795. 
(31) Chambrier, I.; Rosca, D. A.; Fernandez-Cestau, J.; Hughes, D. L.; Budzelaar, P. H. 
M.; Bochmann, M. Organometallics 2017, 36, 1358. 
(32) Rocchigiani, L.; Fernandez-Cestau, J.; Agonigi, G.; Chambrier, I.; Budzelaar, P. H. 
M.; Bochmann, M. Angew. Chem.-Int. Ed. 2017, 56, 13861. 
 
 12 
 
 
 
 
 
Chapter Two: 
 
Synthesis of gold(III) thiolates and their 
photoluminescent properties 
 
 
 
 
 
 
 
 
 
 
 
 
 
Part of this chapter has been published as: Currie, L.; Fernandez-Cestau, J.; 
Rocchigiani, L.; Bertrand, B.; Lancaster, S. J.; Hughes, D. L.; Duckworth, H.; Jones, 
S. T. E.; Credgington, D.; Penfold, T. J.; Bochmann, M. Chem.-Eur. J. 2017, 23, 105 
 
Chapter Two 
 
13 
 
Introduction 
2.1 Photoluminescent metal complexes 
Organometallic complexes are increasingly being used in OLEDs and bioimaging due to their 
photophysical properties.1 Two of the most commonly used metal complexes are six 
coordinate iridium(III)2 and four coordinate platinum(II)3 complexes due to their broad and 
easily tuned emission properties; accessed by using different ligands and synthetic alterations. 
Likewise, many gold(III) complexes are photoluminescent.  
2.1.1 Gold(III) photoluminescence 
The luminescent properties of gold(III) complexes are influenced by several factors. One 
important aspect is the large spin-orbit coupling of gold and other third row transition metals 
that allows population of triplet states.4 The transition between the S1 and T1 states are formally 
spin-forbidden, however spin-orbit coupling enables intersystem crossing and population of 
the T1 state. Subsequent phosphorescence from the T1 to the S0 ground state is also formally 
forbidden but the spin-orbit coupling again enables this transition. These transitions can be 
seen in the Jablonski diagram (Figure 2.1). Phosphorescent emission from the T1 state results 
in a Stokes shift (the difference between the absorption and emission wavelength) and is also 
characterised by longer lifetimes.  
 
Figure 2.1. Jablonski diagram, illustrating emissive and non-emissive pathways. 
There are several non-radiative pathways shown on the Jablonski diagram (Figure 2.1) 
including internal conversion and nonradiative vibrational relaxations. These occur because 
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upon excitation the electron moves to a higher energy level in the same molecular geometry 
as the ground state, this is not usually the lowest vibrational level of that electronic state. The 
molecule can lose energy through vibrational relaxation from a higher vibrational energy level 
(νn) to the lowest vibrational energy level of that electronic state (ν0). If there is overlap of the 
S2,ν0 with a higher vibrational state of S1 there can be internal conversion, the transfer of an 
electron from Sn+1 to Sn. External conversion is also possible, where the molecule loses energy 
to the environment such as solvent.  
In addition, the use of cyclometallating ligands, especially those containing an Au–C bond 
provide both thermodynamic and kinetic stability.4 Gold(III) photoluminescent complexes are 
dominated by those bearing bidentate and tridentate ligands. The more rigid tridentate ligands 
prevent the d8 square planar complexes from undergoing molecular distortions from D4h to 
D2d, which can enable nonradiative decay.
5 
Finally, the ligand type has a large effect on the photoluminescence properties.5d This can be 
illustrated by the (N^N)AuCl2 complex that was only emissive as a solid (298 K), however 
upon substitution of the chlorides for mesityl groups the luminescence was enhanced with 
emission observed in solution at room temperature (Figure 2.2).6 The ligands have different 
σ-donating properties; chloride is a poor σ-donor whereas mesityl is a strong σ-donor. In the 
dichloride complex nonradiative relaxation was thought to occur from d-d states that were 
close in energy but lower than the intraligand (IL) or metal-to-ligand charge transfer (MLCT) 
states. However, a strongly σ-donating ligand such as mesityl raised the energy of the d-d 
states therefore facilitating radiative emission from a IL or MLCT state.   
 
Figure 2.2. The effect of the ligand field strength on the d-d energy levels: left) weak field 
ligand; right) strong field ligand. IL = intra ligand and MLCT = metal-to-ligand charge 
transfer.5d 
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2.1.2 Photoluminescent C^N^C pincer gold(III) complexes  
C^N^C pincer ligands have been used to stabilise gold(III) complexes, functionalisation at the 
fourth position allows synthesis of photoluminescent complexes. Many different σ-donors 
have been investigated including N-heterocyclic carbenes (NHC), phosphines, aryls and 
alkenes, which are used to raise the d-d orbital energy and to minimise nonradiative pathways.  
(C^N^C)Au–Cl (C^N^C = 2,6-diphenyl-pyridine dianion) was nonemissive at room 
temperature and only weakly emissive at 77 K.  However, Che et al. demonstrated that C^N^C 
gold(III) phosphine complexes synthesised through chloride substitution had enhanced 
photoluminescent properties (Figure 2.3).7 Depending on the phosphine used, both monomer 
and binuclear species were synthesised. These gold(III) phosphines were luminescent only at 
77 K (λmax = 484 nm) and had a structured emission band, which is characteristic of C=C and 
C=N vibrations of the C^N^C pincer ligand and is often described as vibronic progression. 
The emission was assigned a metal perturbed 3IL transition based on the C^N^C pincer ligand.  
The binuclear species containing a CH2 linker between two phosphines was red-shifted (λmax 
= 524 nm) compared to the mononuclear complex and it was proposed that emission takes 
place from an eximer where the C^N^C ligands interact in a π-π manner.  
Altering the σ-donating ligand to a NHC gives C^N^C gold(III) complexes that are emissive 
in solution at 298 K (Figure 2.3).8 The wide range of NHCs available has facilitated the 
synthesis of many gold(III) NHC complexes including monomeric species with imidazole and 
benzimidazole based NHC’s and binuclear species. The monomeric and dimeric species had 
λmax > 480 nm with vibronic-structured emission bands that do not shift significantly with 
temperature (> 10 nm). The nature of the NHC has little effect of the emission which is 
proposed to occur from 3IL of the C^N^C cyclometallating ligand. 
 
Figure 2.3. The C^N^C scaffold used with chloride, NHC and phosphine ligands.  
Yam et al. used σ-donating alkynyl ligands to give highly luminescent complexes 
[(C^N^C)Au–C≡C–R] (Figure 2.4).9 The emission spectra of these complexes were 
dominated by a sharp, structured emission band (λmax > 470 nm) at ambient temperatures in 
solution, which showed little sensitivity to alkyne substituents. Emission lifetimes were on the 
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microsecond scale, indicative of a triplet-based emission. The transition was assigned to a 3IL 
metal perturbed π*→π transition based on the C^N^C ligand.  
Interestingly, complexes bearing amino substituted alkynes (C≡C–C6H4–NR2-p) were found 
to have structureless emission bands that are significantly red-shifted (by 4500 cm-1) compared 
to the other alkynyl compounds. The lack of fine structure and the red-shift of the emission 
indicates a different emission pathway. The different emission was proposed to result from the 
amino groups increasing the energy of the π orbital of the alkyne ligand resulting in a 3LLCT 
from the electron-rich aminophenylacetylide ligand to the 2,6-diphenylpyridine ligand 
(3[π(C≡C–C6H4–NR2-p) → π*(C^N^C)]).  
 
Figure 2.4. Photoemissive gold(III) complexes with a 2,6-diphenylpyridine pincer system 
and alkyne ligands.  
Modulating the emission was also achieved through altering the C^N^C ligand scaffold.10 A 
series of C^N^C ligands with a range of different functional groups and extended aryl systems 
were investigated in gold(III) systems that also contain an alkynyl ligand at the fourth position. 
These complexes were emissive, with a range of emissions observed from λmax = 476 nm to 
660 nm in solution at 298 K. The emission was proposed to occur from intraligand 3[π–π*] 
excited states. Again, the emission could be red-shifted if an amino substituted alkyne was 
used and was assigned as a 3LLCT. The emission in a PMMA matrix resembled that of a 
dichloromethane solution.  
The tendency of amino substituted alkynyl complexes to give red emissive complexes led to 
the development of a complex using a C≡C–C6H4N(C6H5)2-p alkyne.
11 In this case, a red 
structureless emission band was assigned as a LLCT 3π[C≡C–C6H4N(C6H5)2-p] → 
π*(C^N^C) transition. When incorporated into an OLED device the emission shift was shown 
to depend on the concentration of complexes, with a red shift of 150 nm observed at high 
concentrations.  
Alkynyl ligands have also been used as linkers in more complex dendrimer systems which can 
be incorporated into OLED devices based on carbazoles,12 extended aryl systems13 and other 
delocalised systems.14 
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Further derivatives of the C^N^C gold(III) pincer system have been used in combination with 
an aryl functionality to produce emissive complexes suitable for used in OLEDs.15 Tuning of 
the emission was possible by altering the functional group attached to the arene in a similar 
fashion to an alkynyl linker. 
Bochmann et al. demonstrated that gold(III) complexes supported by C^N^C systems 
containing a central pyrazine instead of a pyridine had a more pronounced emissive properties 
(Figure 2.5).16 1, with a weak σ-donating chloride, is strongly emissive at 77 K in the solid 
state (λmax = 560 nm) with a structured emission that is redshifted from the weakly emissive 
pyridine system by 40-50 nm. The redshift occurs because the π-π* energy gap in pyrazine is 
0.95 eV less than in pyridine.16-17 Substitution of the chloride for strongly σ-donating ligands 
such as cyanide or acetylide (Figure 2.5), gave complexes with enhanced photoluminescent 
properties. Additionally, gold(III) species with weaker σ-donors such as a pyrazolate, were 
emissive in solution at ambient temperatures. All the complexes emit in the yellow to green 
region, with the emission spectra showing vibronic progression. The transition was assigned 
to a metal perturbed 3IL transition centred on the 2,6-diphenylpyrazine ligand, which was 
further supported by DFT calculations. Modulation of the emission properties of this system 
was also achieved through protonation and alkylation of the pyrazine nitrogen (blue shifts 
emission) or addition of metal ions (a slight red shift of emission). A red shift of the emission 
was observed on cooling from 298 K to 77 K, this temperature dependence of the emission 
led to the identification of a thermally activated delayed fluoresce (TADF) process. TADF 
occurs when the T1 and S1 excited states are close in energy allowing repopulation of the S1 
from the T1 at higher temperatures, where the emissive pathway is an S1 to S0 transition. 
 
Figure 2.5. Photoemissive complexes based on the gold(III) 2,6-diphenylpyrazine system. 
Subsequent to the work carried out in this chapter, Bochmann et al. investigated the emissive 
properties for pyridine and pyrazine based C^N^C gold(III) complexes with alkyl ligands 
(Figure 2.6).18 Substitution of position R with different alkyl groups gave a series of complexes 
where the emission is dependent on the pKa of the alkyl ligand precursor. A blue shift of the 
emission was observed in both ligand systems for alkyl groups with stronger electron donors, 
allowing fine tuning of the emission properties. Again, there was a red shift of complexes 
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bearing a pyrazine-based pincer ligand compared to the corresponding pyridine complexes. 
The emissions were assigned to 3IL(C^N^C)/3ILCT ((C6H4
tBu) → pz/py*) transitions. 
 
Figure 2.6. CNC gold(III) alkyl complexes. 
2.2 Gold(III) thiolates 
Traditionally thiolate ligands have been associated with gold(I) complexes and there is a 
plethora of examples. There are comparatively fewer examples for gold(III). Gold(I) and 
gold(III) are often described as behaving as soft or hard Lewis acids respectively, using this 
categorisation it may be expected that thiols would make more stable complexes with gold(I) 
than with gold(III). Examples of gold(III) thiolate compounds include the tetrathiolate 
complexes such as [Au(SAr)4]
- or [X2Au(µ-SR)2]2.
19 These complexes have been used as 
molecular wires and in the study of redox behaviour of disulfides.  
Gold(III) thiolate complexes supported by cyclometallating ligands have been predominantly 
used in studies into biological activity (Figure 2.7).20 There is only one study into 
photoluminescence that included a gold(III) thiolate supported by a C^N^C pincer, however 
it was described as non-emissive (left in Figure 2.7).7 In comparison, the photoluminescent 
properties of gold(I) thiolates have been extensively studied.21 
 
Figure 2.7. Cyclometallated gold(III) thiolates. 
2.3 Objectives 
The gold(III) complexes above show the nature of the pincer system and the substituents used 
have a large effect on the complexes photoluminescent properties. The pyrazine based 
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gold(III) complexes are of particular interest because were shown to be photoluminescent with 
weak σ-donating substituents. This work aims to investigate the use of thiolates, as weak σ-
donating ligands, with pyrazine gold(III) complexes. There are significantly fewer of gold(III) 
thiolates compared to the plethora of gold(I) thiolates, with none of the previous gold(III) 
thiolate reported as photoluminescent. This work investigates the synthesis and 
photoluminescence properties of a series gold(III) thiolates with different thiolates and pincer 
ligands to investigate their effects on the photoluminescence properties. For these 
investigations, complexes 1 and 2 were used as the starting materials (Figure 2.8).  
 
Figure 2.8. Gold(III) chlorides supported by CNC pincer ligands 
Results and Discussion 
2.4 Synthesis of gold(III) thiolates 
A series of gold(III) thiolates were synthesised from 1 through substitution of a chloride for a 
thiolate ligand. Complexes 3–8 were synthesised using the same method: 1, the corresponding 
thiol and potassium carbonate were dissolved in acetone and stirred at room temperature for 
3 hours (Scheme 2.1). The complexes were isolated as solids in yields 35 - 99 %. Longer 
reaction times of 18 hours were required for 7 and 8, there were further purification steps and 
mechanical loss resulting in the lower corresponding yields. 
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Scheme 2.1. Synthesis of gold(III) thiolates 3 – 8. 
A slightly altered method was required for the synthesis of 9 and 10, due to the air sensitivity 
of thiols. Therefore the reactions were carried out under inert conditions and using dried and 
degassed toluene (Scheme 2.2). The reaction time remained 3 hours for these complexes, 
which were isolated as air-stable solids in 83 % (9) and 80 % (10) yield. 
 
Scheme 2.2. Synthesis of gold(III) thiolates 9 and 10 under inert conditions. 
The synthesis of complex 11, with the pyridine based pincer ligand, used the first method (2, 
2-naphthalenethiol and potassium carbonate) but required a longer reaction time of 18 hours 
(Scheme 2.3). 11 was isolated as a solid in a 67 % yield. 
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Scheme 2.3. Synthesis of 11 using the pyridine ligand system. 
The synthesis of these complexes required mild reaction conditions, using a weak base and 
room temperature. All these C^N^C gold(III) thiolate complexes were air and moisture stable. 
An additional method was developed for the synthesis of complexes that required longer 
reaction times. This method used a stronger base, potassium tert-butoxide, which required the 
use of inert conditions and dried and degassed solvent (Scheme 2.4). This reduced the reaction 
times for 7 and 8 from 18 hours to 6 hours. 7 and 8 were again isolated as solids in 84 % and 
73 % yield respectively. 
 
Scheme 2.4. Synthesis of 7 and 8 using a different method. 
The complexes were characterised by 1H and 13C NMR spectroscopy and elemental analysis. 
Across the series of complexes, the 1H NMR spectra showed similar shifts for the pincer 
protons. The H8 proton environment (Figure 2.9) showed a dependence on the nature of the 
thiolate, for the alkyl thiol 8 the H8 shifted ~ 1.0 ppm from the average of the other complexes, 
with the alkyl thiol resulting in deshielding compared to the more shielding aryl thiols.  
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Figure 2.9. Numbering scheme used in NMR assignments. 
2.4.1 Solid state structures 
It was possible to obtain crystals of several of the complexes that were suitable for x-ray 
analysis.  
In the crystallisation of 3 there were two different types of crystal formed, red plates (Figure 
2.10) and yellow blocks (Figure 2.11). The red plates contained two independent molecules in 
the unit cell. Both crystal forms showed the expected connectivity of 3. The main difference 
in the molecular geometries between the two crystal forms are the torsion angles between the 
Au-S-C and S-aryl planes, which are 50.1(4) and 58.2(3) ° for the two molecules in the red 
crystal and 94.3(6) ° in the yellow crystal. Neither crystal structure showed the presence of 
solvent molecules, therefore these two structures are polymorphs. Interestingly, under UV 
irradiation only the red crystals were emissive.  
 
Figure 2.10. Structure of 3 in the red polymorph. The unit cell contained two independent 
molecules. Selected bond distances (Å) and angles (º): Au1-S1 2.273(1), Au2-S2 2.277(1), 
Au1-N11 2.006(3), Au2-N21 2.017(4), Au1-C122 2.086(4), Au1-C162 2.091(4), Au2-C222 
2.083(4), N11-Au1-S1 175.66(8), N21-Au2-S2 172.2(1), C122-Au1-N11 80.5(1), C162-
Au1-N11 80.6(1), C122-Au1-S1 95.46(9), C162-Au1-S1 103.38(9), C222-Au2-N21 80.6(1), 
C262-Au2-N21 80.1(1), C222-Au2-S2 91.8(1), C262-Au2-S2 107.49(9), Au1-S1-C171 
110.2(2), Au2-S2-C271 110.9(1), torsion Au1-S1-C171-C172 50.1(4), torsion Au2-S2-C271-
C272 58.2(3). 
N21 
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Figure 2.11. Structure of 3 in the yellow polymorph. Selected bond distances (Å) and angles 
(º): Au1-S7 2.276(2), Au1-N1 2.022(6), Au1-C22 2.088(7), Au1-C62 2.080(7), N1-Au1-S7 
170.94(18), C22-Au1-N1 81.3(3), C62-Au1-N1 79.8(3), C22-Au1-S7 89.6(2), C62-Au1-S7 
109.2(2), Au1-S7-C71 116.6(3), torsion Au1-S7-C71-C72 94.3(6). 
Complex 5 also crystallised as a mixture of red and yellow crystals, similar to the 
crystallisation of 3. The structures of the different polymorphs are shown in Figure 2.12. The 
torsion angles between the gold plane and the S-aryl plane were similar 52.3(5)° for the red 
form and 56.5(3)8° for the yellow form.  
 
Figure 2.12. Structure of 5 left) in the red polymorph. Selected bond distances (Å) and 
angles (º): Au1-S1 2.263(2), Au1-N1 2.006(6), Au1-C6 2.069(6), Au1-C16 2.080(6), N1-
Au1-S1 174.3(2), C6-Au1-N1 80.6(3), C16-Au1-N1 80.1(2), C6-Au1-S1 93.8(2), C16-Au1-
S1 105.6(2), Au1-S1-C25 109.5(2), torsion Au1-S1-C25-C34 52.3(5); right) yellow 
polymorph Au1-S1 2.2837(8), Au1-N1 2.014(3), Au1-C6 2.095(3), Au1-C16 2.086(3), N1-
Au1-S1 174.05(7), C6-Au1-N1 80.7(1), C16-Au1-N1 80.2(1), C6-Au1-S1 104.68(8), C16-
Au1-S1 94.53(8), Au1-S1-C25 109.8(1), torsion Au1-S1-C25-C34 56.5(3). 
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The difference in emission between the two polymorphs of 5 (2-Np) can be clearly seen in 
Figure 2.13 where a mixture of the two crystalline forms are shown under white light and UV 
light. Under UV light the red polymorph is emissive whereas the yellow polymorph is not.  
 
Figure 2.13. Different emission of two polymorphs of 5 under white or UV light at 298 K. 
All other complexes crystallised as only one form. The structures of 4 and 7 (Figure 2.14 left 
and right respectively) were obtained and showed the expected connectivity and coordination 
environment. The crystals analysed were both yellow.  
  
Figure 2.14. left) structure of 4. Selected bond distances (Å) and angles (º): Au1-S1 
2.289(1), Au1-N1 2.009(4), Au1-C6 2.104(4), Au1-C16 2.090(4), N1-Au1-S1 174.0(1), C6-
Au1-N1 80.2(2), C16-Au1-N1 80.7(2), C6-Au1-S1 104.9(1), C16-Au1-S1 94.1(1), Au1-S1-
C25 109.4(1), torsion Au1-S1-C25-N3 49.8(4). right) structure of 7 Au1-S1 2.2785(9), Au1-
N1 2.009(2), Au1-C6 2.097(3), Au1-C16 2.084(3), N1-Au1-S1 173.88(7), C6-Au1-N1 
80.2(1), C16-Au1-N1 80.7(1), C6-Au1-S1 105.87(8), C16-Au1-S1 93.19(8), Au1-S1-C25 
111.1(1), torsion Au1-S1-C25-N3 35.2(3). 
The structure of 9 again showed the expected connectivity (left, Figure 2.15). Complex 11 was 
the only compound that crystallised with a solvent molecule, dichloromethane (right, Figure 
2.15). Both crystals were yellow.  
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Figure 2.15. left) structure of 9. Selected bond distances (Å) and angles (º): Au1-S1 
2.2781(9), Au1-N1 2.017(2), Au1-C6 2.090(4), Au1-C16 2.090(4), N1-Au1-S1 171.62(8), 
C6-Au1-N1 80.4(1), C16-Au1-N1 80.5(1), C6-Au1-S1 107.9(1), C16-Au1-S1 91.2(2), Au1-
S1-C25 112.7, torsion Au1-S1-C25-C26 77.2(3); right) structure of 11 · CH2Cl2 the CH2Cl2 
molecule is omitted for clarity. Au1-S1 2.282(2), Au1-N1 2.019(5), Au1-C7 2.078(5), Au1-
C17 2.070(5), N1-Au1-S1 170.7(1), C7-Au1-N1 80.4(2), C17-Au1-N1 80.7(2), C7-Au1-S1 
108.7(1), C17-Au1-S1 90.3(2), Au1-S1-C26 112.0(2), torsion Au1-S1-C26-C35 72.5(5). 
Across the series of gold(III) thiolate complexes there are no significant alterations in bond 
lengths. The Au-S bond ranges from 2.263(2) Å in 5 to 2.289(1) Å in 4. The N-Au-S angle 
that would be 180 ° in an ideal square-planar geometry is distorted from linearity in all 
complexes, the largest distortion was 170.7(1) ° in 11 and least the distorted is 175.7 ° in 3. 
This distortion is likely to occur from the steric repulsion between the tert-butyl substituents 
of the pincer ligand and the thiolate group. These are comparable to the previously reported 
gold(III) thiolate supported by a C^N^C ligand, with a very slightly longer Au-S bond 2.296(2) 
Å and a distorted N-Au-S angle of 176.5(1) °.7 
2.5 Photoluminescence 
The observation that the complexes appeared red was unusual as the previously reported 
gold(III) complexes supported by the pyrazine C^N^C ligand had been yellow in the absence 
of additives.16 The photoemission of these previous complexes was based on a structured 
emission at 540 nm. Therefore, the absorption and emission properties of these complexes was 
studied.  
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2.5.1 Absorption properties of 3 – 11  
The UV/Vis absorption spectra of 3 – 11 are similar to those of previously studied C^N^C 
pincer complexes. The spectra are dominated by low-energy absorption bands, with 
characteristic vibronic progression, these are attributed to a metal perturbed intraligand 
transition (1IL) in the C^N^C pincer ligand (Chapter 6, Table 6.2). The absorption maxima of 
these complexes, in the 420–440 nm region, is not in agreement with the deep-red colour of 
complexes in a dichloromethane solution observed by the naked eye. The red colour might 
instead be explained by the weak, broad absorption tail in the 470–530 nm region. 
The differences between the pyridine and pyrazine ligands can be clearly illustrated in Figure 
2.16. The low energy band of 11 (2-Np), with a pyridine based C^N^C pincer, is significantly 
blue shifted in comparison to 5 (2-Np), with the same naphthyl thiolate but instead supported 
by a pyrazine based C^N^C pincer. The shift in absorption results from lower π* level of 
pyrazine compared to pyridine.16 The tail that is tentatively assigned to the deep-red colour of 
5 (2-Np) in a dichloromethane solution can be seen above 470 nm. The absence of such a tail 
in 1 ((C^Npz^C)Au-Cl) and 11 ((C^Npy^C)Au-2-Np) is likely to correspond to their yellow 
colour. 
 
Figure 2.16. Comparison of UV/Vis absorption spectra of 1, 5 and 11 in CH2Cl2 (5 × 10
-5 
M). 
2.5.2 Emission properties of 3 – 11  
The emission properties of 3 – 11 were studied in the solid state (298 K and 77 K), in 
dichloromethane solution (298 K and 77 K) and as a 10% doped sample in PMMA 
(polymethylmethacrylate) (298 K) and are shown in Tables 6.3, 6.4 and 6.7 (Chapter 6). The 
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emissions of complexes 3 – 11 can be separated into two different groups based on either red 
or green emission.  
The green emissive complexes are 4 (py) and 6 (Quin), which both contain N-heterocyclic 
aryl thiolates, and 11, which is supported by a pyridine based C^N^C ligand. 4 and 6 are 
weakly to non-emissive at room temperature in the solid state, but cooling to 77 K green 
emission is observed at 534 and 532 nm with a vibronic structured emission band. In a 
dichloromethane solution and a 10% doped PMMA matrix at 298 K a weak green emission is 
observed for both 4 and 6. The green emission (λmax = 540 nm) showed no concentration 
dependence between 10-4 and 10-2 M in a dichloromethane solution at 298 K. This is similar 
to the emission of the previously reported gold(III) complexes with a C^Npz^C ligand, 
therefore is tentatively assigned to a 3IL transition. Similar behaviour is observed for 11, which 
is emissive only at 77 K, but is blue shifted from 4 and 6. The emission assigned to a 
3IL(C^Npy^C) band showing a typical structured profile at 517 nm, similar previously 
observed emissive gold(III) complexes with this ligand. 
The red emissive complexes (3 (Ph), 5 (2-Np), 8 (Ad), 9 (tBu) and 10 (1-Np)) are gold(III) 
thiolates supported by the pyrazine-based C^N^C pincer system. These complexes have a 
range of thiolate functionalities including: aryls, substituted aryls and alkyl groups, which 
significantly do not contain any heteroatoms. They are emissive at room temperature in the 
solid state, with broad unstructured low-energy bands observed above 600 nm. Upon cooling 
to 77 K the emission spectra of 5 (2-Np) and 8 (Ad) remain unchanged, however there is a 
blue shift observed for 3 (Ph), 9 (tBu) and 10 (1-Np). In a 10 % doped PMMA matrix at 298 
K there is red emission (λmax > 600 nm) observed for 3, 5, 8, 9 and 10. In a dichloromethane 
solution 5 (Np-2), 8 (Ad), 9 (tBu) and 10 (Np-1) are red emissive with λmax > 670 nm, upon 
cooling to 77 K there is a blue shift the emission, but the emission remains in the red region 
with λmax > 600 nm. In the emission bands of several complexes in frozen conditions (at 77 K) 
there is the appearance of a shoulder around 540 nm, this may indicate a mixed emission based 
on both green and red emissive pathways.   
In addition, the excitation bands for these complexes differ from the absorption spectra. This 
can be exemplified in the case of 5 (2-Np), where the emission at 298 K is associated with a 
sharp low-energy excitation band at λex = 540 nm (top Figure 2.17). This indicates that the 
low-energy tail in the UV/Vis spectra is associated with the red emission. This is different 
from the excitation of 11 (py 2-Np), which more closely represents the previously observed 
absorption spectra (Figure 2.16: UV/Vis spectra; Figure 2.17 shows excitation and emission 
bands). 
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Figure 2.17. Top complex 5 (CH2Cl2, 10
-4 M): emission at 298 K (red solid line), emission 
at 77 K (black line), excitation at 298 K (red dotted line); Bottom complex 11 (CH2Cl2, 10
-4 
M): emission at 77 K (green solid line) excitation at 77 K (green dotted line). 
The two crystal polymorphs observed for 5 (2-Np) in Section 2.3.1 appeared to show different 
emission properties under a UV light. Microcrystalline samples of purely red crystals 
(obtained through slow evaporation of a saturated dichloromethane solution of 5) or purely 
yellow crystals (obtained through slow evaporation a solution of 5 in petroleum ether) were 
prepared for photoluminescence studies. At 298 K, the red crystals were emissive with λmax = 
650 nm, whereas the yellow crystal were not emissive. Upon cooling to 77 K the red crystals 
were still red emissive (λmax = 653 nm) and the yellow crystals were also emissive with a λmax 
= 539 nm, with a structured green emission band. This reveals that the same complex has two 
different emission pathways, which are dependent on sample treatment.  
The lifetimes of all the complexes in PMMA are the result of two different components; a 
prompt emission with a short lifetime of 25–50 ns (5 %), which is assigned to photoexcited 
singlet states, and more dominant delayed component in the range of 0.3 µs (95 %). This 
longer lifetime in the µs range is indicative of a triplet based emission.  
2.5.3 Extending the photoluminescent studies 
The two different emissions observed for these complexes were unexpected. Therefore, to gain 
further insight into the potential origins of the different emission pathways and, in some cases, 
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the dual emission pathways the dependence on concentration, solvent and temperature were 
probed.  
The emission of 5 (2-Np) at 77 K is concentration dependant because upon decreasing its 
concentration in a dichloromethane solution from 10-2 M to 10-4 M there is a slight blue shift 
in the emission band and the appearance of a shoulder (red and black lines, Figure 2.18). 
Further decreasing the concentration to 10-5 M results in a predominantly green emission band 
(green line, Figure 2.18). The dominance of the red emission at high concentrations may 
indicate that the transition is dependent on the formation of aggregates. This is not observed 
at 298 K because at this temperature the green emission is very weak for all complexes, 
therefore the red emission will dominate. There are examples of gold(I) and platinum(II) 
compounds where the photoemission is linked to, and in some cases modulated by, metal-
metal aggregation, however, there are no such interactions previously reported for gold(III) 
complexes.4, 22  
 
Figure 2.18. Normalized photoemission spectra of 5 (2-Np) in CH2Cl2 at different 
concentrations at 77 K. 
The concentration dependence of the UV/vis absorption spectra were also probed at higher 
concentrations of 5 (2-Np). At higher concentrations the tail observed in the UV/Vis spectra 
increases in intensity, up to 10-3 M. At even higher concentrations absorption is also observed 
at longer wavelengths with the tail extending to 550 nm (Figure 2.19). The absorption at this 
wavelength matches the region where a band is observed in the excitation spectra in Figure 
2.16. This may also indicate the presence of aggregates as an important factor on the emission 
pathway because of the appearance of absorption at 550 nm observed only at high 
concentrations.  
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Figure 2.19. UV-Vis spectra of 5 (2-Np) in CH2Cl2 at different concentrations 298 K. 
Following these observations, which potentially indicate the formation of aggregates influence 
the emission pathway, solvent effects were investigated. Different solvents were used to see if 
the solvent intermolecular interactions compete or influence aggregation formation. At 298 K, 
the emission of 5 (2-Np) in a dichloromethane solution is red (λmax > 680 nm), this is slightly 
blue shifted in a Me-THF solution (λmax > 660 nm) and further shifted in a toluene solution 
(λmax > 640 nm). Overall the solvent effect is minimal and only red emission is observed, 
therefore in these conditions the solvent is not altering the emission pathway.  
Upon cooling to 77 K, green emission is observed for 5 (2-Np) in Me-THF (λmax = 520 nm), 
whereas the solutions of 5 (2-Np) in dichloromethane and toluene remain red emissive. 
Therefore, under these conditions the solvent is affecting the emission pathway. The potential 
solvent effects upon the emission of 9 (tBu) were also investigated; at 298 K in 
dichloromethane (10-4 and 10-2 M) the solution is red emissive, upon cooling to 77 K a mix of 
red and green emission is observed at 10-4 M and red emission at 10-2 M. In a Me-THF solution 
there is no emission at 10-4 M and red emission only observed in a 10-2 M solution. Upon 
cooling to 77 K only green emission is observed at both concentrations. In this case there is 
both an effect of the solvent and concentration indicating that the molecular environment plays 
an important role.  
This set of complexes have shown two emission pathways either red or green. Accessing one 
emission pathway has been possible through crystallisation of pure microcrystalline solids 
(2.5.2) or through solution treatment such as at low temperatures. Successive freeze thaw 
cycles also facilitated access of a single emission pathway. Freezing a solution of 9 (tBu) (10-
2 M) in dichloromethane to 77 K produces a red emissive sample (red line, Figure 2.20). 
However, upon warming to just above the melting point of the solvent and refreezing leads to 
a mixed emission, which appears orange to the naked eye and the emission band clearly shows 
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the overlapped signals of the red and green emission (blue line, Figure 2.20). Repeating this 
cycle several times generates a predominantly structured green emission, assigned to 
3IL(C^Npz^C) transition (green line, Figure 2.20). Upon warming to room temperature, the 
expected red emission is regenerated. This cycle can be repeated with no degradation of the 
complex. This is further evidence that the emission pathway may be dependent on 
intermolecular interactions as there is no change to the complex during the cycle. The 
successive freeze thaw cycles may alter the intermolecular interactions or geometry favoured 
by the complex. 
 
Figure 2.20. The changing emission spectra of 9 (tBu) (10-2 M); Red line: upon freezing to 
77 K; Blue line: thawing to melting point and refreezing at 77 K; Green line; 4 successive 
freeze thaw cycles and refrozen at 77 K. 
Concentration appears to influence the emission pathway, with red emission dominating at 
high concentrations. This may indicate that aggregation of complexes is an integral 
requirement in this emission mode. Doping a PMMA matrix with varying concentrations of 5 
(2-napthyl thiolate, a predominantly red emissive gold(III) thiolate) and 6 (quinoline thiolate, 
a green emissive gold(III) thiolate) showed that the effect concentration had on different the 
emission modes. Upon increasing the concentration of green emitting complex 6 in a PMMA 
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matrix the photoluminescence quantum yield (PLQY) decreases (left Figure 2.21). In contrast 
increasing concentrations of 5 increases the PLQY (right Figure 2.21). The PLQY of 5 
increases from ΦPL < 0.01 at 1 wt% loading to ΦPL = 0.11 at 50 wt% loading. This is also 
accompanied by a slight red shift with increased loadings. The decrease in the PLQY for 6 
resembles the concentration-dependant quenching which has previously been observed for 
Ir(ppy)3.
23 The opposing trend in the PLQY of 5 indicates aggregation-induced 
photoluminescence enhancement.24 The doping of different polymer matrices (polystyrene 
and polyvinyl carbazole (PVK)) resulted in the same trends in emission for 5 and 6.  
   
Figure 2.21. The effect of doping concentrations of 5 and 6 in a PMMA matrix upon the 
quantum yields (298 K). 
2.6 Crystal packing  
The difference in emission between the two polymorphs of 5 (2-Np) can be clearly seen in 
Figure 2.13 where a mixture of the two crystalline forms are shown under white light and UV 
light. Under UV light the red polymorph is emissive whereas the yellow polymorph is not. 
This difference was also observed in microcrystalline samples of 5 (Section 2.5.2). Due to the 
lack of compositional variation, the dramatic difference in their photophysical properties may 
result from different molecular interactions in the solid state.  
Closer analysis of the crystal packing of the two polymorphs for both 3 (Ph) and 5 (2-Np) 
shows similarities between two red polymorphs. The red polymorph of 3 is made up of dimers 
formed by a head-to-head π-interaction with pyrazine rings of neighbouring molecules 
adopting a “parallel offset” orientation (Figure 2.22). The distance between the planes of the 
pincer ligands in these dimers is relatively short at 3.306 Å. 
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Figure 2.22. The packing of the red polymorph of 3. 
In contrast, the yellow polymorph of 3 forms one-dimensional stacks where the pyrazine ring 
of one molecule is superimposed on the Au-S bond of its nearest neighbour (Figure 2.23). The 
o-phenyl protons of the thiophenolate ligand interacts with two pyrazine-N atoms of its 
neighbour molecules in the stack in a H···N···H arrangement (a, Figure 2.23). The separation 
between molecular planes is 3.472 Å, this is larger than in the red polymorph.  
 
Figure 2.23. The packing of the yellow polymorph of 3. 
The red polymorph of 5 shows the same type of pyrazine-pyrazine π interactions in a parallel 
offset orientation as seen in the red polymorph of 3 (Figure 2.24). In the π-stacked dimers 
there is again a short intermolecular distance between the planes of the pincer ligands of 3.235 
Å.  
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Figure 2.24. The packing of the red polymorph of 5. 
The packing of the yellow polymorph of 5 differs from the yellow polymorph of 3 as it is 
arranged in head-to-tail rods (Figure 2.25). This is dominated by the S⸱⸱⸱π interactions between 
the thiolate sulfur and the pyrazine ring of the neighbouring molecule. The distances between 
the planes of the pincer ligands is longer than in the corresponding red polymorph at 3.482 Å.  
 
Figure 2.25. The packing of the yellow polymorph of 5. 
The other crystals obtained for complexes 4, 7 and 9 were yellow and only one polymorph of 
each complex was obtained. The packing of 4 is dominated by the formation of N⸱⸱⸱H 
interactions between the nitrogen of the thiolate and C-H bonds on the pincer ligand (Figure 
2.26). This is likely to the dominant intermolecular interaction for both 4 and 6, therefore the 
absence of heteroatoms in the red emissive complexes may enable different intermolecular 
interactions as they are not dominated by N⸱⸱⸱H interactions. The inter-plane distance of 3.410 
Å is a similar distance to that observed in the yellow polymorphs of 3 and 5.  
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Figure 2.26. The crystal packing of 4. 
The packing of 9 was also through the formation of dimers through parallel offset π–π 
interactions, but here the pyrazine ring of one molecule is aligned with one of the Au-C bonds 
of a second molecule (Figure 2.27). The inter-plane distances are longer at 3.469 Å, which is 
a similar distance to the yellow polymorphs of 3 and 5 and the packing of 4.  
 
Figure 2.27. The crystal packing of 9. 
In the packing of 11 the phenyl pyridine moieties of neighbouring molecules align with an 
inter-planar distance is 3.349 Å (Figure 2.28). There is also one molecule of dichloromethane 
that cocrystallised. 
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Figure 2.28. The crystal packing of 11. 
The red polymorphs of 3 (Ph) and 5 (2-Np) are both formed of dimers based on pyrazine-
pyrazine π- interactions with short inter-planar distances of 3.306 Å and 3.235 Å. These are 
not observed in the yellow polymorphs of the corresponding molecule or in the packing of the 
yellow crystals 4, 9 and 11. The yellow polymorphs are based in the pyrazine ring interacting 
either with an Au-S bond or a phenyl ring of a neighbouring molecule. All the yellow crystals 
had larger inter-planar distances. Therefore, the formation of pyrazine-pyrazine π-interactions 
may be responsible for the red emission, which may occur in the formation of aggregates in 
solution.  
2.7 Diffusion NMR 
The experiments in this section were carried out in conjunction with Dr Luca Rocchigiani. 
NMR spectroscopy was used to investigate whether the intermolecular interactions observed 
in the solid state, that are proposed to influence the photoluminescent properties, could also 
be observed in solution. The red emission is possibly linked to close π-π interactions in the 
solid state, however the red emission is also observed in solution which could indicate the 
persistence of intermolecular π-interactions. Two separate NMR spectroscopy methods were 
used investigate the potential of aggregation in solution of complexes 1 (Cl), 3 (Ph) and 5 (2-
Np).  
The first method studied the concentration dependence of the chemical shifts signals in the 1H 
NMR spectra. The concentration was gradually increased from a 10-4 M solution to a saturated 
solution with a concentration greater that 10-2 M (the concentration used in photoluminescent 
studies). Over this gradient the greatest change in chemical shift (δ) was observed for H2 and 
H5, which are hydrogen atoms on or next to the pyrazine ring (Figure 2.9 for NMR assignment 
and Figure 2.29 for the chemical shifts at different concentrations). This correlates with the 
head-to-head π-stacking interactions in the red polymorphs and therefore could indicate that 
this interaction also persists in solution. The observed shift of H2 and H5 is not large, which 
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indicates that only a proportion of the molecules are interacting in this π-π manner in solution. 
There was very little change in the chemical shifts of signals corresponding to the thiolate 
ligand with increasing concentrations; this is also agreement with the solid-state environment 
where the close intermolecular interactions are between the planes of the pincer ligands.  
 
Figure 2.29. Variation in proton shifts with increasing concentration of: left) 3; right) 5. 
Using a monomer-dimer equilibrium model it is possible to quantify the proportion of 
dimerization, assuming the observed chemical shift (δ) is an average between those of the 
monomer and dimer. This is shown by Equation 2.1 where fm and fd are the molar fractions of 
monomers and dimers, M and D are the limit chemical shift values of monomer and dimer, 
respectively. This can be manipulated to give Equation 2.2 where the observed chemical shift 
is a function of K, the association constant. 
 a) di =dM fM +dD fD =
[A]
[A]0
dM +
2[A2 ]
[A]0
dD
 
b) di =dM + (dD -dM )
(1+8K[A]0 )
1/2 -1
(1+8K[A]0 )
1/2 +1
 
Equation 2.1 (a) and 2.2 (b). Used to calculate monomer-dimer equilibrium. 
After fitting chemical shift versus concentration trends, the molar fractions of dimers were 
obtained using Equation 2.3. At the highest investigated solution of 5 (7.6 × 10-2 M) the 
proportion of dimers is 18 % and for 3 (5.6 × 10-2 M) the proportion of dimers is approximately 
9 %. 
fD = –1+
2[A]0
[A]0 +
1+8K[A]0 -1
4K
 
Equation 2.3. Used to calculate the molar fractions of dimers in solutions of 3 and 5. 
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The rates of diffusion of 3 and 5 were also probed using PGSE (pulse gradient spin echo) 
NMR experiments in which the dependence of the resonance intensity (I) on a constant waiting 
time and on a varied gradient strength G is described by Equation 2.4.  
ln
I
I0
= (gd 2 )Dt d -
D
3
æ
è
ç
ö
ø
÷G
2
 
Equation 2.4. The dependence of Dt upon the resonance intensity (I) and a varied gradient 
strength (G). 
Plotting ln(I/I0) against G
2 can be used to identify the self-diffusion coefficient values (Dt) 
from which the structural parameters can be approximated. The relationship between Dt and 
hydrodynamic dimensions is expressed by the modified Stokes-Einstein equation (Equation 
2.5) where k is the Boltzmann constant, T is the temperature,  is the solution viscosity, c is 
the “size factor”, which depends on the solute-solvent radius ratio and f is the “shape factor”. 
Identification of the hydrodynamic dimensions using this equation made it possible to deduce 
the change in dimensions over a range of concentrations. 
Dt =
kT
ph fc abd3
 
Equation 2.4. The modified Stokes-Einstein equation. 
Assuming a monomer/dimer equilibrium, the observed P values (𝑃 = 𝑓𝑐 √𝑎𝑏𝑑
3
= 𝑘𝑇/𝜋𝜂𝐷𝑡) 
can be treated as the average between the parameters of both monomer (PM) and dimer (PD), 
according to Equation 2.5 where xM and xD are the molar fractions of monomer and dimer at 
a given concentration. PM parameters can be derived from X-ray structures of monomers, by 
approximating their shape to ellipsoids. PD parameters have been calculated by using packing 
data derived by X ray diffraction. 
Pi = PM xM +PDxD 
Equation 2.5. The observed parameters based on a monomer/dimer equilibrium. 
The structural parameters were shown to be slightly dependent upon the concentration, 
indicating weak self-aggregation. These experiments gave 26 % dimerization for 5 at 7.6 × 
10-2 M and 21 % dimerization of 3 at 5.6 × 10-2 M. 
Both methods indicate that at low concentrations the complexes are predominantly monomers. 
This aggregation behaviour was also observed for 1, but to a lesser extent, this is probably 
because the interactions are pincer ligand based, therefore all pyrazine based complexes are 
able dimerise and form π-π interactions. The thiolates showed a higher percentage of 
Chapter Two 
 
39 
 
dimerization presumably due to the increased solubility of the naphthyl thiolate resulting in 
higher concentrations in solution and hence more dimerization.   
2.8 Theoretical calculations 
The work in this section was carried out by Helen Duckworth and Dr Tom Penfold.25 
Density function theory (DFT) and time-dependent density functional theory (TDDFT) 
calculations were performed to gain further insight into the effect of supramolecular 
interactions upon the photophysical properties of the complexes. Complex 5 (2-Np) was 
chosen as the model for these complexes because it had shown both red and yellow emission. 
Three different structural dispositions were optimised: an isolated molecule, a dimer based in 
the pyrazine-pyrazine aggregations that was observed in the red polymorph of 5 and a dimer 
based on the yellow polymorph of 5 that contained S⸱⸱⸱π interactions between a thiolate and a 
pyrazine of a neighbouring molecule. All optimised calculated structures agree with those in 
the X-ray crystal structures. This is demonstrated by both similar intramolecular distances and 
inter-plane distances between the structures based on dimers: red dimer had a calculated 
distance of 3.26 Å matching the 3.235 Å in the X-ray structure, similarly the yellow dimmer 
had a calculated distance of 3.45 Å and 3.482 Å in the X-ray structure. 
The frontier orbitals calculated for the different structures show similarities between the 
yellow dimer and the monomer. The LUMO for the yellow dimer is based on the 
cyclometallated C^N^C ligand of one molecule and the HOMO is located mainly on the 
thiolate of the same molecule (Figure 2.30). In the monomer the similar frontier orbitals are 
observed. This indicates that the emission from the yellow polymorphs are based on isolated 
molecules, not on aggregates.  
The red dimer’s frontier orbitals are different, the HOMO is again located mainly on one 
thiolate ligand, but the LUMO is delocalised over the two pyrazine ligands of neighbouring 
π-stacked molecules (Figure 2.30). This bimolecular molecular orbital is likely to be 
responsible for the intense unstructured red photoemission.  
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Figure 2.30. The HOMO and LUMO frontier orbitals for 5 in left) the yellow dimer based 
on S⸱⸱⸱π interactions; right) red dimer based on pyrazine-pyrazine interactions. 
The calculated emission from the optimised triplet geometry of the red dimer of 5 is 704 nm 
in agreement with the red emission observed. However, for the yellow dimer and the monomer 
of 5 the, the transition energy is very low (>850) so the non-radiative emission rate will be 
larger. Calculations suggest that the emission observed arises from a transition from the second 
triplet state (T2), which gives a calculated emission of 585 nm for the yellow dimer and 573 
nm for the monomer. This gives a transition of HOMO-2→LUMO both of which are centred 
on the C^N^C cyclometallated ligand confirming the 3π-π*(C^Npz^C) transition previously 
assigned.  
The calculations support the theory that aggregation and intermolecular interactions influence 
the emission pathway. The aggregation through pyrazine-pyrazine π-π interactions induce an 
alternative emission pathway to the green, structured emission based on isolated molecules 
assigned to a 3IL(C^N^C) transition. The emission based on the aggregates is likely to be a 
charge-transfer transition from the π-stacked dimeric pyrazine moiety to a thiolate ligand 
3LLCT([(C^Npz^C)2]→SR). The observation of two components in the emission spectra in 
Chapter Two 
 
41 
 
either a frozen solution or polymer matrix, compared to a single, red-shifted, emission in 
solution can be rationalized on the basis of two emissive states of very similar energy. 
Conclusion 
Stable gold(III) thiolates can be synthesised using mild conditions, with those bearing a 
pyrazine-based pincer ligand being photoluminescent at room temperature. This emission 
occurs either via an 3IL(C^N^C) transition resulting in green structured emission or a 
3LLCT([(C^Npz^C)2]→SR) transition resulting in a red emission. The luminescence observed 
is dependent on the supramolecular arrangement both in the solid state and solution. The 
polymorphs obtained for 3 and 5 have different emission properties, both form a polymorph 
that at 298 K is red emissive and a yellow polymorph that at 298 K is nonemissive. The red 
emission is attributed to the formation of head-to-head π-stacked dimers of neighbouring 
pyrazine rings in a “parallel offset” orientation. Complexes containing a heteroatom in the 
thiolate ligand did not adopt these conformations as the predominant intermolecular 
interaction was between the heteroatom and a C-H bond of a neighbouring molecule.   
The red emission was observed in a polymer matrix, in solution and in the solid state. The 
persistence of aggregates in solution based on π-stacked dimers was observed through NMR 
studies. Theoretical calculations show that dimerization through pyrazine-pyrazine π 
interactions produced a LUMO delocalized over two molecules further supporting the 
observations that aggregation is related to the red emission. In addition, successive freeze thaw 
cycles allowed controlled alteration of the emission pathway from red to green.  
The concentration effect upon the two emission pathways was evident in PMMA matrices; 
while the green 3IL(C^N^C) emission is subject to quenching with increasing concentration, 
the photoluminescence quantum yield of the red emission increases with increasing 
concentration. To the best of our knowledge, this is first detailed study of aggregation-
enhanced emission in gold(III) chemistry. 
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Introduction 
3.1 Gold Catalysis 
The last 10-15 years have seen a tremendous growth in the use of gold complexes as 
homogeneous catalysts for a multitude of organic transformations.1 The most widespread 
application of gold(I) salts are as Lewis acids for the activation of unsaturated substrates 
(alkynes and alkenes) towards nucleophilic attack. In these systems, the key step is the 
formation of an intermediate π-complex, where the unsaturated bond is activated thus 
facilitating nucleophilic attack (Scheme 3.1). The substrate is then released through 
protodeauration, where an Au–C bond is broken and a C–H bond is formed, regenerating the 
gold(I) catalyst.2 Throughout this process there is no change in the oxidation state of the metal. 
 
Scheme 3.1. Gold(I) catalysed alkene/alkyne bond activation. 
More recently there has been interest in the development of gold catalysed C–C cross coupling 
reactions and oxidative arylations.3 These reactions are based on key steps including: oxidative 
addition, transmetallation and reductive elimination. These are commonly seen in other 
transition metal catalysed cross coupling reactions such as the Suzuki-Miyaura reaction, but 
less frequently observed for gold systems.4 Scheme 3.2 shows a prototypical system, first a 
gold(I) complex undergoes transmetallation with an arylboronic acid, forming a gold(I)-aryl 
complex.3e This species is oxidised from gold(I) to gold(III) using a strong, sacrificial 
oxidising agent such as a hypervalent iodine species. Subsequent electrophilic aromatic 
substitution forms a second Au–C bond and, finally, reductive elimination forms a C–C bond 
releasing the biaryl and regenerating the gold(I) species. Unlike the Suzuki- Miyaura reaction, 
these reactions often require the use of strong external oxidising agents, such hypervalent 
iodine, because oxidation of gold(I) to gold(III) is energetically unfavourable.3b,d,e Even 
though palladium-based catalysis remains ubiquitous due to their remarkable efficiency, the 
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capability of gold to selectively activate C–H bonds, as well as very fast reductive elimination, 
has attracted notable interest.  
 
Scheme 3.2. Gold catalysed oxidative arylation forming C-C bonds.3e 
There are considerably fewer reported C–X cross coupling reactions with gold. Nevertheless, 
an interesting example of a gold catalysed C–N and C–O cross coupling reaction enabled the 
coupling of alcohols and amines with benzoquinolines (Scheme 3.3).5 This system negates the 
use of sacrificial oxidants and highlights the importance of ligand design. Ribas et al., 
proposed the following mechanism: initial coordination of a benzoquinoline to a gold(I) 
carbene complex, which undergoes oxidative addition of a C–X bond. This is followed by 
ligand exchange by either the alcohol or amine followed by reductive elimination, in which a 
new C–Nuc bond forms and a gold(I) species is regenerated (Scheme 3.3). The system was 
found to perform much better when benzoquinolines were used instead of phenyl pyridine 
ligands. This was proposed to be due to the rigidity of the benzoquinoline blocking rotation 
that is possible in a phenyl pyridine ligand and increased the stability of the oxidative addition 
product.  
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Scheme 3.3. Catalytic C-N and C-O bond formation without external oxidant.  
To better understand these catalytic cycles and to help develop better performing systems, 
there has been a concerted effort to understand the fundamental redox steps6 and the structure 
of intermediates, particularly those of gold(III).7 A recent review by Bourissou et al. covers 
key examples of oxidative addition, transmetalation, migratory insertion and, most interesting 
for this work, reductive elimination.6  
This thesis also focuses on the sufur based ligands, which are often considered catalyst poisons 
due to the formation of strong metal sulfur bonds.8 This is one of the major problems to 
overcome in the development of catalytic C–S bond forming processes. Therefore, the 
reactivity of gold(III) complexes with thiols is of interest. 
3.2 Oxidative addition to gold(I) species 
Oxidation of gold(I) to gold(III) is difficult due to the high oxidation potentials (see Section 
1.3). It can be achieved using strong sacrificial oxidants such as selectfluor9 or hypervalent 
iodine,3b,e however the low tolerance to a wide range of functionalities limits the scope of 
substrates available. Oxidative addition of C–X bonds in Suzuki–Miyaura palladium based 
catalysis is often rate determining,4b but this is considerably more facile than in gold systems. 
In the Suzuki–Miyaura reaction a range of simple palladium catalysts can be used including 
Pd(PPh3)4 Pd(OAc)2 and PdCl2(PPh3)2, whereas the equivalent gold systems are unable to 
undergo oxidative addition.10 Various strategies have been developed to facilitate oxidative 
addition of a wider range of substrates. One approach to overcome this lack of reactivity used 
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chelating ligands with a smaller bite angle, such as in the bent diphosphine gold(I) species, to 
allow oxidative addition of an aryl halide (Scheme 3.4).11 In this bent gold(I) system the 
complex had a preorganised coordination environment that favours the formation of a gold(III) 
product unlike linear gold(I) complexes.  
 
Scheme 3.4. Oxidative addition of aryl halides using ligands with a bent geometry. 
Alternatively, abstraction of a halide from hemilabile (P^N)gold(I) complexes can promote 
oxidative addition of aryl halides, such as in a recent system by Bourissou et al. (a Scheme 
3.5), which was further developed into a catalytic system to produce biaryls. The first step, 
before oxidative addition, is abstraction of the chloride by a silver salt. The weakly 
coordinating anion SbF6 forms a weak F5Sb-F-Au interaction which is displaced by an aryl 
halide, this undergoes oxidative addition and is further stabilised by the hemilabile P,N 
ligand.12  This methodology of halide abstraction has also been successfully applied by Toste 
et al. in the oxidative addition of strained C–C bonds (b, Scheme 3.5).13  
 
Scheme 3.5. (a) Oxidative addition of aryl halides using silver to abstract a halide from the 
gold centre; (b) oxidative addition of a strained C–C bond.  
Considering the use of sulfur based ligands in this thesis, it is also of note that oxidative 
addition of fluorinated disulfides to gold(I) dithiolates gives gold(III) tetrathiolates (Scheme 
3.6).14 This reaction is reversible with reductive elimination regenerating a gold(I) dithiolate 
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and a disulfide. The relative stability of the gold(III) tetrathiolates was linked to the use of 
electron-deficient fluorinated thiolates. This reaction is of interest if it could be incorporated 
into a catalytic C-S bond forming system where the disulfide is used as an oxidant instead of 
a strong external oxidising agent.  
 
Scheme 3.6. Oxidative addition of disulfides to a gold(I) dithiolate species. 
3.3 Reductive elimination from gold(III) species 
Reductive elimination is the reverse of oxidative addition and in gold species is often more 
facile than oxidative addition. The most favourable conditions are thought to be the opposite 
to oxidative addition, often requiring geometrically unrestrained complexes. Consequently, 
the stabilisation of highly reactive gold(III) species has used chelating and pincer ligands to 
avoid reductive pathways.7,15  
There have been investigations into many different C–C bond forming reductive elimination 
reactions and there are a range of different factors that have been proposed to influence it.16 
These include the electronic properties of arenes that affect the formation of biaryls, it was 
observed that electron rich arenes underwent reductive elimination much faster than electron 
deficient arenes.17 The charge of the complex has also been proposed to influence the rate of 
reductive elimination because in some systems cationic complexes have faster rates of 
reductive elimination than the corresponding neutral complex.18  
Identification of the mechanism for C–C reductive elimination depends strongly on the 
system. Various intermediates have been proposed including, for some systems, transient 3-
coordinate gold(III) complexes. These highly reactive and unobservable intermediates result 
from the loss of one ligand through either dissociation of a phosphine ligand (a, Scheme 3.7),19 
or silver abstraction of a chloride (b, Scheme 3.7)20. The importance of the dissociation of a 
phosphine ligand can be shown through the suppression C-C reductive elimination when an 
excess phosphine was used. Due to fast reductive elimination from the proposed reactive 
intermediates formed, identification and isolation of the reactive species is challenging. 
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Scheme 3.7. a) Dissociation of phosphine triggering C-C reductive elimination; b) Chloride 
abstraction triggering C-C reductive elimination. 
In other cases, C–C reductive elimination has been proposed to originate from 4-coordinated 
gold(III) complexes.21 Toste et al. reported that reductive elimination from phosphine gold(III) 
biaryl complexes was the fastest transition-metal C–C reductive elimination with k ≥ 0.22 s–1 
at 221 K (Scheme 3.8).22 Reductive elimination was observed at -52 °C (221 K) from the 
starting neutral species, but addition of excess phosphine was proposed to displace a chloride 
by forming a cationic species, which underwent reductive elimination even faster than the 
neutral species.  
 
Scheme 3.8. Fast C–C reductive elimination. 
Reductive elimination of carbon-heteroatom bonds is rare compared to C–C reductive 
elimination, however there are several interesting examples, such as the formation of C(sp3)–
X23 and C(sp2)–X20 carbon-halide bonds, C(sp2)–N24 and C(sp2)–P25 bonds (Scheme 3.9, a-e). 
All these C–X or C–E reductive elimination reactions are proposed to occur from cationic 
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three-coordinate intermediates, formed through either silver abstraction or dissociation of a 
halide. By comparison C-S reductive elimination has been less well explored.  
 
Scheme 3.9. Reductive elimination from gold(III) complexes of: a) C-I bonds; b) C-F bonds; 
c) C-I bonds; d) C-P bonds; e) C-N bonds. 
3.4 Use of thiols as reducing agents  
The reducing nature of thiols has been used in the synthesis of gold nanoparticles via the Brust-
Schiffrin nanoparticle synthesis. This has been studied experimentally showing the first steps, 
prior to nanoparticle formation, to be reduction of gold(III) halides by thiols to gold(I) species 
and disulfides (Scheme 3.10).26 Final reduction of the gold(I) species by sodium borohydride 
gives thiol protected gold nanoparticles.  
 
Scheme 3.10. The reduction of gold(III) species to give gold(I) species and dithiolates. 
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Computational studies have further investigated individual steps and have shown that the first 
step is displacement of a halide by a thiol, followed by the halide abstracting a proton to form 
[AuX3SR]
- and HX, a second substitution by HSR through this two-step process forms 
AuX2(SR)2 and HX which is able to undergo reductive elimination to form a gold(I) species 
and a disulfide.27 
Gold(I) thiolates can form aggregates through aurophilic interactions. The nature of gold(I) 
thiolate species has been of interest as the can be precursors to nanoparticles.28 There have 
been several different proposals for the stoichiometry and coordination environments of 
gold(I) aggregates. 
In addition, there has been an increasing interest in gold metallodrugs and understanding 
potential interactions with biologically relevant molecules such as glutathione.29 Glutathione 
is an  SH containing tripeptide and is found in biological redox systems.30 Glutathione is often 
overexpressed in cancer cells and has been shown to provide a deactivating pathway for cis-
platin,31 the most successful metallodrug, by forming strong Pt-S bonds.32 It has been proposed 
that some gold(III) anticancer agents can be reduced by glutathione.33  
3.5 C-S reductive elimination from metal complexes 
C-S reductive elimination has not been widely studied as C-C reductive elimination, but there 
are examples of either C-S being studied in catalytic cycles or separately for several transition 
metals.34 In the palladium(II) system, isoelectronic to gold(III), C-S reductive elimination 
allowed access to a range of thioethers, including dialkyl sulfides, alkyl aryl sulfides and diaryl 
sulfides (Scheme 3.11).34c,35  
 
Scheme 3.11. C-S reductive elimination from P(II) complex. 
There is one previously reported example of C–S reductive elimination from gold(III).36 This 
occurs upon the reaction of cyclometallated aryl-pyridine gold(III) chelate complexes and 
cysteine containing peptides with an S–H functionality (Scheme 3.12). Reductive elimination 
resulted in the functionalisation the of C^N ligand with peptides through formation of C–S 
bonds. The proposed intermediates were again cationic, similar to the C–X reductive 
elimination reactions discussed above. The mechanism of reductive elimination was not fully 
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explored in the paper. In addition, these authors were unable to trigger C-S reductive 
elimination from the analogous cyclometallated 2-phenyl pyridine complex. 
 
Scheme 3.12. C-S reductive elimination. 
Since this work was published, Spokoyny et al. demonstrated that C-S reductive elimination 
from gold(III) complexes can be used in the cystine arylation of peptides and proteins.37 This 
was shown to be a selective and efficient method to modify complex biomolecules with a 
plethora of aryls.  
 
Scheme 3.13. C-S reductive elimination to give functionalised biological moieties. 
3.6 Stability of the (C^N^C)Au-X system 
Despite the reducing properties of thiols, we have previously shown that cyclometallated 
C^N^C pincer ligands provide excellent protection against reduction and allow isolation of 
stable gold(III) thiolates (see Chapter Two and Scheme 3.14).38  
 
Scheme 3.14. Synthesis of a gold(III) thiolate stabilised by a C^N^C pincer ligand.  
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The C^N^C system has been shown to be very stable to reductive elimination allowing 
isolation of highly reactive species that were previously unobservable, for example the 
hydride,39 hydroxide40 alkyne41 and alkene42 complexes.   
Although the C^N^C system helps stabilise gold(III) against reduction it is sensitive to strong 
acids and undergoes protodeauration of one Au–C bond with trifluoroacetic acid resulting in 
a (C^N) chelate with a pendant aromatic ring (Scheme 3.15).43 The reaction was found to be 
pKa dependent as the weaker acetic acid was incapable of protodeaurating the Au–C bond in 
the same complex. 
 
Scheme 3.15. Protodeauration of a C^N^C gold(III) by trifluoroacetic acid. 
The reaction of pincer gold(III) aryl complexes with [H(OEt2)2]
+[H2N[B(C6F5)3]2]
- (HAB2), a 
strong acid with a weakly coordinating anion, showed the Au-C bond in the pincer ligand is 
selectively protodeaurated, this was proposed to be because it is trans to another Au-C bond 
(Scheme 3.16).44 Studies into these protodeaurated species showed that 
metalation/protodeauration is reversible and sometimes dynamic with diethyl ether mediated 
proton shuttling.  Reductive elimination can be triggered from A upon addition of dimethyl 
sulfide, which displaces the Au-N bond induces fast C-C reductive elimination (Scheme 
3.16).45 Reductive elimination was proposed to occur from a four-coordinate cationic 
intermediate and the rate was strongly dependent on the nature of the substituent.  
 
Scheme 3.16. Protodeauration and C-C reductive elimination from gold(III) stabilised by a 
C^N^C pincer. 
3.7 Objectives 
This chapter will investigate reductive elimination from C^N^C gold(III) complexes triggered 
by thiols. This is of interest because there has been recent development of gold catalysed cross 
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coupling reactions, which has led to a renewed interest to understand the fundamental redox 
steps for gold complexes.    
In addition, gold(III) complexes have been shown to be anticancer agents, which in the cellular 
environment are subject to a high concentration of thiols such as glutathione. These have been 
proposed to reduce gold(III) complexes to gold(I) complexes. Therefore, it would be 
beneficial to have a greater understanding of how C^N^C gold(III) complexes react with 
thiols. 
Results and Discussion 
3.8 Addition of adamantyl thiol to 2  
The gold(III) thiolate complexes were synthesised using a thiol in the presence of a base (see 
Chapter 2).38 However, if 2 is reacted with adamantyl thiol (HSAd) in the absence of base the 
C–S reductive elimination product 12 and a gold(I) species, initially postulated to be 13, are 
observed (Scheme 3.17).  
 
Scheme 3.17. Reductive thiol-induced elimination to give 12 and 13 in the absence of a 
base. Ad = adamantyl.  
To gain mechanistic insight into the reaction of 2 with adamantyl thiol, further reactions were 
explored using in situ NMR spectroscopy. Adamantyl thiol was used as a prototypical thiol in 
this system because the signals do not overlap with those of 2 and, as a solid, it is easier to 
handle. For complete reductive elimination two equivalents of adamantyl thiol were required. 
In the presence of only one molar equivalent of adamantyl thiol the reaction remains 
incomplete giving a mixture of starting material and reductive elimination product. Addition 
of further thiol to this mixture gives complete conversion to 12 and 13.  
The structure of the reductive elimination product 12 was confirmed by 1H and 13C NMR 
spectroscopy and high resolution mass spectrometry, where the expected isotopic pattern was 
observed. 1H NOESY NMR revealed the presence of spatial interactions between adamantyl 
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signals (H11) and both H8 and H2. This was ascribed to free rotation around the C3–C4 bond 
of 12 leading to close spatial interactions (Figure 3.1).  
 
Figure 3.1. 1H NOESY spectrum of 12 showing interactions between H8, H2 and H11 
(CD2Cl2, 25 °C). 
When the reaction was scaled up, 12 was isolated as a white solid in 94 % yield. The 1H NMR 
spectrum of the in situ reaction mixture of 12 and 13 differed from that a pure sample of 12, 
this is likely to be because 12 and 13 interact through coordination of a gold(I) species to the 
pyridine nitrogen, whereas the pure sample of 12 shows no coordination to the pyridine 
nitrogen. This is seen most clearly in the shift of H1 from δ = 8.26 ppm to δ = 7.76 ppm (Figure 
3.2). 
Chapter Three 
 
56 
 
 
Figure 3.2. Aromatic region of 1H NMR spectra of 12; top) isolated sample of 12 bottom) in 
situ reaction mixture (CD2Cl2, 25 °C). 
The gold by-product formed upon reduction is proposed to be [AuCl(HSAd)]x (13) and over 
time precipitates from the solution as a white solid. This decrease in solubility could be due 
to nucleation resulting from aurophilic interactions between gold(I) centres forming polymers, 
oligimers or aggregates which precipitate as they become larger.28 There are previous 
examples of gold(I) oligomeric species formed through reduction of a gold(III) species such 
as the reversible oxidative addition of fluorinated aryl disulfide to gold(I) thiolates. In this 
case, one decomposition product observed was proposed to be an insoluble oligomeric 
material [AuSR]n generated from [RSAuSR]
-,14 this is similar to 13. 
3.9 Addition of other acidic compounds to 2  
Reductive elimination was not observed upon addition of a range of X–H acidic compounds 
to 2, even over extended periods of time. The X–H compounds investigated were carbazole, 
amines (acidic N–H), phenols (acidic O–H) and malonates (acidic C–H). The addition of 
strong acids, such as hydrochloric acid and trifluoroacetic acid, to 2 leads to protodeauration 
but not reductive elimination.44 
Table 3.1 shows the range of pKa values in DMSO for the different compounds that were 
reacted with 2. The strong acids, hydrochloric acid and trifluoracetic acid, with low pKa values 
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(1.8 and 3.45 respectively) protodeaurated 2, whereas no reactivity was observed for many of 
the weaker acids with high pKa values.  
Acid pKa values in 
DMSO at 25 °C 
Acid pKa values in 
DMSO at 25 °C 
HCl 1.846 p-Me-PhSH 10.8247 
F3CCO2H 3.45
46 CH3(CH2)3SH 17.0
46 
H3CCO2H 12.3
46 Carbazole 19.8748 
PhOH 18.046 dimethylmalonate 15.8849 
tBuOH 32.550   
Table 3.1. pKa values for a range of acidic compounds. 
The pKa value for the adamantyl thiol is likely to be similar to 1-butanethiolthiol. This pKa 
value is comparable to the weaker acids which showed no reactivity, therefore the acidity is 
not the only contributing factor to the reactivity and highlights the unexpected reactivity 
observed upon addition of adamantyl thiol to 2. 
3.10 Investigating a possible mechanism for C-S reductive elimination 
In order to gain additional mechanistic insights, we explored the reactivity of 2 with varying 
concentrations of adamantyl thiol to investigate the kinetic behaviour.  
3.10.1 Investigating rates of C-S reductive elimination 
Kinetic studies were performed to find the order of the reaction. The decay of 2 was followed 
by 1H NMR spectroscopy with the thiol in great excess of the 2 (more than 10 equivalents). 
Under these conditions, the reaction can be treated as pseudo first order as the concentration 
of adamantyl thiol does not change significantly over the course of the reaction and is treated 
as a constant. This gives the first order rate equation: 
𝜐 =
𝑑[𝟐]
𝑑𝑡
= −𝑘𝑜𝑏𝑠[𝟐]                               𝑘𝑜𝑏𝑠 = 𝑘[𝐻𝑆𝐴𝑑] 
This can be rearranged to give the following equation: 
[𝟐] =  𝑒−𝑘𝑜𝑏𝑠𝑡  
Figure 3.3 (left) shows monoexponential decay of 2 over the reaction duration, which follows 
the equation above. This means that under these reaction conditions the process is first order 
in 2, the observed rate constants ranged between 7.4 × 10-4 s–1 and 1.8 × 10-3 s–1. Therefore, 
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one equivalent of 2 is required in the rate determining step. The value of kobs followed linearly 
the concentration of thiol (right, Figure 3.3), which means that under these conditions the 
reaction is also first order in thiol. As kobs = k[HSAd] the value of the rate constant for the 
reaction can be calculated and is k = 3.57 × 10-3 ± 0.15 × 10-3 s-1mol-1dm3. Therefore, one 
equivalent of adamantyl thiol and 2 are required in the rate determining step and the overall 
reaction is second order.  
 
Figure 3.3. left, the decay of 2 at different concentrations of HSAd; right, the rate constants 
against the concentration of HSAd (CD2Cl2, 25 °C). 
The presence of air and water appeared to have no effect on the rate of reductive elimination, 
when the reaction was carried out in dry solvent under an atmosphere of dinitrogen the rate 
and product of the reaction were the same.   
3.10.2 Observation of a third species in the kinetic investigations 
At high concentrations of adamantyl thiol an additional species was observed in the 1H NMR 
spectrum during the kinetic investigations. The observed mixture had signals in the 1H NMR 
spectrum corresponding to 2, 12, 13 and a fourth species, 14. As the concentration of 
adamantyl thiol was increased, whilst all other parameters remained unchanged, the 
proportion of 14 was observed to increase.  The evolution of the mixture over the course of 
the reaction is shown in Figure 3.4 and shows that near the start of the reaction 2 has converted 
into equal proportions of 12 and 14. Over the course of the reaction the proportion of 14 
decreases and is not observed at the end of the reaction. 
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Figure 3.4. The molar fraction of different species over the reaction duration upon addition 
of 21 molar equivalents of thiol to 2 (CD2Cl2, 25 °C).   
To identify this species, 50 equivalents of adamantyl thiol were added to 2 and the sample was 
cooled to 223 K. At this temperature, the proportions of the reagents remained near constant 
and 2 did not undergo reductive elimination, a small proportion of 2 precipitated due to the 
decreased solubility at lower temperatures. 14 was shown to be symmetric, and contain signals 
corresponding to one adamantyl group. Therefore, the complex was proposed to be 
(C^Npy^C)Au–SAd (14) and was potentially formed due to the large excess of thiol displacing 
the chloride with a thiolate (Scheme 3.18). This reaction also resulted in the formation of one 
equivalent of hydrochloric acid. Similar reactivity has been proposed by calculations in the 
formation of gold nanoparticles, where exchange of one halide in AuX4
- by one thiol to 
produce AuX3HSR + Cl
- which converts to AuX3SR
- + HX.27  
When the mixture was warmed to 298 K the reaction proceeded to give a mixture of 12 and 
13. These observations were combined to give an initial possible reaction mechanism, where 
14 may be in an intermediate (Scheme 3.18), however this was probed with further reactions.  
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Scheme 3.18. Initial proposal of a possible reaction mechanism of 2 with an excess of 
adamantyl thiol giving 14 as a possible intermediate. 
14 was independently synthesised from 2 using potassium tertbutoxide and adamantyl thiol 
and isolated as a yellow solid in 91 % yield (Scheme 3.19). 
 
Scheme 3.19. The synthesis of 14 in dichloromethane at room temperature. 
To probe the validity of the initial proposed mechanism in Scheme 3.18, it was investigated 
whether 14 underwent reductive elimination upon addition of adamantyl thiol. When three 
molar equivalents of thiol were added to 14 no reaction was observed. However, upon addition 
of 50 molar equivalents of adamantyl thiol to 14 the reductive elimination product 12 and a 
white precipitate were observed, with complete conversion obtained after two months. These 
reaction times are much slower than in the kinetic experiments, therefore it is unlikely that 14 
is an intermediate. Instead, it was proposed that 14 formed in a proposed as a side reaction.  
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3.10.3 Reactivity of 2 with hydrochloric acid 
The formation of 14 upon addition of a large excess of adamantyl thiol to 2, is proposed to 
occur through chloride exchange also resulting in one molar equivalent of hydrochloric acid. 
This potential reaction was investigated by adding one molar equivalent of hydrochloric acid 
to a solution 14 and monitoring by 1H NMR spectroscopy. The reaction gave almost 
immediate formation of 2 and release of one equivalent of adamantyl thiol. The adamantly 
thiol then reacted with 2, as previously described, to give 50% conversion to 12 and 13 
(Scheme 3.20), this further emphasises the need for two molar equivalents of adamantyl thiol 
because of the incomplete conversion with one molar equivalent. This reaction demonstrates 
that the exchange of the thiol with the chloride is fast and the conversion of 2 to 14 is 
reversible.  
 
Scheme 3.20. Reaction of 14 with hydrochloric acid to give 2, followed by subsequent 
reductive elimination to give 12 + 13. 
3.10.4 Effect of altering the ligand system up on the rate 
The effect of altering the ligand system on the reaction was investigated to see if the Au-N 
displacement was kinetically relevant. 1 was used as it contains a central pyrazine instead of 
a pyridine. The pyrazine is less basic than pyridine, therefore has a weaker Au-N bond. If there 
is an alteration in the rate of the reaction between 1 and 2 it could indicate that the displacement 
of the Au-N bond is the rate determining step. 
The reaction with three molar equivalents of adamantyl thiol with 1 gave C-S reductive 
elimination resulting in the formation of 15 and 13 (Scheme 3.21). 15 was characterised by 
1H, 13C spectroscopy and accurate high resolution mass spectrometry, where the expected 
isotopic pattern was observed. 
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Scheme 3.21. 1 reacts with thiol to give C-S reductive elimination product 15 and gold(I) 
product 13. 
The consumption of 1 was studied by varying the concentration of thiol (left, Figure 3.5). 
Using the same methodology as in Section 3.10.1, it was demonstrated that the reaction is first 
order in 1 as shown by its monoexponential decay. It is also first order in adamantyl thiol 
(right, Figure 3.5). The rate is k = 2.54 × 10-3 ± 0.03 × 10-3 s-1mol-1dm3. 
    
Figure 3.5. left) the decay of 1 at different concentrations of HSAd; right) the first order rate 
constants against the concentration of HSAd (CD2Cl2, 25 °C).  
Despite the difference in basicity between pyridine and pyrazine, the rate of reaction of 
adamantyl thiol with both 2 and 1 are very similar, and therefore displacement of the Au-N 
ligand does not appear to be rate determining in the C-S reductive elimination mechanism.  
3.10.5 Establishing a mechanism 
Combining these observations gives us the proposed mechanism for the C-S reductive 
elimination from 2 (Scheme 3.22). Importantly, two molar equivalents of adamantyl thiol are 
required for complete reductive elimination, however the reaction is first order in adamantyl 
thiol so only one molar equivalent is required in the rate determining step. The major pathway 
to reductive elimination is proposed to go via first a protodeauration and formation of a 
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bidentate gold(III) chlorothiolate intermediate. This requires one molar equivalent of 
adamantyl thiol and one molar equivalent of 2 as shown in the kinetic investigations where 
the reaction was second order. This step is comparable to previous studies, which have shown 
acids to protodeaurate the pincer gold(III) systems.43-44 Subsequent displacement of the Au–
N bond by the second molar equivalent of adamantyl thiol forms a conformationally flexible 
system that can undergo reductive elimination. It is likely that the reductive elimination results 
from a four-coordinate species as the rate increases with increased thiol concentrations, 
however we are unable to isolate any species that would prove this hypothesis. The final step 
is reductive elimination to form a regiospecific C–S bond. 
The thiol-induced reductive elimination of the 2 and 1 proceed at comparable rates, suggesting 
that displacement of the Au–N bond is not rate-limiting. Therefore, the rate limiting step is 
likely to be the protodeauration by adamantyl thiol.   
The observation of 14 at the beginning of the reaction when a large excess of adamantyl thiol 
is used led to the proposal of a side pathway to reductive elimination (the lower half of Scheme 
3.22). In this side reaction, 2 was converted to 14 when a great excess of thiol was used. This 
was reversible as it forms one equivalent of hydrochloric acid which converts 14 back to 2. 14 
can also undergo reductive elimination upon reaction with adamantyl thiol giving C-S 
reductive elimination, but at a considerably slower rate.  
Overall, the reaction sequence is reminiscent of the reductive aryl-aryl coupling process 
proposed by Vicente et al. for the reaction of bis-aryl gold(III) complexes (C^N)Au(aryl)Cl 
with phosphines.21,51  
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Scheme 3.22. Proposed mechanism of C-S reductive elimination from 2, the black pathway 
is the major pathway and the blue pathway is the potential minor pathway. 
3.11 Addition of an aryl thiol to 2 
The reactivity of 2 with the aryl thiol, 2,4,6-trimethylthiophenol, was investigated to compare 
to adamantyl thiol, an alkyl thiol. Upon addition of three molar equivalents of 2,4,6-
trimethylthiophenol to 2 reductive elimination was observed to give 16, 17 and free ligand 
(L2) (Scheme 3.23). Increasing the proportion of 2,4,6-trimethylthiophenol added to 2 to 12 
molar equivalents altered the proportion of 16 and L2, there was an increase in free ligand 
(L2) observed and a decrease of 16.  
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Scheme 3.23. The reaction of 2 with 2,4,6-trimethylthiophenol. 
The formation of free ligand was not observed upon the reaction of 2 with adamantyl thiol. 
The different reactivity observed could be because of the stronger trans influence of the aryl 
thiolate in the proposed chlorothiolate intermediate. This proposed intermediate could be 
formed upon protodeauration of one Au-C bond and coordination of an aryl thiol at the 
remaining vacant position. In this proposed intermediate the aryl thiolate is trans to an Au-C 
bond and it is expected that the aryl thiolate would have a stronger trans influence than an 
alkyl thiolate. When the trans influence is coupled with the lower pKa of 2,4,6-
trimethylthiophenol a second protodeauration may be possible. It could also indicate that 
under these conditions the rate of displacement of Au-N is similar to that of protodeauration 
of the second Au-C bond. 
3.12 Reactivity of adamantyl thiol with 18 
The addition of adamantyl thiol to 1 and 2, which are both supported C^N^C based pincers, 
triggered C-S reductive elimination. Therefore, we decided to investigate the reactivity of the 
bidenate system 18 with a C^N chelate (18 was synthesized by Morwen Williams, Scheme 
3.24).52  
 
Scheme 3.24. Synthesis of 18. 
The reactivity of the bidentate chelate system 18 (Scheme 3.25) was investigated by adding 
12 molar equivalents of adamantyl thiol to a solution of 18 and the reaction monitored by 1H 
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NMR spectroscopy. Upon addition of adamantyl thiol, there was an immediate colour change 
observed. The 1H NMR of this reaction showed a mixture of 18 and a new product, this was 
proposed to result from displacement of the Au-N bond by an adamantly thiol.  
 
Scheme 3.25. Reaction of 18 with adamantyl thiol. 
In an attempt to increase the rate of reaction it was heated at 60°C. Over the course of the 
reaction four possible intermediates were observed, until after two months the reaction was 
complete. The final composition of the reaction was 80% C-S reductive elimination 19 and 
20% L18. 19 was characterised by 1H, 13C NMR spectroscopy and high resolution mass 
spectrometry, which showed the expected isotopic pattern.  
The potential mechanism for this reaction could result from initial displacement of the Au-N 
bond by adamantly thiol. The subsequent species formed in the reaction with adamantyl thiol 
could be a C^N chelate species with either a dichloride, two isomers of the 
monochloridethiolate or as a dithiolate. These species could be in equilibrium, but formation 
of either reductive elimination to give 19 or protodeauration to give L18 is likely to be 
irreversible. The difference in reactivity between 2 and 18 is likely to occur due to lack of an 
Au-C bond in a trans position to another Au-C. This makes protodeauration more difficult and 
instead the adamantyl thiol can directly displace the Au-N bond. After forming a 
monochloridethiolate or dithiolate the Au-C bond is trans to an Au-S bond, potentially 
allowing protodeauration and formation of L18. The extended time for C-S reductive 
elimination and mixture of products does not make 18 an ideal system to study C-S reductive 
elimination. Therefore, the C^N^C pincer system is more useful in studying C-S reductive 
elimination and protodeauration.  This reaction is different to the previous example of C-S 
reductive elimination where no reactivity was observed upon the addition of cysteine 
containing peptides to the phenyl pyridine gold(III) complex.36  
3.13 Reactivity of adamantyl thiol with (C^N^C)AuR complexes 
Under the same experimental conditions that triggered C-S reductive elimination from 2, 
adamantyl thiol was added to (C^N^C)Au–R (R =Me (19), C6H4-p-F (20) and C≡CC6H4-m-
OMe (21)) complexes and the reactions were monitored by 1H NMR spectroscopy. Thiol 
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addition triggered selective C–C reductive elimination from all complexes to give 22, 23, 24 
and the gold(I) by product 25 (Scheme 3.26). These conditions are milder than stepwise 
protocol of HAB2 and dimethylsulfide previously used to facilitate C-C reductive elimination 
and tolerated the acetylide functionality that previously reacted directly with HAB2.
45 The rate 
of reductive elimination was substituent dependant, with C(sp2)–C(Sp2) reductive elimination 
taking 6 days, C(sp2)–C(Sp3) reductive elimination taking 24 days and C(sp2)–C(sp) reductive 
elimination taking 6 months for just 50% conversion.  
 
Scheme 3.26. The reactions of C^N^C gold(III) complexes with adamantyl thiol to give C–
C reductive elimination.  
A similar mechanism to that proposed for C–S reductive elimination is anticipated, with 
protodeauration by one molar equivalent of adamantyl thiol followed by displacement of the 
Au-N bond by a second molar equivalent of adamantyl thiol. This would give a possible 
intermediate (Figure 3.6) which could potentially undergo either C–S or C–C reductive 
elimination (the proton drawn on the thiol could also potentially be on the pyridine nitrogen). 
As only the C–C bond forming product is observed we propose that C–C reductive elimination 
is favoured over C–S. This could be because the rate of reductive elimination forming a C–C 
bond is faster than C–S. Previous examples forming biaryls through reductive elimination of 
a C-C bond from gold were shown to be exceptionally fast.22 It is presumed that the rate 
determining step is again protodeauration as only the starting material and the product are 
observed in the 1H NMR spectrum.  
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Figure 3.6. Potential intermediate. 
The nature of the gold(I) species formed upon C– reductive elimination was explored with 
diffusion NMR to establish a hydrodynamic volume of the gold(I) thiolate. The reaction of 20 
with adamantyl thiol was used because there were no overlapping signals observed in the 1H 
NMR spectrum at the end of this reaction, which produced 23, free thiol and the gold(I) 
thiolate species. This allowed the reaction mixture to be probed using PGSE (pulse gradient 
spin echo) NMR experiments where the dependence of the resonance intensity (I) on a 
constant waiting time and on a varied gradient strength G (Equation 3.1) can be used to 
identify the self-diffusion coefficient values (Dt) 
ln
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Equation 3.1. The dependence of Dt upon the resonance intensity (I) and a varied gradient 
strength (G). 
Plotting ln(I/I0) against G
2 can be used to identify the self-diffusion coefficient values (Dt) 
from which the structural parameters can be approximated. The relationship between Dt and 
hydrodynamic dimensions is expressed by the modified Stokes-Einstein equation (Equation 
3.2) where k is the Boltzmann constant, T is the temperature,  is the solution viscosity, c is 
the “size factor”, which depends on the solute-solvent radius ratio and f is the “shape factor”.  
Dt =
kT
ph fc abd3
 
Equation 3.2. The modified Stokes-Einstein equation. 
The hydrodynamic volume calculated for the species present in the mixture are 184 Å3 for 
adamantyl thiol and 727 Å3 for 23 (Table 3.2). The Au(I) complex had a hydrodynamic 
volume of 1500 Å3, which is about 8 times larger than free thiol. Therefore, it can be 
reasonably assumed that the Au(I) product exists as a small [ClAu(HSAd)]n cluster, with an 
average n close to 7. These species may grow to a point that they become the insoluble as a 
white precipitate is observed after the reaction.  
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Species Hydrodynamic 
Radius  
Hydrodynamic 
Volume 
AuSAd 7.1 Å  1500 Å3 
HSAd 3.53 Å  184 Å3 
23 5.58 Å  727 Å3 
 
Table 3.2. The hydrodynamic radii and volumes of species measured by PGSE NMR 
experiments. 
3.14 Reactivity of adamantyl thiol with (C^N^C)Au–ER (ER = OR, NR) complexes 
The study was extended to further gold(III) heteroatom species in the hope of triggering C–E 
reductive elimination. Addition of three molar equivalents of adamantyl thiol to (C^N^C)Au–
O–C6H4-p-F (26) gave 14 almost immediately (Scheme 3.27). The reaction is analogous to the 
synthesis of 14 with the phenolate used instead of the tert-butoxide (Scheme 3.19). This 
reaction demonstrates that the Au–S bond is stronger than the Au–O bond. No further 
reactivity between 14 and the excess two molar equivalents of adamantyl thiol was observed 
over the time that this reaction was monitored.  
 
Scheme 3.27. Reaction of 26 with adamantyl thiol to give 14. 
The pincer gold(III) carbazole complex 27 was synthesised to investigate the potential for C–
N reductive elimination. 27 was isolated as an orange solid, 59 % yield (Scheme 3.28). The 
carbazole was chosen as a gold(III)–NR2 species because the lone pair is delocalised, and it 
was hoped that 27 would not be protonated as in the case of 26.  
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Scheme 3.28. The synthesis of 27. 
Addition of three molar equivalents of adamantyl thiol to 27 gave C-S reductive elimination 
over 7 days (Scheme 3.29). The mechanism is thought to be similar to that proposed for C-S 
reductive elimination from 2. After protodeauration and displacement of the Au-N bond forms 
a geometrically unrestrained complex that could potentially undergo either C-S or C-N 
reductive elimination, however in this case C-S is favoured over C-N bond formation.  
 
Scheme 3.29. Reaction of 27 with adamantyl thiol to give 12. 
Combining these observations allows proposals of potential trends in reductive elimination 
reactions from gold(III) complexes. The rate of reductive elimination changes depending on 
the starting gold(III) complex, and protodeauration appears to be the rate determining step. 
The nature of the substituent cis to the Au–C bond influences the rate of protodeauration.   
Reductive elimination is the final and irreversible step in each reaction. Bond formation is 
proposed to occur from a four-coordinate species (analogous to Figure 3.6 and Scheme 3.22). 
In this intermediate there is the potential for different bonds to be formed through reductive 
elimination. In complexes 19-21 there is potential to form either C–C or C–S bonds, however 
C–C bonds are favoured. When 2, 14 and 27 were used, only 12 was observed, indicating that, 
C–S bond formation is favoured over C–N or C–Cl bond formation. In all reactions where 
adamantyl thiol was added to a gold(III) complex there was strong selectivity in the bond 
forming step.  
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The most interesting observations from this work are that thiols can cleave Au–C bonds and 
trigger C–S reductive elimination from neutral gold(III) complexes. In addition, when 
adamantyl thiol is added to a (C^N^C)Au–R complex C–C reductive elimination is triggered. 
These mild conditions are tolerant of a range of different functionalities, specifically the 
reductive elimination of C(sp2)-C(sp) bond that was not possible with previous methods.  
3.15 C-S Reductive elimination via a stepwise methodology  
In the mechanism in Scheme 3.22, it was proposed that C–S reductive elimination takes place 
via protodeauration followed by displacement of the Au–N bond. The mechanism for this was 
based on observations and previous work triggering C–C reductive elimination from gold(III) 
aryl complexes.45 Adamantyl thiol appeared to combine these properties. Extending this 
stepwise protocol to the gold(III) thiolate complex 14 allowed us to further test the proposal 
that protodeauration and displacement lead to reductive elimination in a stepwise manner. 
Addition of HAB2 to a solution of 14 was monitored by 
1H NMR spectroscopy over 2 weeks 
until no further changes were observed (Scheme 3.30). In the 1H NMR spectrum after addition 
the HAB2 14 was not observed, therefore protodeauration of 14 was fast. The major product 
formed was speculated to be a dimeric species 28. This is a much longer reaction than the 
previous reaction of HAB2 with (C^N^C)Au–Ar where the formation of an ether complex A 
(Scheme 3.16) was formed immediately, therefore as protodeauration was fast, it was 
proposed that dimerization was slow.  
 
Scheme 3.30. The reaction of 14 with HAB2 to give 28 (anions have been omitted). 
Complex 28 results from the dimerization of two protodeaurated species. Its structure was 
proposed based on several features in the 1H NMR spectrum. Firstly, the two t-butyl signals 
(δ = 1.36 ppm and 1.14 ppm) indicate the formation of an asymmetric species. Secondly, sharp 
signals corresponding to diethyl ether indicate that the final product does not contain 
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coordinated diethyl ether. Finally, in the aromatic region of 28 it was not possible to observe 
all expected peaks at 298 K (top, Figure 3.7), however upon cooling to 260 K all expected 1H 
signals are observed. The slow exchange of the protodeaurated aryl ring was proposed to be 
because of restricted rotation of the aryl in the sterically demanding dimer.  
 
Figure 3.7. 1H NMR spectrum of the aryl region of 28 at 295 K (red) and 260 K (blue). 
Crystallization of 28 allowed structural characterisation and confirmation the structure 
suggested by NMR spectroscopy (Figure 3.8). The complex cation consists of two gold centres 
linked by bridging thiolates. The unit cell contains a dication (lying about a centre of 
symmetry) and two NH2(B(C6F5)3)2 anions. Each gold centre is in a square-planar environment 
bonding to pyridine N-atom, the o-carbon atom of one of its phenyl group substituents, and 
the bridging sulfur atoms of the two S-adamantyl ligands. The pendant aryl ring is twisted out 
of the plane of the C^N ligand by 51.3(4)° around the C(16)–C(161) bond to accommodate 
the steric bulk of the two bridging adamantyl thiolates. The two adamantyl groups are mutually 
trans and almost perpendicular to the central Au2S2 plane, with Au–S(1)–C(1) angles of 
103.2(3) and 98.9(3) °. The sterically congested ligand sphere leads to distortions of the 
normally planar gold coordination sphere, e.g. the C(9)-Au-S angle is reduced to from the 
expected 180° to 163.44°. The bridging Au–S bonds are quite different in length and reflect 
the trans influence of the C^N ligand, with the one trans to the pyridine N-atom being 0.15 Å 
shorter than the bond trans to the phenyl C-atom.  
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Figure 3.8. Side and partial top view of the cation in 28. Left) H atoms, tert-butyl groups 
and anions are omitted for clarity. Right) H atoms and anions are omitted for clarity.  
Ellipsoids are drawn at 50%. Selected bond distances [Å] and angles [°]:Au-C(122) 
2.066(8), Au-N(11) 2.108(7), Au-S(1) 2.323(2), Au-S(1) 2.469(2), S(1)-C(1) 1.880(9); 
C(122)-Au-N(11) 81.2(3), C(122)-Au-S(1)  94.3(3), N(11)-Au-S(1) 174.4(2), C(122)-Au-
S(1) 163.4(3), N(11)-Au-S(1) 101.2(2), S(1)-Au-S(1) 84.02(8) 
Previously, there has been one other structurally characterised gold(III) bridged thiolate 
(Figure 3.9).53 In that example the gold(III) centres are in a typical square planar environment 
and the bridging thiolates bend out of the plane.  
 
Figure 3.9. A structurally characterised dimeric gold(III) thiolate, the second gold centre is 
out of the plane of the page.  
3.16 Addition of dimethyl sulfide to 28 
Reductive elimination from 28 can be triggered upon addition of excess dimethyl sulfide 
(Scheme 3.31). A possible mechanism for this is through dimethyl sulfide displacing an Au-
N and Au-S bond to form an unstable intermediate which can undergo reductive elimination. 
Reductive elimination results in C-S bond formation giving 12 and a gold(I) species, likely to 
be [Au(SMe2)2][AB2].  
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Scheme 3.31. Addition of SMe2 to 28 to give C-S bond formation.  
This is an example of reductive elimination from a cationic intermediate, which have 
previously been shown to be faster than neutral analogues. Qualitative studies showed the rate 
of reductive elimination increases with increasing amount of dimethyl sulfide which could 
indicate a four-coordinate intermediate.  
This stepwise approach of protodeauration of an Au–C bond and subsequent displacement of 
Au–N and Au–S bonds demonstrates that combining these two steps leads to reductive 
elimination and supports the mechanism proposed in Scheme 3.22.  
3.17 Investigating the stepwise protocol with further gold(III) heteroatom species 
The stepwise protocol was extended to other heteroatom species with the aim of inducing 
further C-E (E = N, O) bond formation, however different reactivity patterns were observed. 
Addition of HAB2 to a solution of 26 resulted in the formation of a diethyl ether complex 29 
(Scheme 3.32).54 29 is unstable and decomposed over 3 hours at room temperature. 
 
Scheme 3.32. The reaction of 26 with HAB2. 
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The unusual high frequency shift of the diethyl ether CH2 signal at δ = 4.68 ppm in the 
1H 
NMR spectrum is in agreement with the 1H NOESY spectrum of 29, which showed a through 
space interaction between the diethyl ether CH2 and H
8 (Figure 3.10).  
 
Figure 3.10. The interaction between H8 and CH2 of the coordinated ether molecule in 
complex 29. 
The stepwise protocol is unsuitable for triggering C–O reductive elimination. This is possibly 
because the oxygen lone pair is the most basic site in this molecule, therefore first to be 
protonated and is subsequently displaced by a molecule of diethyl ether forming 29 and 
phenol. Consequently, for protodeauration to occur there must not be a more basic site than 
the Au-C bond, such as an available oxygen lone pair in 26. This is similar reactivity to the 
reaction of 26 with adamantyl thiol where 14 was formed instead of C-S reductive elimination. 
To avoid the reactivity observed with 26, the complex 27, with a carbazole functionality, was 
used to investigate the stepwise protocol. Addition of HAB2 to 27 gave the protodeaurated 
species 30, demonstrating that the carbazole nitrogen is not preferentially protonated (Scheme 
3.33). 
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Scheme 3.33. Reaction of 27 with HAB2, followed by addition of dimethyl sulfide. 
In the 1H NOESY spectrum of 30 chemical exchange was observed between the two tertiary 
butyl signals. This is shown through negative cross peaks between the inequivalent tertiary 
butyl signals (Figure 3.11). This exchanging environment is likely to occur through reversible 
protodeauration of the two Au-C bonds facilitated by diethyl ether, as seen upon 
protodeauration of 2.44  
 
Figure 3.11. NOE spectrum of 30, the negative peaks are white and between the two tertiary 
butyl signals which are exchanging with each other. 
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It is possible to calculate the rate of chemical exchange using Equation 3.3, where τm is the 
mixing time, IXX is the intensity of diagonal peaks and IXY is the intensity of cross peaks, the 
relative integral intensities are extracted from the NOE spectrum.55 Here the rate is 1.23 s-1, 
which is slightly faster than that previously observed for proton shuttling in 2.44 
𝑘 =
1
𝜏𝑚
𝑙𝑛
𝑟+1
𝑟−1
     𝑟 =  
𝐼𝐴𝐴𝐼𝐵𝐵
𝐼𝐴𝐵𝐼𝐵𝐴
 
Equation 3.3. Used to calculate the rate of chemical exchange in NOESY spectrum. 
Addition of dimethyl sulfide resulted in C–H activation, formation of 31 and release of the 
carbazole (Scheme 3.30).42 This reactivity was unexpected as previously the dimethylsulfide 
had displaced the Au-N(pyridine) bond. Potentially the formation of a gold(III) 
dimethylsulfide cation is more stable and proton is transferred to the carbazole, therefore 
halting the fluctional behaviour observed for 30.  
These reactions show that many factors are important when attempting to trigger reductive 
elimination from C^N^C gold(III) systems. In the first step to form a protodeaurated species 
there must not be a more basic site than the Au–C bond such as in 26, in the absence of such 
functionality it is possible to form the protodeaurated species 28 and 30. In the second step, 
addition of dimethyl sulfide, it is possible to displace an Au–N bond in 28, however in 30 it 
led to C–H activation, therefore the protocol is not easily extended to other systems. The 
stepwise method can be used to trigger reductive elimination from 14 leading to C–S bond 
formation.   
Conclusion 
We have shown that selective C–S bond formation is possible via reductive elimination from 
gold(III) species, by two different methods. Addition of adamantyl thiol triggered reductive 
elimination from 2 at ambient temperatures. We have proposed a mechanism for this reaction 
by combining a series of observations. This reaction was extended to other C^N^C gold(III) 
pincer systems from which it was possible to trigger C–C reductive elimination. This reactivity 
is unique to thiols, so far, no other acidic compounds trigger this reactivity. A stepwise 
methodology was also used to trigger C–S reductive elimination. Structural characterisation 
of an intermediate showed an interesting thiolato-bridged dimer species where the large steric 
demands distorted the normally square planar geometry around gold(III). Application of this 
stepwise methodology to other gold(III) heteroatom species showed interesting reactivity, but 
no reductive elimination.  
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Introduction 
4.1 Transmetallation reactions  
Transmetallation agents are frequently used in coupling reactions where they are crucial in the 
transfer of an organic functional group to a metal centre.1 Gold itself has been used in the 
transmetallation of other metal centres including nickel, palladium, platinum, iron, titanium 
and rhodium.2 This reactivity has been applied to bimetallic catalysis, where gold has been 
employed as a transmetallating agent to other gold centres or group 11 catalysts.3 More 
recently, p-block compounds have been used in the transmetallation of gold centres.  
4.1.1 Boronic acids in transmetallation reactions 
Boronic acids have proved to be versatile building blocks in organic synthesis, specifically in 
palladium catalysed cross-coupling reactions.4 The best-known of these palladium cross-
coupling reactions is the Suzuki-Miyaura reaction, in which transmetallation of Pd–X bonds 
by boronic acids in the presence of a base forms Pd–C bonds, and subsequent reductive 
elimination from this species leads to C-C bond formation (see Section 3.1).5 
Boronic acids have also been used in the transmetallation of Au–X bonds in both gold(I) and 
gold(III) systems. Transmetallation of gold(I) halide bonds (X = Cl, Br) by boronic acids 
requires the presence of caesium carbonate acting as a base (a, Scheme 4.1); complete 
conversion was observed upon heating to 50 °C.6 Altering the base to potassium hydroxide 
facilitates conversion at room temperature (b, Scheme 4.1).7 This was proposed to go through 
either the in situ formation of a gold hydroxide species or a borate.  
 
Scheme 4.1. The transmetallation of gold(I) species by boronic acids. 
The base-free transmetallation of (C^N^C)gold(III) hydroxide with boronic acids was 
observed upon heating to 60 °C and was compatible with a range of aryl and heterocycle 
boronic acids (Scheme 4.2).8 The gold(III) aryl complexes formed were shown to be 
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photoemissive. This protocol has since been applied to the synthesis of highly luminescent 
gold(III) aryls that have been used in OLED devices.9  
 
Scheme 4.2. The transmetallation of a gold(III) hydroxide by boronic acids. 
Alternately, gold(III) aryls can be synthesised through the coupling of an Au–Cl bond with a 
boronic acid by using a palladium catalyst in the presence of a base at elevated temperatures 
(Scheme 4.3).10 The gold(III) aryls produced are again highly luminescent.  
 
Scheme 4.3. The coupling of an Au-Cl bond with a boronic acid using a palladium catalyst. 
Under more forcing conditions (heating to 150 °C), the base and catalyst free transmetallation 
of gold(III) chloride using a boronic acid was achived.11 This reaction is only compatible with 
electron-deficient aryl boronic acids, limiting the scope of the reaction. A C^C^N gold(III) 
fluoride complex required slightly less harsh conditions (heating to 70 °C) to facilitate the 
transmetallation of an Au–F bond by a boronic acid, however it only proceeded with electron-
deficient fluoroaryl boronic acids (Scheme 4.4).12  
 
Scheme 4.4. Transmetallation of an Au-F bond with fluorinated boronic acids. 
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A C^N-stabilised gold(III) difluoride underwent facile transmetallation using boronic acids 
(conversion is observed at room temperature), however it is also able to undergo reductive 
elimination with C-C coupling products observed.12 Similarly, the transmetallation of Au–F 
bonds by boronic acids in other gold complexes has been proposed, however only the C–C 
coupling products formed upon reductive elimination are observed.13 
More recently, boronic acids have been used in a range of catalytic gold coupling reactions. 
Chapter Three, Figure 3.2, showed the use of a boronic acid in catalytic oxidative arylation.14 
Boronic acids have also been used in the gold catalysed coupling of allyl halides with aryl 
boronic acids15 and coupling of terminal alkynes with boronic acids.16 
4.1.2 Transmetallation using organozinc reagents 
Organozinc reagents are also widely used in synthetic chemistry, although they are less air 
stable than boronic acids, but they are more tolerant of functional groups than the 
corresponding magnesium or lithium reagents.17 Different organozinc reagents have varying 
reactivity; dialkyl zinc reagents are much more reactive than the corresponding alkyl zinc 
halides. In palladium catalysis, organozinc reagents are used as transmetallation reagents in 
the Negishi coupling reaction that couples an organozinc reagent and an organohalide to form 
a new C–C bond.18 In this reaction oxidative addition of the organohalide C–X bond forms a 
palladium(II) complex, this is followed by transmetallation of a Pd–X bond by an organozinc 
halide which forms a Pd–C bond and subsequent reductive elimination forms a new C–C bond.  
Another palladium catalysed reaction that is relevant to this work is the Fukuyama reaction 
because it involves the formation of a metal-thiolate species and M–S bond transmetallation. 
The Fukuyama reaction couples a thioester and organozinc reagent to form a ketone (Scheme 
4.5).19 The mechanism is proposed to go via oxidative addition of a thioester to palladium, 
followed by the transmetallation of a Pd–S bond by organozinc reagent and subsequent 
reductive elimination forming a C–C bond. The thioester can be synthesised from carboxylic 
acids with the overall transformation of carboxylic acid to ketone.  
 
Scheme 4.5. The Fukuyama reaction. 
Despite the wide use of organozinc reagents with other transition metals the reports of 
reactivity with gold are limited to two reactions. Firstly, the reaction of (Ph3P)AuCl with B 
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results in both transmetallation and displacement of the phosphine to give two Au–C bonds 
(Scheme 4.6).20  
 
Scheme 4.6. The reaction of an organozinc reagent with a gold(I) complex. 
The second example uses adamantylzinc bromides (both 1-AdZnBr and 2-AdZnBr, Ad = 
adamantyl), which can be reduced to the corresponding diadamantylzincs to give four different 
organozinc reagents.21 All four of these complexes can be used in the transmetallation of 
(R3P)AuCl to give a new Au–C bond (Scheme 4.7). When the adamantylzinc bromides were 
used the product could not be isolated and instead were only observed in situ. The 
diadamantylzinc compounds proved to be superior reagents for transmetallation of the Au–Cl 
bond allowing isolation of (R3P)AuAd .  
 
Scheme 4.7. An organozinc reagent transmetallating an Au–Cl bond. 
4.1.3 Silanes and stannanes in transmetallation reactions 
Other p-block compounds have been investigated as transmetallation reagents with both gold 
and other transition metals. Silyl reagents are used in transition metal cross couplings 
catalysis,22 such as the palladium catalysed Hiyama coupling, which uses organic halides and 
organosilanes to give a carbon–carbon bond.23 
The reactivity of gold complexes and a range of silanes has shown them to be transmetallation 
reagents.1 The stoichiometric transmetallation of Au–O bonds with R-Si(OMe)3 has been 
demonstrated for gold(I) species (Scheme 4.8).24 The intermediates in this reaction can be 
isolated and characterised and contain an oxygen bonded to both gold and silane. A wide range 
of functional groups were shown to be transferred to gold, including aryls, vinyls and allyls. 
 
Scheme 4.8. Transmetallation of Au-O bonds with silanes. 
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Trimethylarylsilanes were used to transfer an aryl group to gold in gold-catalysed oxidative 
arylation (Scheme 4.9).25 A comprehensive mechanistic study into this catalytic reaction 
allowed elucidation of the mechanism. A simplified description of this includes: oxidation of 
the gold(I) complex by a hypervalent iodine species, this undergoes electrophilic aromatic 
substitution of a silane and subsequent C–H auration of an aryl C–H bond; finally, reductive 
elimination forms a C–C bond and regenerates the gold(I) complex.  
 
Scheme 4.9. Arylsilanes in gold catalysed oxidative arylation. 
The use of stannanes in palladium catalysis is well known; the Stille reaction couples 
stannanes with organic electrophiles.26 Stannanes have also been used in the transmetallation 
of gold species, such as in the formation of the gem-diaurated furyl complex (Scheme 4.10).27 
Identification of this reaction was part of a study on gold(I) catalysed cyclisation and stannyl 
transfer. 
 
Scheme 4.10. Transmetallation of a gold(I) species using stannanes. 
Other transmetallation reactions using both stannanes and gold have involved bimetallic 
catalysis where catalytic amounts of Pd/Au allow the addition of stannanes to alkynes.28 In 
this reaction the gold was proposed to activate the alkyne.  
4.2 Compounds containing an Si–B in transmetallation reactions 
In the synthesis of new C–E  bonds (E = B, Si, Sn), compounds containing bonds between two 
main group elements (boron, silicon, tin) can be used.29 One example is the use of 
unsymmetrical diboranes, which have proved versatile reagents in the formation of C–B 
bonds.30 Alternatively, compounds containing an Si–B bond have been developed where the 
difference in electronegativity between silicon and boron leads to highly stereoselective 
reactions.29 Application of Si–B compounds has been widely used in organic synthesis.31 The 
most extensive studies have used Si–B activation to functionalise unsaturated bonds.  
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These Si–B bond containing compounds can react with transition metal complexes and display 
a range of reactivity. With low-valent metals oxidative addition of the Si–B bond leads to the 
formation of M–Si and M–B bonds (Scheme 4.11).32 These complexes can react with C=C 
bonds through migratory insertion, which forms a C–B bond and subsequent reductive 
elimination to form a C–Si bond, leading to functionalisation of an unsaturated bond. 
 
Scheme 4.11. Oxidative addition of an Si–B bond to a transition metal. 
Alternatively, strong nucleophiles can react with Si–B compounds by attacking the more 
electrophilic Lewis acidic boron.29 When metal complexes are used this results in 
transmetallation forming a M–Si bond.33 There are two different mechanisms proposed for 
this reaction, either transmetallation with anionic nucleophiles or transmetallation through σ-
bond metathesis (Scheme 4.12).29 The transmetallation with anionic nucleophiles has 
predominantly been observed for alkali or alkali earth metal alkoxides and carbanions, 
whereas σ-bond metathesis has predominantly been observed for transition metal alkoxides 
and hydroxides. In these transmetallation reactions a M–Si bond is always formed in 
preference to an M–B bond. This has been used to make several Cu–Si complexes which have 
subsequently been used in a range of catalytic studies.34 To the best of our knowledge there 
have been no studies using gold complexes.  
 
Scheme 4.12. Transmetallation using Si-B compounds via: a) anionic nucleophiles or b) 
through σ-bond metathesis. 
The Si–B bond can also be activated by non-metal nucleophiles to release a silicon 
nucleophile, allowing intermolecular silyl transfer (Scheme 4.13).35 This differs from much of 
the silicon chemistry where silanes are used as electrophiles (see Scheme 4.9 for a silicon 
based electrophile).  
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Scheme 4.13. Metal free activation of the Si–B bond.29 
4.3 Gold-silyl complexes 
Two methods have previously been used in the synthesis of complexes containing Au–Si 
bonds, either silyl lithium reagents or oxidative addition of a Si–Si bond. Gold(I) silyl 
complexes were synthesised in the 1980s using silyl lithium reagents and phosphine gold(I) 
chlorides.36 More recently a series of phosphine gold(I) silyl complexes have been synthesised 
the same methodology by Bourissou et al. to investigate their reactivity.37 A sterically 
demanding silyl group (SitBuPh2) was used to increase the stability of the gold(I) silyl 
complex. These complexes were shown to undergo syn-insertion of alkynes into the Au–Si 
bond to form air stable gold(I) vinyl complexes (Scheme 4.14). A range of alkynes were 
investigated, with internal alkynes taking longer to react (up to 4 weeks at 65 °C). These 
gold(I) complexes were used in the transmetallation of stannanes and as transmetallation 
reagents in the palladium catalysed coupling with an aryl iodide or an allyl bromide. 
Decreasing the steric bulk of the silyl group by using a triphenyl silyl (R3P-Au-SiPh3) 
increased the reactivity towards insertion reactions and the insertion of allenes was observed.  
 
Scheme 4.14. The insertion of alkynes into Au–Si bonds. 
Studies into the mechanism of this reaction showed that first the alkyne coordinates the 
phosphine gold(I) silyl species to form a π complex, which then inserts into the Au–Si bond.38 
The syn insertion is a result of a concerted inner-sphere mechanism. 
Gold(III) complexes containing Au–Si bonds have been observed upon the oxidative addition 
of Si–Si σ bonds to gold(I) species.39 The reaction of a disiliane-bridged diphosphine with the 
chlorogold(I) dimethylsulfide complex resulted in intramolecular oxidative addition of the Si–
Si σ bond (a, Scheme 4.15). The initial complex formed is thermally unstable and upon 
warming to room temperature the gold(III) complex is reduced to gold(I) diphosphine 
containing a disiloxane, which is formed with either water or oxygen acting as the oxygen 
source. Addition of gallium trichloride vastly increased the stability of the gold(III) complex, 
due to formation of the stable poorly coordinating GaCl4
- anion.  
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Based on the previous observations, a phosphine gold(I) chloride was activated by gallium 
trichloride at -80 °C, through chloride abstraction (b, Scheme 4.15). This facilitates subsequent 
intermolecular oxidative addition of a disilane to form a gold(III) bissilyl complex. This 
complex was unstable at temperatures above -60 °C.  
 
Scheme 4.15. Oxidative addition of a Si–Si σ bonds to form Au–Si bonds: a) intramolecular 
oxidative addition; b) intermolecular oxidative addition.  
4.4 Objectives 
Transmetallation is a key step in transition metal catalysed cross-coupling reactions. In 
palladium-catalysed coupling reactions a wider range of transmetallation reagents are used to 
install a range of functionality. By comparison, the transmetallation of gold complexes is 
underexplored. Much of the attention so far focused on boronic acids, however new examples 
of transmetallation could lead to systems with a tolerance to different functionalities. With the 
current advances in gold catalysed coupling reactions it is important to understand this key 
step. There are few examples of transmetallation of gold species by organozinc halides and no 
studies with gold(III) species, therefore this work is going to probe their reactivity. 
Another transmetallation reagent that has received significant amounts of interest are Si-B 
reagents due to the polarisation of the bond to give an electronegative silicon centre. Therefore, 
this chapter is going to investigate the potential of transmetallation of gold(III) species with 
Si–B compounds. There have been no reports of the reactivity of the Au–Si bonds in gold(III) 
complexes, this is presumably due to the decrease in stability of the complexes that have so 
far been synthesised. It is hoped that the C^N^C pincer provides additional stability to probe 
the reactivity of complexes isolated.  
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Results and Discussion 
4.5 Reaction of 2 and 1 with aryl zinc iodide 
To investigate the reactivity of organozinc compounds with gold(III) complexes, two molar 
equivalents of 0.5 M THF solution p-Me-phenyl zinc iodide were added to a solution of 2 in 
tetrahydrofuran (Scheme 4.16). This resulted in the formation of complex 32, where p-Me-
phenyl zinc iodide acted as an iodide source. 32 was isolated as a solid in 52% yield and 
characterised by 1H and 13C NMR spectroscopy and elemental analysis.  
 
Scheme 4.16. The reactivity of organozinc reagents with 2. 
The largest change in the 1H NMR spectrum between 2 and 32 was the shift in the H8 proton, 
in closest position to the halide. In 32 it is observed at δ = 8.52 ppm (CD2Cl2) compared to the 
reported 1H NMR spectrum of 2 where it is observed at δ = 7.77 ppm (DMSO-d6), it is 
important to note that there is a change in solvent.40 Therefore, under these conditions 2 had 
undergone halide exchange instead of the desired transmetallation reaction. 
Repeating the reaction of two molar equivalents of p-Me-phenyl zinc iodide with 2, but 
changing the solvent to toluene results in the formation of a transmetallation product 33 
(Scheme 4.17). 33 was isolated as a solid in 88% yield and characterised by 1H and 13C NMR 
spectroscopy and elemental analysis. This reaction is also observed when toluene-d8 was used 
as a solvent, therefore 33 is not the product of C–H activation of a solvent molecule.  
 
Scheme 4.17. The reaction of an organozinc reagent with 2 to give 33. 
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Therefore, p-Me-phenyl zinc iodide can be used in the transmetallation of an Au–Cl bond to 
form an C^N^C gold(III) aryl complex. C^N^C gold(III) aryl complexes have previously been 
synthesised in a two-step synthesis from 2.8 The first step of this synthesis is the formation of 
a hydroxide species, which once isolated could be reacted with the desired boronic acid upon 
heating to 60 °C in toluene to give the gold(III) aryl. Previous cases of direct transmetallation 
of an Au–X bond (X = Cl, F) required forcing conditions.11, 12 Forcing conditions were used 
in the transmetallation of the Au–F bond, which was only compatible with electron-deficient 
fluoroaryl boronic acids (Scheme 4.4).12 In addition, the gold(III) aryls formed directly from 
an Au–Cl bond required the use of a palladium catalyst. (Scheme 4.3).10 By comparison, these 
conditions are considerably more favourable.  
Previously, the synthesis of gold(III) aryls from 1, where a pyrazine is substituted for the 
pyridine, has proven to be more difficult as the corresponding hydroxide species cannot be 
formed. Therefore 1 was dissolved in toluene and reacted with two molar equivalents of p-
Me-phenyl zinc iodide (Scheme 4.18). This reaction results in the formation of 34, however 
the synthesis required a second purification step, where a solution of 34 in toluene was stirred 
with a water/alcohol mix to dissociate any ions bound to the pyrazine nitrogen. 34 was isolated 
in a 91 % yield and the 1H and 13C NMR spectra confirmed its formation. 
 
Scheme 4.18. The reaction of an organozinc reagent with 1 to give 34. 
The final 1H NMR spectrum showed a small amount of an unidentified impurity 
(approximately 5 %). It is likely that these could be separated if this synthesis was to be widely 
applied. For example, in the synthesis of 1, the final product is heated to 110 °C in DMSO to 
remove coordinated mercury ions.41 
4.6 Reaction of 14 with aryl zinc iodide 
Metal-sulfur bonds are typically considered strong bonds and the exposure of catalysts to 
sulfur containing species can result in catalyst poisoning.42 Despite this, the hard-soft acid-
base description is sometimes used to describe metal complexes. Using this analogy, where 
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gold(III) is described as a hard acid and a thiolate as a soft base, one may expect the Au(III)–
sulfur bonds, to be weaker than an Au(III)–O bond (two hard species). However, we have 
previously shown that the reaction of thiols with gold(III) phenolate complexes results in the 
formation of an Au–S bond (Section 3.13). The dissociation of Au–S bond in the diatomic 
AuS species has been experimentally determined as 308(5) kJ/mol,43 higher than that of Au–
O bonds in diatomic AuO species experimentally determined as 225 kJ/mol,44 comparison of 
these values may be limited as they were obtained using different methods. 
Therefore, further understanding of the nature of the Au–S bond would be advantageous. The 
(C^N^C)Au–SR complexes synthesised in Chapters Two and Three are stable to air and water, 
but the Au–S bond can be broken in the presence of a strong acid (HCl in section 3.9.3). As 
well as understanding the nature of the Au–S bond, it would be interesting to exchange an Au–
S bond for a potentially more synthetically useful Au–C bond through transmetallation.  
Following the success of the reactions of organozinc reagents with 1 and 2, two molar 
equivalents of p-Me-phenyl zinc iodide were added to a solution of 14 in toluene (Scheme 
4.19). The transmetallation product 33 was isolated as a solid in 70% yield. To the best of our 
knowledge, this is the first example of transmetallation of an Au–S bond.  
 
Scheme 4.19. The reaction of an organozinc reagent with 14 to give 33. 
To investigate the range of gold(III) thiolate species that can be used in this reaction 11 and 4 
were dissolved in toluene-d8 and reacted with two molar equivalents of p-Me-phenyl zinc 
iodide (Scheme 4.20). This led to the formation of transmetallation products 33 and 34 
respectively. Therefore, these reaction conditions are tolerant of alkyl, aryl and heterocycle 
thiolates.  
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Scheme 4.20. The reaction of gold(III) thiolates 11 and 4 with an organozinc reagent. 
When the reactions in Scheme 4.19 and 4.20 were studied by in situ 1H NMR spectroscopy, 
the spectrum of the finished reaction had no signals corresponding to the thiolate or formation 
of free thiol. Instead a black precipitate was observed; this could be because of formation of 
reduction products. The removal of the thiolate species with the zinc prevents the potential for 
reductive elimination from the gold(III) aryl species formed as seen in Chapter 3.  
4.7 Reaction of 14 with boronic acids 
Boronic acids have proved to be versatile transmetallation agents capable of the 
transmetallation of Au–O, Au–F and Au–Cl bonds. The reaction of 14 with 1.5 molar 
equivalents p-methoxyphenyl boronic acid in toluene at room temperature showed no change 
in the 1H NMR spectrum over 24 hours. After heating the reaction for 60 °C for 48 hours there 
was still no change observed in the 1H NMR spectrum. Therefore, boronic acids are unsuitable 
reagents for the transmetallation of Au–S bonds under these conditions.   
4.8 Reaction of Au–O bonds with boron reagents  
Boron reagents are widely used in synthetic chemistry and boronic acids have previously been 
used in the transmetallation of an Au–O bond.8,14 Therefore, reactivity with gold(III) 
complexes containing an Au–O bonds with several boron based reagents were investigated. 
The reaction of the gold(III) hydroxide 35 with pinacolborane (H–Bpin) at room temperature 
resulted in the formation of a gold(III) hydride 36 (Scheme 4.21). The formation of the hydride 
is likely to be through transfer of the hydride from the pinacolborane and formation of a strong 
B–O bond in HO–Bpin. As there are several previously reported syntheses of 36, this reaction 
was not investigated further.45  
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Scheme 4.21. The reaction of 35 with H–Bpin. 
Addition of bis(pinacolato)diborane to (C^N^C)Au-OR (R = H and tBu) in a J Young NMR 
tube was monitored by 1H and 11B NMR spectroscopy, but no changes were observed (Scheme 
4.22). Upon heating to 60 °C there was still no change observed in the 1H or 11B NMR spectra. 
Therefore, despite the potential to form a strong B–O bond, the B–B bond is more stable than 
the B–H bond and formation of an Au–B bond was not favoured under these conditions.  
 
Scheme 4.22. The no reaction between either 35 or 37 with bis(pinacolato)diborane. 
Previous reports of the reaction of bis(pinacolato)diborane with potassium tert-butoxide 
results in quaternarization one boron centre through the formation of a third B–O bond, which 
consequently alters the polarisation of the B–B bond.30b These have been considered as mild 
sources of nucleophilic boron compared to the stronger boryls.46 As these sp2–sp3 diboranes 
have been used as boron nucleophiles their reactivity with Au–O bonds was probed. The 
reaction of (C^N^C)Au–OR (R = H and tBu) and (Bpin)2 in the presence of potassium tert-
butoxide resulted the formation of the previously reported anionic boron species but this did 
not react further with the gold complex 37.  
4.9 Investigating the reaction of Au(III)-O bonds with Me2PhSi–Bpin  
Dimethylphenylsilyl boronic pinacol ester (Me2PhSi–Bpin) is commercially available, and 
previous reports of its transmetallation of M–O bonds made it an interesting reagent to 
investigate with this system.29 The transmetallation of gold(III) complexes by boronic acids 
had found 35 to be a successful starting point.8 Therefore, this was the first starting material 
chosen. The reaction of 35 in toluene-d8 with two molar equivalents of Me2PhSi-Bpin was 
monitored by 1H NMR spectroscopy but unfortunately gave a complicated mixture of products 
Chapter Four 
 
95 
 
as well as decomposition of the gold(III) species. The reaction of (C^N^C)Au–(OAcF) in 
toluene-d8 with two molar equivalents of Me2PhSi-Bpin also resulted in decomposition. 
However, the reaction of (C^N^C)Au–(OtBu) (37) in toluene-d8 with two molar equivalents 
of Me2PhSi-Bpin cleanly formed a single product over 24 hours (Scheme 4.23). The structure 
of 38 was confirmed by 1H and 13C NMR spectroscopy.  
 
Scheme 4.23. The synthesis of 38. 
1H NOESY NMR revealed the presence of spatial interactions between the methyl groups on 
the silicon (H14) and both those of the C^N^C pincer ligand (H8) and the o-phenyl protons 
(H11) (Figure 4.1).  
 
Figure 4.1. 1H NOESY spectrum showing spatial interactions between H8 and the functional 
groups on the silicon in complex 38 (C6D5CD3, 25 °C). 
Diffusion NMR using PGSE (pulse gradient spin echo) NMR experiments confirmed that all 
signals ascribed to 38 diffused at the same rate, indicating that an Au–Si bond had been 
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formed. The signals corresponding to the solvent, unreacted Me2PhSi–Bpin and 
tBuO–Bpin 
all diffused at faster rates. Therefore Me2PhSi–Bpin is a suitable reagent in the 
transmetallation of Au–OtBu species to form a gold(III) silyl complex.  
Optimisation of this synthesis was not as straight forward as initially expected. In the synthesis 
in Scheme 4.23, 37 was formed in situ by reacting 2 with one molar equivalent of potassium 
tert-butoxide. However, isolating a pure sample of 37 was unsuccessful despite its synthesis 
being reported.47 If a sample of 37 in 90 % purity was reacted with Me2PhSi–Bpin a mixture 
of decomposition products was observed and therefor was unsuccessful in the synthesis of 38. 
There was no reaction upon addition of two molar equivalents of Me2PhSi–Bpin to 2 in CD2Cl2 
over 2 days at room temperature. Addition of potassium tert-butoxide to a mixture of 2 and 
Me2PhSi–Bpin also resulted in the formation of decomposition products.  
The optimised conditions developed required 2 and 1.5 – 2.0 molar equivalents of potassium 
tert-butoxide to be suspended in toluene. Heating to 60 °C and shaking this suspension 
resulted in the formation of a clear and bright-yellow solution. The 1H NMR spectrum 
confirmed the conversion of 2 to 37 and the presence of excess potassium tert-butoxide. To 
this solution was added 1 – 2 molar equivalents of Me2PhSi–Bpin and the reaction was left at 
room temperature until complete conversion after 24 hou`rs. The reaction did not appear to 
improve greatly by increasing the molar equivalents of Me2PhSi–Bpin to 5. However, 37 
converted to 38 more cleanly if there was an excess of potassium tert-butoxide present. 
Interestingly, the excess potassium tert-butoxide observed in the initial 1H NMR spectrum of 
37 was immediately consumed upon addition of Me2PhSi–Bpin. This indicates that 
transmetallation is aided by the presence of a base.  
This synthesis differs from previous synthetic methodologies used to make gold silicon 
species, which have used lithiation of the silane or oxidative addition of an Si-Si bond. The 
reaction conditions used here are much milder and proceed at room temperature.  
Decomposition was observed upon exposing 38 to air. In addition, filtering 38 without drying 
the filter overnight resulted in decomposition, indicating that 38 is water sensitive. The Au–Si 
bond is therefore less stable than Au–C and Au–S bonds which are both stable to atmospheric 
conditions. The weaker Au–Si bond may also be able to react with other substrates, potentially 
through expanding the coordination sphere of silicon, which is not possible for gold(III).  
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4.9.1 Initial experiments into insertion reactions 
The previously isolated gold(I) silicon species were capable on inserting alkynes into the Au–
Si bond. Initial studies of the reactivity of 38 with alkynes used an unactivated alkyne (2-
butyne) and an activated alkyne (dimethyl acetylenedicarboxylate).  
The samples of 38 were filtered prior to addition of the alkynes to remove any excess solid 
potassium tert-butoxide due to previous reports of the reactivity of Me2PhSi–Bpin with 
alkenes in the presence of potassium tert-butoxide.48 Filtration was often a cause of 
decomposition of 38, presumably due to small quantities of water in the filter. Addition of an 
excess of the two alkynes (5 to 10 molar equivalents) to solution of 38 in toluene was 
monitored by 1H NMR spectroscopy at room temperature. Over one month no changes were 
observed in the 1H NMR spectrum, therefore we observed no insertion reactivity.  
Conclusion 
We have shown that the organozinc reagent p-Me-phenyl zinc iodide can be used in the 
transmetallation of Au–Cl and Au–S bonds under the conditions described above. This reduces 
the number of steps in the synthesis of gold(III) aryls compared to previous reports. By varying 
the reaction conditions either halide exchange or transmetallation products were isolated 
cleanly. It has been previously discussed that the transmetallation of alkyl groups to gold 
centres has been under-explored.1 Therefore, extending this study to other commercially 
available organozinc reagents could result in new functionalised species and would explore 
the potential scope of this reaction.  
We have also shown that it is possible to use Si–B compounds in the transmetallation of 
gold(III) alkoxides. This is the first report of an Au–Si bond that is stable at room temperature 
without being part of a chelate ligand. The water-sensitivity of these Au–Si complexes resulted 
in frequent decomposition and limited the reactivity studies. Further investigations into the 
reactivity of 38 could be of interest. Potentially synthesising C^N^C gold silyl complexes with 
bulkier substituents might stabilise the Au-Si bond, as previously demonstrated by Bourissou 
et al.. The possibility using more forcing conditions in the insertion reactions or investigating 
the insertion other unsaturated substrates such as isocyanides and carbon monoxide into 
Au(III)–Si bonds may also be of interest.  
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Introduction  
Recent interest in the development of gold(III) based anticancer agents has its origins in the 
success of cisplatin, a widely used platinum(II) anticancer agent, isoelectronic with gold(III).  
5.1 Platinum based anticancer agents 
The break through discovery of cis-diamminedichloroplatinum(II) (cisplatin) in 1965 helped 
establish a new area of anticancer drugs based on metal complexes.1 Cisplatin has been in 
clinical use since 1979 and is still used today in the treatment of testicular, ovarian, lung and 
breast cancers.2 Cisplatin is a neutral, square-planar, platinum(II) complex (left, Figure 5.1); 
the corresponding trans isomer is less active.3 Following its success, further square-planar 
platinum(II) complexes have been developed and entered clinical use including carboplatin4 
and oxaliplatin5 (middle and right, Figure 5.1). 
 
Figure 5.1. Left to right: cisplatin, carboplatin and oxaliplatin. 
Understanding the mode of action of a drug is complex and many years of investigations have 
led to the elucidation cisplatin’s mode of action (simplified scheme in Figure 5.52).3,6 The 
active species has been identified as [Pt(NH3)2Cl(OH2)]
+, which is formed through partial 
hydrolysis of cisplatin. This compound is proposed to bind to nitrogen donors of purine bases 
(adenine and guanine) in DNA, which distorts the DNA double helix structure. The binding 
occurs through displacement of a water molecule in the active species. The distorted DNA 
structure that is formed is recognised by DNA repair enzymes and leads to cell apoptosis (cell 
death). The active species ([Pt(NH3)2Cl(OH2)]
+) can also be deactivated by the formation of 
Pt-S bonds with glutathione (GSH), which is often over-expressed in cancerous cells.  
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Figure 5.2. A simplified mode of action of cisplatin. 
Although cisplatin can be a very powerful therapeutic agent, there are several drawbacks to 
its use as a chemotherapy drug, such as strong side effects including: vomiting and damage to 
the nervous system and kidneys, and acquired resistance (when it enters the cell in sub-toxic 
concentrations).2 In an attempt to overcome the side effects and make systems that target 
cancerous cell specifically, interest has turned to more complex platinum systems as well as 
new metallodrugs based on other transition metals.7 This includes recent interest in gold(I) 
and gold(III) anticancer agents.8 This chapter focuses on gold(III) systems, with particular 
interest in gold(III) NHC complexes supported by C^N^C pincer ligands. 
Despite its drawbacks, cisplatin is still the benchmark to which all metallodrugs are compared. 
For a metallodrug to be considered as a viable option it must be more active against and 
specific than cisplatin. The anticancer activity is quantified by an IC50 value which is specific 
for each complex and cell line. It is the concentration required to inhibit 50% of the cells from 
growing, therefore a successful anticancer drug would have a low IC50 for cancerous cell lines 
and a high IC50 for the noncancerous cell lines. 
5.2 Cyclometallated gold(III) complexes as anticancer agents  
Significant initial interest in gold(III) anticancer agents was based on them being isoelectronic 
to platinum(II) complexes, both are d8 square planar complexes.8 In physiological conditions 
thiols are thought to reduce gold(III) complexes, however complexes containing Au-C bonds 
are more stable to reduction to gold(I) and gold(0) by cellular reductants such as GSH and 
ascorbic acid.9 Various cyclometallated complexes, employing a range of ligand systems 
including: (C^N), (C^N^N) and (C^N^C), have been reported to show promising anticancer 
properties.8-10 Figure 5.3 depicts a representative selection of gold(III) complexes that have 
been investigated as anticancer agents. Complex C is one of the initial gold(III) complexes to 
exhibit anticancer properties.11 The complex showed high cytotoxicity against several 
cancerous cell lines and further analogues were synthesised through chloride substitution that 
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also showed anticancer properties. C had poor solubility in aqueous media, but solubility was 
increased upon chloride substitution. The substitution reactions of the chloride ligand by N, S 
and O donors is reminiscent of cisplatin’s reactivity with water.11-12 The anticancer properties 
were proposed to be caused by the inhibition of the enzyme thioredoxin reductase (TrxR).13  
Complex D, supported by a C^N ligand, showed anticancer properties against several cancer 
cell lines, with slightly lower activity than cisplatin.14 The cationic complex E stabilised by a 
tridente N^N^C, showed similar anticancer properties, but also activity against several 
cisplatin resistant cell lines.14-15 Both D and E were resistant to reduction by cellular thiols and 
investigations into their interactions with biological processes showed inhibition of TrxR.16 
The anticancer properties of F showed greater inhibition of the growth of cancer cells over 
health cells.9,17 This complex was water soluble, which is an advantageous property for an 
anticancer agent. In addition, studies into its reactivity with GSH showed adduct formation. It 
was suggested that either F or its GSH adduct damaged the endoplasmic reticulum leading to 
cell death. Complex G uses the same supporting ligand but a different hydrophilic ligand, 
dithicarbonate.18 Both F and G were designed as cationic complexes that combine both 
lipophilic and hydrophilic ligands to increase both water solubility and cell uptake.10a,19 
Complex G is considerably more toxic to cancer cells than to healthy cells and showed good 
selectivity. It was unreactive towards GSH and was shown to target deubiquitinases, which 
are involved in many intercellular processes.  
Complex H showed anticancer activity but its analogues, synthesised through chloride 
substitution to give thiosalicylate, dithiocarbamates and catecholate complexes, showed 
higher activity than H against the cell lines tested.20 Interestingly, selectivity between 
cancerous and healthy cells is observed for the cationic dithiocarbamate-substituted 
complexes. When probing intracellular targets, this group of complexes were shown to induce 
reactive oxygen species (ROS) production.  
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Figure 5.3. Examples of cyclometallated gold(III) complexes with anti-cancer properties. 
With this range of complexes several different potential cellular targets have been suggested 
and investigated. Interestingly they all differ from the targets of cisplatin, which they were 
initially synthesised to mimic. Whereas cisplatin predominantly causes cell death through 
DNA binding these complexes have been shown to induce ROS production,20d interact with 
the endoplasmic reticulum,17 or with proteines21 including disulfide reductases9 and 
deubiquitinases.18 It is important to note that the identification of an interaction with a cellular 
target does not confirm that specific interaction is responsible for cell death. 
5.3 Gold(III) carbene complexes as anticancer agents 
Complexes of N-heterocyclic carbenes (NHCs) have been identified as promising anticancer 
agents.22 The strong M-NHC σ bonds are often stable to physiological conditions and the 
structure of the carbenes are easily synthetically modulated.22a 
Several gold(III) NHC complexes studied for their anticancer properties are shown in Figure 
5.4. Complex I, bearing one NHC group and three chlorides, inhibits cell growth of several 
cancerous cell lines but was less active than cisplatin.23 Interestingly, its gold(I) analogue (with 
one NHC and one chloride ligand) is a more potent anticancer agent. It was proposed that the 
gold(III) complex (I) was likely to be reduced by cellular thiols, limiting its activity. Complex 
J, containing a second NHC, has lower IC50 values than both I and cisplatin.
24 The increase in 
inhibition of proliferation was linked to an increase in lipophilicity. Again, the gold(I) 
analogue was more active than J and it was proposed that J was reduced by cellular thiols.  
The cationic complex K was shown to have low IC50 values against cancerous cells and was 
more active than cisplatin.25 It was proposed that the active species resulted from dissociation 
of one NHC ligand. Cationic complexes using these ligands were two orders of magnitude 
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more active than neutral species, this was linked to an increased lipophilicity of two NHCs.  
Once again, the gold(I) analogue bearing two NHC ligands showed high activity, almost 
identical to K. This could indicate that the active species is a gold(I) complex, however the 
potential activity with reductants, such as cellular thiols, was not discussed.  
The N^N^N based gold(III) NHC complexes L and M were designed to be reduced under 
physiological conditions to form a gold(I) NHC complex and release highly fluorescent 2,6-
bis(imidazol-2-yl)pyridine and 2,6-bis(benzimidazol-2-yl)pyridine ligands.26 Reactions of 
these complexes with glutathione (GSH) did reduce the complexes, releasing the fluorescent 
moiety, [GSAu-NHC] and GSSG. Cystine based compounds were also able to trigger 
reduction but ascorbic acid was insufficiently reducing. In addition, variation of the NHC R 
groups altered the water solubility (pharmaceutical agents are ideally water soluble), gold(III) 
NHC complexes with methyl substituents were water soluble, but the complexes with longer 
alkyl chains were insoluble. Anticancer studies showed suppression of tumour growth, with 
the gold(I) NHC presumed to be the active species formed in situ, therefore these complexes 
are both fluorescent probes and anti-cancer agents.  
 
Figure 5.4. Gold(III) NHC complexes. 
Many of these gold(III) NHC complexes were proposed to be reduced to gold(I) species by 
cellular reductants, which were the active species. In some systems the gold(I) was 
independently synthesised and these analogous were more active than the corresponding 
gold(III) NHC complexes. Therefore, understanding the reactivity of these gold(III) NHCs 
with cellular reductants, such as thiols, is important.  
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5.4 (C^N^C)gold(III) NHC complexes as anticancer agents  
The C^N^C pincer system has been widely used for a broad range of applications due to its 
stabilisation of gold(III). Through alteration of X in (C^N^C)Au-X, a plethora of different 
complexes including phosphines,27 pyridines,27 acetylides28 and thiolates28 have been 
synthesised and tested as anticancer agents. A study into the potential anticancer properties of 
(C^N^C)Au-SPh demonstrated that it was not an active anticancer agent.28   
While the gold(III) NHC complexes in Section 5.3 were vulnerable to reduction, the C^N^C 
pincer allows access to stable NHC complexes. Initial studies into cationic gold(III) NHC 
complexes used N (Figure 5.5).29 This complex was particularly potent, with sub-micromolar 
IC50 values against several cancerous cell lines that were lower than cisplatin and active 
against cisplatin-resistant cell lines.29b,30 Interactions with DNA were observed, this was 
proposed to be through intercalation. It was also shown to poison topoisomerase I, an enzyme 
that unwinds DNA. Due to its high activity in vitro, in vivo studies in mice were carried out 
and showed suppression of tumour growth without causing weight loss or death of the mouse.  
 
Figure 5.5. A C^N^C gold(III) NHC complex. 
Further alterations on this lead complex looked at changing both the pincer ligand and the 
NHC. Altering the length of the alkyl groups attached to the nitrogen in the NHC showed that 
butyl groups had the highest activity and selectivity for inhibiting growth of cancer cells over 
healthy cells, while increasing the length further decreased the activity (left, Figure 5.6).31 An 
NHC linking two gold(III) pincer complexes was shown to be less toxic than N.29b Altering 
the C^N^C pincer ligand resulted in higher IC50 values than N, reducing the toxicity (right, 
Figure 5.6).29b  
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Figure 5.6. Further C^N^C gold(III) NHC complexes. 
To understand how the C^N^C gold(III) NHC complexes target cellular mechanisms, two 
complexes were developed as probes (Figure 5.7).31 These complexes contain two separate 
functionalities, one photoactive and the other able to undergo click chemistry, while 
maintaining the basic scaffold of the C^N^C gold(III) NHC complexes. Neither probe 
complex had an adverse effect on the bioactivity compared to the complexes they were 
modelling, they were both potent anticancer agents. The probes were suitable for use in both 
in vivo and in vitro studies. They showed that gold(III) NHCs bind to six different proteins, 
which had previously been identified as potential anticancer targets.  
 
Figure 5.7. C^N^C gold(III) NHC probe complexes. 
The C^N^C system was further altered through substitution of the central pyridine for a 
pyrazine and addition of tert-butyl groups. Two NHC complexes (41 and 42) using this ligand 
system showed anticancer properties (Figure 5.8).28 Further alterations allowed investigations 
into the effects the substituent and the charge of the complexes upon the anticancer properties.  
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Figure 5.8. Pyrazine based C^N^C gold(III) NHC complexes. 
In vitro antiproliferative studies using human promyelocytic leukaemia (HL60) cells showed 
cell proliferation was inhibited by 41 and 42 at 10 µM concentration of complex. IC50 values 
were determined for a range of cell lines including HL60 (Human Leukaemia), MCF-7 
(Human Breast Adenocarcinoma), A549 (Human Lung Adenocarcinoma Epithelial) and for 
comparison, healthy cells MRC-5 (Human Fetal Lung Fibroblast). Low IC50 values were 
observed for 41 against all cell lines, including healthy and cancerous, this lack of selectivity 
is undesirable. 41 had lower IC50 values than cisplatin, showing an increase in toxicity 
especially against cisplatin resistant cell lines. There was a difference in activity between 41 
and 42, with 41 being the more active, which was proposed to result from a higher cellular 
uptake of 41. This was proposed to result from polarity differences because 42 is more 
hydrophilic than 41. 
Investigations into interactions with potential cellular mechanisms showed that a mixture of 
41 and GSH did not react over 72 hours. This is the typical experiment time for the anticancer 
studies, indicating that this is not a deactivating pathway. 41 and 42 were shown to stabilise 
secondary DNA structures, it was proposed that both the π system and cation are required for 
DNA stabilisation. The final cellular target investigated was the inhibition the of MDM2−p53 
interaction. Disruption of the binding of MDM2 with p53, a protein that inhibits tumour 
growth, has been identified as a promising anticancer target. A strong interaction between 41 
and MDM2 was observed, specifically with the hydrophobic area. Due to the interaction of 
41 with intracellular targets it was identified as a promising lead molecule for future 
development of gold(III) anticancer agents. 
Subsequently, C^N^C stabilised gold(III) acyclic carbene complexes decorated with amino 
acid derivatives were developed (Figure 5.9).32 Investigations into their anticancer properties 
showed high activity against cancerous cells with IC50 values calculated for the most potent 
compounds for cell lines including HL60, MCF-7, A549, HCT-116 (colon), MDA-MB-231 
(breast adenocarcinoma) and compared to healthy cells (MRC-5). The overall activity was 
similar to 41, the selectivity for antiproliferation towards cancerous cells over healthy cells 
was still poor, though marginally more selective. 
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Figure 5.9. Acyclic carbenes with amino acid derivatives. 
Investigations into their reactivity with GSH showed the oxidised GSSG species forming after 
24 hours. Identification of the gold species formed was less conclusive but was assumed to be 
a gold(I) product, therefore these complexes are more sensitive to GSH than 41. The final 
cellular target investigated for these species the formation of reactive oxygen species (ROS). 
There was no increase in ROS formation for any complex, therefore it was proposed as an 
unlikely cause of cytotoxicity for this class of compounds.  
In this system it was possible to assess the impact of anion alteration. The anticancer properties 
of the same complex were investigated with both [SbF6]
- and [BF4]
- anions. There was no 
perceived difference in the antiproliferative effects at low concentrations, at higher 
concentrations the SbF6 analogue gave lower cell viabilities indicating limited implication of 
anions into the cytotoxic mechanism.  
A further approach to add complex functionality to C^N^C gold(III) NHC complexes used a 
modified benzimidazole based NHC.33 The position R on the NHC was decorated with 
bioactive moieties, including estradiol and biotin (Figure 5.10). Altering the linker length 
showed longer linkers (n = 5 in all cases) had the largest effect on the in vitro antiproliferation 
activity. The complexes showed slightly higher IC50 values against MCF-7 and MRC-5 than 
41 and showed no activity against A549. The uptake of complexes by cancer cells was 
selective towards those expressing the corresponding receptors. However, that selectivity did 
not translate to the higher activity in the antiproliferative assay where the compounds appeared 
generally less toxic that the non-vectorized complex 41. The interactions of the vectorised 
complexes with a potential biological target: the G-quadruplex structure of DNA revealed a 
reduced interaction compared to 41.  That reduced interaction with secondary DNA structures 
may explain the reduced antiproliferative activity. 
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Figure 5.10. Pincer gold(III) NHC complex decorated with bioactive molecules, n = 1, 3, 5.  
5.5 DNA binding properties  
The investigations into cellular targets for 41 and 42 looked at number of potential targets, 
including secondary DNA structures. Both strongly interacted with G-Quadruplexes and i-
motifs. These are formed from single stranded DNA rich in guanine and cytosine respectively. 
The potential for other nucleotides to form secondary structures has been investigated. 
Thymine can also from quartets however they are less stable the G-quartets because they are 
unable to form a stabilising interaction with alkali metal cations.34  
5.5.1 G-quadruplexes 
G-quadruplex forming sequences are found in the telomeric region of DNA, at the ends of 
eukaryotic chromosomes.35 Telomeres are made up of many repeating guanine units and 
correspondingly cytosine in the other strand. They are supposed to protect or buffer the coding 
region of the chromosome from degradation. These single stranded guanine rich sequences 
can assemble into four stranded DNA structures called G-quadruplexes.34 A G-quadruplex is 
formed from two or more π stacked guanine tetrads (G-quartet) linked in a stable planar 
arrangement by hydrogen bonded Hoogsteen pairings (Figure 5.11). In addition, the presence 
of alkali metal cations (represented as an orange circle, Figure 5.11) are important as they 
coordinate to oxygen atoms and can influence the stability of the structure. The stability of the 
G-quadruplexes is also affected by variable length of the loops on the exterior of the G-
quadruplexes, which are made of DNA bases not participating in the formation of a quartet.34 
The loops also allow the formation of cavities on the exterior of the G-quadruplexes which 
could be potentially interact with drug molecules. 
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Figure 5.11. left) A G-quadruplex; middle) a representation of quartet; right) a 
representation of the stacked system showing stacked quartet and loops of different sizes.34 
Telomerase is a normally inactive enzyme that allows telomere extension and is activated in 
many human cancers.36 Extending telomeres, extends the lifetime of a replicating cell, further 
removing cancer cells from normal cellular regulation. Telomerase recognizes only the linear 
form of DNA, so stabilizing the G-quadruplex structure in the telomeres could inhibit 
telomerase activity leading to the inhibition of cancer cells’ immortality.37 
A G-quadruplex sequence is also found in the promotor region of the MYC proto-oncogene, 
its formation can repress the transcription of this gene.38 The MYC proto-oncogene is 
overexpressed in almost 80% of solid tumours, therefore it is an interesting target to allow 
potential control of oncogene expression.   
The ability of gold(I) complexes to stabilise G-quadruplexes has been investigated in the case 
of the caﬀeine-based bis(NHC)gold(I) cation (Figure 5.12). Crystallographic data showed 
three gold complexes per G-quadruplex interacting through π stacking into accessible 
tetrads.39 Mass spectrometry confirmed the occurrence of aggregates of the complex with G-
quadruplexes with ratios from 1:1 to 1:3 in solution.  
 
Figure 5.12. Gold(I) complex used to stabilised G-quadruplexes. 
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The gold(III) complexes, shown in Figure 5.13, interact with G-quadruplexes but not with 
double-stranded DNA.40 The strongest binding affinity value was observed for the binuclear 
complex on the left. This affinity for G-quadruplexes was comparable to other metal-based 
complexes.41  
 
Figure 5.13. Gold(III) complexes used to stabilise G-quadruplexes. 
5.5.2 iMotifs 
DNA sequences rich in guanine have a complementary sequence rich in cytosine, these can 
also form secondary structures which are known as i-motifs (Figure 5.14).42 There is 
considerably less know about i-motifs compared to G-quadruplexes. I-motifs were first 
observed in acidic conditions and are formed of two parallel duplexes, arranged in an 
antiparallel fashion, which intercalate through hemiprotonated cytosine-cytosine base pairs 
(left, Figure 5.14).43 The ability to trigger folding depending on the pH of the media has been 
investigated, allowing reversible i-motif formation.42 
 
Figure 5.14. a) Hemiprotonated cytosine- cytosine base pair; b) Schematic view of an i-
motif.42 
There are examples of interactions between other nucleotides in the loop regions contributing 
to stabilisation of i-motifs, such as the formation of an A-T base pair.44 The nature of cations 
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present in solution is also thought to affect the conformations formed.45 Furthermore, 
development of sequences of i-motifs that are stable at physiological pH instead of acidic pH 
have been investigated.46 Again, stabilization of i-motifs is an interesting potential target for 
anticancer drugs because they have been shown to alter both telomerase activity and oncogene 
expression in similar manor to G-quadruplexes.42 
These secondary structures are of interest, but their formation requires single cytosine-rich 
strands of DNA to be freed from their complement. In order to understanding their formation 
DNA transcription has been examined, a process during which the double helix of duplex 
DNA is unwound releasing single stranded DNA.47  
5.6 Objectives 
This work follows the previous research by the Bochmann and Che groups into gold(III) NHC 
complexes stabilised by pincer ligands that have shown promising anticancer properties. As 
discussed, alteration of the NHCs with biologically relevant molecules has been probed, but 
simple NHC complexes such as N and 41 are more potent anticancer agents. Extending the 
series of complexes in a systematic manner using three pincer ligands and three NHC ligands 
with minor changes could help to identify factors that influence anticancer properties.  
The C^N^C ligand systems chosen to be investigated were 1,5-diphenyl substituted pyrazine, 
pyridine or p-methoxy substituted pyridine. Both the pyridine and pyrazine based C^N^C 
gold(III) have been used anticancer studies, however the p-methoxy substituted pyridine had 
previously only been used in the synthesis of gold(III) hydrides.48 Previous work has shown 
gold(III) NHCs based on 1,3-dimethylbenzimidazolium, 1,3-dimethylcaffeine and 1,3-
dimethylimidazolium to have anticancer properties. To minimise the parameters being varied, 
the dimethyl NHC analogues were used for all complexes. 
Results and discussion 
5.7 Synthesis and characterisation of gold(III) carbenes (40-48) 
The complexes were synthesised using three separate methods, one for each of the different 
NHC ligands. Firstly, the 1,3-dimethylimidazolium NHC’s (40, 43 and 46) were synthesised 
by taking 1.5 molar equivalents 1,3-dimethylimidazolium iodide, one molar equivalent of 
Ag2O and stirring in acetonitrile (Scheme 5.1). A slight excess of 1,3-dimethylimidazolium 
iodide was used due it its hydroscopic nature. The corresponding pincer gold(III) chloride (1, 
2, 39) was added along with an excess of KPF6 for anion exchange. The complexes 40, 43 and 
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46 were isolated as solids in good yields (88 – 94%). This uses a different method than 
previously reported for the synthesis of 43.29a  
 
Scheme 5.1. The synthesis of 40, 43 and 46. 
The 1,3-dimethylbenzimidazolium NHC’s (41, 44 and 47) were synthesised using the same 
methodology to the 1,3-dimethylimidazolium NHCs gold complexes above but using one 
molar equivalent of 1,3-dimethylbenzimidazolium iodide and dichloromethane as the solvent 
(Scheme 5.2). The complexes were isolated as solids in good yields (83 - 96%). This is a 
different method to that previously reported for 41.28 
 
Scheme 5.2. The synthesis of 41, 44 and 47. 
The 1,3-dimethylcaffeine based NHC’s (42, 45 and 48) were synthesised using a different 
methodology because the method described above did translate to this system. The required 
gold(III) chloride (1, 2 or 39) to be stirred with potassium tert-butoxide before adding [9-
methylcaffeinium][BF4] and the reaction was heated overnight (Scheme 5.3). Complexes 42, 
45 and 48 were isolated as solids in reasonable yields (49 - 69%). 
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Scheme 5.3. The synthesis of 42, 45 and 48. 
The synthesis of the p-methoxy substituted complexes 46 and 47 required longer reaction 
times than their analogues based on unsubstituted pyridine and pyrazine ligands. The increase 
in reaction time for the final step from 16 hours to 8 days indicates that the Au–Cl bond 
strength increases in the p-OMe substituted pyridine systems.  
All complexes were characterised by 1H and 13C NMR spectroscopy and elemental analysis.  
A crystal of 46 suitable for X-ray crystallography was obtained (Figure 5.15). The asymmetric 
cell contains two molecules of 46, with nearly identical parameters. The crystal structure 
showed the expected connectivity, with the gold in a distorted square planar geometry. The 
NHC twists out of the plane of the pincer ligand with an angle of 65.6(4) and 66.5(4)° for each 
of the molecules, which is similar to the previously reported L where the angle was 53.6°.29a 
Au–C and Au–N bonds in a trans position to each other across the gold centre have bond 
lengths of Au(1)–C(171) = 1.981(11) Å and Au(1)–N(11) = 2.001(8) Å. In the previously 
reported N with the same NHC but using a pyridine based pincer ligand Au–C(NHC) bond 
was 1.999(7) Å which is similar, however the trans Au–N was 1.975(4) Å is slightly shorter 
than the one observed here. In 41, which used a pyrazine based pincer ligand and a 1,3-
dimethylbenzimidazolium based NHC, the Au−C(NHC) was 1.995(10) Å, which is similar to 
the other two Au–NHC bonds and an Au−N distance of 1.991(9) Å, which is between N and 
46.28 In all the C^N^C supported gold(III) NHC complexes the bond lengths are fairly similar, 
with the largest difference observed for Au–N bond across different pincer ligands, but this is 
still small. However, using a N^N^N based pincer system with an imidazole NHC gives Au–
C(NHC) bond length of. 2.048 Å, which is longer (complexes shown in Figure 5.4).26  
The crystal packing of 46 shows stacks of the cationic gold pincer complex.  There is partial 
overlap of the pyridine and one phenyl ring of the two ligands, approximately 3.5 Å apart.  
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Figure 5.15. Crystal structure of 10, PF6 anion is omitted for clarity. Selected bond distances 
[Å] and angles [°]: Au(1)-C(171) 1.981(11), Au(1)-N(11), 2.001(8), Au(1)-C(162) 
2.071(10), Au(1)-C(122) 2.075(9), C(171)-Au(1)-N(11) 179.1(4), C(171)-Au(1)-C(162) 
99.3(4), N(11)-Au(1)-C(162) 81.5(4), C(171)-Au(1)-C(122) 98.2(4), N(11)-Au(1)-C(122) 
81.0(3), C(162)-Au(1)-C(122) 162.5(4). 
5.8 Anticancer properties of 40 – 48  
Dr Benoit Bertrand carried out all experiments in section 5.8. 
5.8.1 In vitro antiproliferative activity 
The in vitro antiproliferative activity of the complexes was tested against the human lung 
adenocarcinoma epithelial (A549) cell line, which is cisplatin-resistant. The resistance of this 
cell line is thought to result from an over expression of DNA repair enzymes. As the A549 
cell line had previously shown the largest difference in activity between the two gold(III) NHC 
complexes (41 and 42) it was used to see if the systematic changes across the series 40 – 48 
affected their anticancer activity.28 
The antiproliferative activity was investigated at two concentrations 10 and 100 µM in culture 
medium after predilution in DMSO to reach the non-toxic concentration of 1 % DMSO. The 
extent of proliferation of A549 cells was determined using an MTS assay after 72 hours of 
incubation with the complexes (experimental section 6.7.1). In an MTS assay a purple 
compound is produced through the metabolism of an organic molecule (MTS) by living 
mitochondria.  The level of absorption at a given time is proportional to the number of living 
cells under the specific conditions being tested, which is used in the estimation of the cell 
viability upon treatment with the complexes. The viabilities of the cells are shown at 10 and 
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100 µM concentrations for the complexes (Figure 5.16). The viability of the cells in the 
presence of cisplatin (prediluted in water instead of DMSO) is included for comparison.  
 
Figure 5.16. The antiproliferative activity of 40 – 48 against A549 cell line.  
At 100 µM concentration of 40 – 48, all complexes gave less than 10% cell viability except 
for 42 which gave 30% of cell viability after 72 hours, this is similar to what has previously 
been observed.28 Therefore these gold(III) NHC complexes are acting as anticancer agents. 
The pyrazine bases complexes 40 – 42 showed lower levels of antiproliferative activity 
compared to the pyridine base complexes 43 – 45 and p-OMe-pyridine complexes 46 – 48. 
For the complexes with less than 5% viability it can be considered that the complexes 
completely inhibited cell proliferation.  
At the lower concentration of 10 µM of 40 – 48, there was a slight increase in cell viability 
for most complexes, with all complexes apart from 42 showing less than 20% viability. At this 
concentration 42 was nontoxic to the A549 cells with no inhibition of proliferation.  
Cisplatin showed no inhibition of proliferation at either 10 or 100 µM concentration as the 
cell line is cisplatin-resistant. The selectivity between 41 and 42 had been of interest in 
previous studies, but the same difference in viability was not observed between 44 and 45 and 
47 and 48. Complexes 43 – 48 showed generally lower viabilities than observed for the 
pyrazine based system. 
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5.8.2 IC50 values 
As complexes 40 and 43 – 48 had shown strong cytotoxic effects at 10 µM in the initial 
antiproliferative assay, the IC50 values (the concentration to inhibit 50% of cell growth) were 
determined to quantify these observations. The cell viabilities were determined at a range of 
concentrations using an MTS assay, the experiment was repeated three times to give an 
average and standard deviation. These values were then used to determine the IC50 for the 
cisplatin resistant A549 cell line using GraphPad Prism version 5.0 software to identify the 
concentration at which 50% of cell growth is inhibited (Table 5.1). All complexes, except 42, 
were more toxic than cisplatin. Across the series of complexes, they all showed similar 
micromolar level IC50 values. There are no strong trends across the different pincers or the 
NHCs. The previously observed difference between 41 and 42 was not observed for the other 
pincers systems.  
Complex IC50 
cisplatin 33.7 ± 3.728 
40 5.35 ± 0.71 
41 7.8 ± 1.328 
42 >5028 
43 7.97 ± 0.33  
44 5.34 ± 0.12 
45 7.33 ± 0.54 
46 a 
47 5.72 ± 0.29 
48 5.94 ± 0.14 
Table 5.1. IC50 values for 40 – 48. (a) Due to infected cells it was not possible to obtain and 
IC50 value for this complex. 
The previous difference between the IC50 values of 41 and 42 was attributed to the difference 
in hydrophobicity of these two complexes.28 This explanation may justify the low IC50 values 
observed for the pyridine based complexes 43 – 45; the pyridine ligand is more hydrophobic 
than the pyrazine, therefore increasing the hydrophobicity of 45 compared to 42. The same 
explanation is unlikely to be the reason for the p-OMe-pyridine based system as a large 
difference in hydrophobicity is not expected. For the two complexes tested with this ligand 
system, 47 and 48, both had lower IC50 values than their pyrazine analogues, 41 and 42; the 
value for 48 is considerably lower than 42. Altering the size of the π system between the 1,3-
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dimethylimidazolium and 1,3-dimethylbenzimidazolium did not have a significant effect upon 
IC50 values. 
5.9 Investigating the interactions with DNA  
41 and 42 have previously been shown to interact with DNA, specifically stabilising non-
canonical secondary DNA structures: G-quadruplexes and imotifs.28 This interaction was 
proposed as a possible mode of action that contributed to the anticancer properties of these 
complexes. Therefore, the interactions of complexes 40 – 48 with DNA sequences was 
assessed using a Förster resonance energy transfer (FRET) DNA melting assay. A FRET assay 
is used to calculate the change in thermal stability of secondary DNA structures in the presence 
of compounds.49 The FRET assay requires the oligonucleotide being investigated be labelled 
with a fluorescent donor at one end (FAM  (6- carboxyfluorescein) is used in this study) and 
an acceptor at the other end (TAMRA (6- carboxytetramethylrhodamine) is used in this study). 
Over the course of the melt assay, the temperature is increased incrementally from 25 °C to 
95 °C and the emission of the fluorescence donor is monitored. When the single strand of 
DNA is in a folded conformation, such as a G-quadruplex or i-motif, the emission from the 
fluorescence donor is quenched. However, upon heating the DNA structure unfolds and the 
fluorescence donor and acceptor move further apart resulting in a fluorescent emission that is 
proportional to how unfolded the structure is and can be observed and monitored. Tm is the 
temperature at which the emission intensity is halfway between its minimum at low 
temperatures and its maximum at high temperatures, where 50% of the DNA is in a folded 
conformation.49 ΔTm is the difference between Tm in the presence of the complex and Tm of 
the control. The control contains the same concentration of labelled DNA in a buffer solution 
and 0.5 µL of DMSO (same volume and solvent used to dissolve the complexes). This gives 
a value that quantifies the stabilisation (positive ΔTm) or destabilisation (negative ΔTm) of the 
DNA structures.  
A range of FRET labelled DNA sequences were studied which could fold into different 
structures. These included three cytosine rich sequences capable of forming an i-motif: 
hTeloCFRET, c-MycCFRET and hif-1αFRET; a guanine rich G-quadruplex-forming sequence 
hTeloGFRET and double stranded DNA sequence DSFRET. Each of these DNA targets were 
studied at the transitional pH, where 50% of the population can be found in the folded 
conformation. Buffer solutions at known pH values were used, which also contained ions to 
stabilise the secondary structures at their transitional pH. The transitional pH is 6.0 for hTeloC, 
pH 6.6 for c-MycC and pH 7.2 for hif-1α, hTeloG and DS.50  
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An initial screening of the different DNA targets used 50 µM concentration of the complexes 
across all experiments. The concentration of the buffers (10 mM sodium cacodylate buffer at 
the indicated pH with 100 mM sodium chloride) and labelled oligonucleotide (0.2 µM) were 
kept constant. The ΔTm values were calculated, predominantly, by taking the first derivative 
of the melting curve. However, some complexes the melting curves never plateaued and in 
these cases the Tm was calculated manually by taking the intensity at 95 °C as the final 
intensity. This assumes that the secondary structures are unfolded at 95 °C, however the 
intensity of these curves was often much lower than other plateaued curves, so it is possible 
that there were still some stable secondary structures, or some of the DNA had precipitated, 
reducing the maximum fluorescent signal. This manual processing was used for all the melting 
temperatures of complexes 47 and 48, therefore the true ΔTm may be higher. The experiment 
was replicated in triplicate and the errors shown are the standard deviation of the three repeats. 
The positive ΔTm values shown in Figure 5.17 indicate that all the complexes interact and 
stabilise the DNA targets to some degree. The largest ΔTm values are seen for hTeloC and c-
MycC sequences, indicating strong stabilisation of i-motif structures under weakly acidic 
conditions. There were smaller ΔTm values for the i-motif structure based on the hif-1α 
sequence at pH 7.2. There was strong stabilisation of the G-quadruplex structure formed by 
the hTeloG sequence. By comparison, the interactions with double-stranded DNA was 
minimal, the highest values were observed for the p-OMe-pyridine based complexes 46 – 48 
and 44.  
 
Figure 5.17. ΔTm for complexes 40 – 48 with DNA targets.  
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The trends of activity can be more clearly observed by focusing on the DNA sequences with 
the largest ΔTm values (hTeloC, c-Myc and hTeloG shown in Figure 5.18). For each DNA 
structure, the p-OMe-pyridine based complexes (orange Figure 5.18, 46 – 48) provide 
marginally greater stabilisation than the pyridine based complexes (red Figure 5.18, 43 – 45) 
which in turn are more stabilising than the pyrazine based complexes (blue Figure 5.18, 40 – 
42). The NHC with the largest ΔTm is the 1,3-dimethylbenzimidazolium based carbene for 
each of the pincer systems. For the pyrazine and p-OMe-pyridine pincer systems the 1,3-
dimethylimidazolium based NHC had a slightly larger ΔTm than the caffeine based NHC, this 
order was reversed for the pyridine based pincer system, with a slightly larger stability 
observed for the caffeine based NHC compared to the 1,3-dimethylimidazolium.  
 
Figure 5.18. ΔTm of hTeloC, c-Myc and hTeloG using complexes 40 – 48, arranged by 
DNA. 
In the previous study of 41 and 42, it was proposed that the combination of the extended π-
system, charge and potential for hydrogen bonding to the uncoordinated pyrazine nitrogen 
acted in cooperation to stabilise the DNA structures. This family of complexes all contain a 
π-system and are charged and all stabilise the structures to a varying degree. However, the 
pyridine-based complexes do not have an uncoordinated nitrogen to enable hydrogen bonding, 
however they still interact, indicating that hydrogen bonding is not essential for stabilisation. 
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The initial screening, used to identify changes in stabilisation for each complex and DNA 
sequence, exposed the secondary DNA structures a 1:250 ratio of DNA to complex. A dose 
response assay was investigated to establish the stabilising effect of these complexes at lower 
concentrations. 44 and 47 were chosen this assay because the 1,3-dimethylimidazolium NHC 
had shown the strongest interactions in the initial screening. It also allowed direct comparison 
of the three C^N^C pincer ligands without altering the NHC because the dose response of 41 
had previously been investigated.28 Three DNA sequences hTeloC, hTeloG and double 
stranded DNA used were because these sequences cover three different structures, i-motif, G-
quadruplex and double helical DNA. The dose response experiments were duplicated and the 
errors shown are the standard deviation of the two experiments.  
The ΔTm response of 0.2 µM hTeloC labelled oligonucleotide at pH 6.0 buffer to varying 
doses of complexes 44 and 47 is shown in blue on the two graphs in Figure 5.19. The 
concentrations used are 0.25, 0.5, 1, 2, 5, 10, 20, 30 and 50 µM of complex, however a 
logarithmic scale is used to see the range of concentrations graphically. The degree of 
stabilisation is minor at concentrations below 10 µM for 44 and below 5 µM for 47. 
Concentrations of both 44 and 47 above 5 µM considerably stabilise the folded conformation. 
This indicates that 25 equivalents of complex:  oligonucleotides were required to provide 
stabilisation for both complexes. The experiment was repeated using the same dilutions of 44 
and 47 with 0.2 µM hTeloG labelled oligonucleotide in pH 7.2 buffer and the resultant ΔTm 
are shown in red on the two graphs in Figure 5.19. There is a large ΔTm for 44 and 47 above 
10 µM, at lower concentrations the stabilisation is much less. The experiment was repeated 
again using the same dilutions of 44 and 47 with 0.2 µM double stranded labelled 
oligonucleotide in pH 7.2 buffer and the changes in stabilisation (ΔTm) are shown in green in 
the graphs of Figure 5.19. Low ΔTm values were observed below 30 µM indicating that much 
more complex is needed to stabilise DS structures than either i-motif or G-quadruplex 
structures. 
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Figure 5.19. The ΔTm of hTeloC (blue), hTeloG (red) and DS (green) DNA sequences at a 
range of concentrations (left) complexes 44; (right) complex 47.  
At complex concentrations of 50 µM, the melting temperatures of the DNA structures are all 
positive, indicating the stabilisation of all structures; hTeloC is stabilised the most and double 
stranded the least. At low concentrations, less than 2 µM, there is very little stabilisation of 
any of the secondary structures. However, between these limits there are concentrations where 
the secondary structures are stabilised but there is minimal interaction with double stranded 
DNA.  
The dose response of 41 with these DNA sequences using the same conditions has been 
reported.28 It showed strongest interactions with the hTeloG sequence (40 °C at 20 µM) and a 
slightly weaker interaction with hTeloC (28 °C at 20 µM). These ΔTm values gradually 
decreased with decreasing concentrations up to 2.5 µM upon which the interactions 
considerably decreased. Again, there was least interaction with double stranded DNA 
sequence (14 °C at 20 µM). At 5 µM there was stabilisation of the secondary DNA structures 
and minimal stabilisation of double stranded DNA.  
The three (C^N^C)Au-(1,3-dimethylimidazolium) complexes, 41, 44 and 47, all stabilise 
secondary DNA structures. 41 stabilised hTeloG more than 44 and 47. Whereas 44 and 47 
provided the greatest stabilisation to hTeloC. All stabilised double stranded DNA sequences 
the least. Complex 44, with the pyridine C^N^C pincer ligand shows the largest stabilisation 
of secondary structures, whist not stabilising double stranded DNA at 20 µM.  
The most important outcome of the dose response assay is the observation that there are 
concentrations at which only the secondary structures are stabilised, between 5 and 20 µM. 
This is because it indicates a preference or specificity for non-canonical DNA structures. If 
these compounds were to be developed as anticancer agents, their interactions with the 
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secondary structures may serve to direct specifically to cells that were replicating rapidly, 
interfering with replication and therefore selectively target cancerous cells over healthy cells.    
5.10 Do thiols mimic the reactivity of glutathione (GSH)? 
Glutathione (GSH) is a tripeptide with an S–H functionality that has previously been shown 
to reduce gold(III) anticancer agents that are stabilised by N-donor pincer ligands.26 It is often 
over-expressed in cancerous cells and it has been demonstrated that cisplatin can react with 
glutathione to form of Pt–S bonds, which is a pathway in its deactivation.3,6  
Bochmann et al. previously studied the reactivity of complexes 41 with GSH in a dimethyl 
sulfoxide-d6 (DMSO-d6)/D2O mixture as the solvent.
28 The 1H NMR spectrum showed that 
after 6 days the major product was still 41, however additional signals indicated further 
products being formed. Due to the longer reaction time required (6 days) for additional 
products to be formed, compared to the 3 days required in the study of the biological activity 
experiments, it was concluded that the reaction of 41 and GSH was unlikely to be a 
deactivating pathway for 41.  
A limitation of the work reported by Bochmann et al. is the reduced solubility of the gold(III) 
complexes in the DMSO/D2O solution that is required to solubilize GSH. To overcome the 
solubility difference of GSH and C^N^C gold(III) NHC complexes, adamantyl thiol was used 
to mimic GSH. It is an alkyl-thiol and is soluble in DMSO, which is also a suitable solvent to 
dissolve (C^N^C)AuNHC complexes at concentrations detectable by 1H NMR spectroscopy. 
We previously demonstrated that thiols react with neutral gold(III) complexes to trigger either 
C-C or C-S reductive elimination (Chapter 3). 
Addition of 1 molar equivalent of adamantyl thiol to complexes 40 – 45 was studied by 1H 
NMR spectroscopy. The reaction was left at room temperature and monitored at regular 
intervals. After 3 days (the time required for the antiproliferation study) there was no change 
in the 1H NMR spectra for any of the complex. After 7 days there were additional signals 
observed in the 1H NMR spectra of 40, 42, 43 and 45. After 14 days the additional signals in 
the spectra for 40, 42, 43 and 45 had increased and there were also additional signals in the 1H 
NMR spectrum of 41. The only complex that appeared not to react with adamantyl thiol was 
44. The 1H NMR spectra for all complexes after 14 days showed that the main species present 
were still the unreacted starting materials. The reaction that had progressed the furthest over 
14 days was that of 43 and adamantyl thiol, the reaction mixture comprised of 87% of 43 to 
13% of a new product. The compound formed was not identified but could be reduction 
product as observed in Chapter 3. Therefore, there is minimal reactivity between adamantyl 
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thiol and complexes 40 – 45, with no reaction over the timescale of the antiproliferation study 
(3 days). This is similar to the reaction of 41 with GSH.28 
In the in vitro environment, the concentration of GSH is much higher than that of the complex. 
Therefore, the number of equivalents of adamantyl thiol was increased to 15 molar 
equivalents. In addition, the solvent was changed to dichloromethane to mimic the conditions 
used to study C-S reductive elimination. Complex 43 was chosen due to it showing the highest 
reactivity in the initial experiment. The reaction was monitored by 1H NMR spectroscopy. 
There were no changes observed in the 1H NMR spectrum over 2 months. Therefore it seems 
that the adamantyl thiol is unable to trigger reduction of (C^N^C)AuNHC complexes under 
these conditions in the same manner as previously observed in Chapter 3. These cationic 
complexes appear stable to reduction by adamantyl thiol over a time period greater than the 
biological assays, even at high concentrations of adamantyl thiol in a dichloromethane 
solution, in agreement with reactivity previously reported by Bochmann et al..28  
Conclusion  
We have synthesised and characterised a series of new gold(III) NHC complexes supported 
by pincer ligands. The antiproliferation study and IC50 values showed that these complexes 
are active as anticancer agents. The complexes were shown to interact and stabilise secondary 
DNA structures including i-motifs and G-quadruplexes. A dose response study showed that at 
low concentrations the secondary structures were stabilised, but there was little to no 
stabilisation of double-stranded DNA with these complexes, indicating a strong selectivity for 
non-canonical DNA structures. The lack of reactivity of these complexes with thiols, even at 
high concentrations, indicates a different mode of action of these complexes compared to 
many other gold(III) complexes have been previously proposed to interact with thioredoxin 
reductase. It also agrees with previous reports of the stability of C^N^C pincer ligands to 
biological thiols. This study further supports the potential of gold(III) NHC complexes as 
anticancer agents. Future work should investigate the use of NHCs decorated with biologically 
relevant moieties in combination with the pyridine or p-methoxypyridine ligand system that 
was shown to strongly interact with secondary DNA structures. It may also be interesting to 
combine this work with that of Che where increased selectivity for cancerous cells was 
observed for NHCs with longer alkyl groups attached to nitrogen.   
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6.1 General procedures 
When specified, manipulations were performed by using standard Schlenk line techniques 
under dry N2 or in a MBraun Unilab glovebox with a high capacity recirculator (<1.0 ppm O2 
and H2O). Nitrogen was dried by passing through columns of supported P2O5, with moisture 
indicator, and activated 4 Å molecular sieves. Anhydrous solvents were freshly distilled from 
appropriate drying agents. CD2Cl2 and toluene-d8 was stored in the glovebox over activated 4 
Å molecular sieves. The balances used were a Mettler Toledo AG104 (precision 0.1 mg) or 
KERN ACJ 220-4M (precision 0.1 mg). (C^Npz^C)AuCl (1),1 (C^Npy^C)AuCl (2),2 
(C^Npy^C)AuMe (19),3 (C^Npy^C)Au(p–C6H4F) (20),
3 (C^Npy^C)AuOC6H5 (26),
4 
(C^Npy^C)AuOH (35),3 [H(OEt2)2][H2N(B(C6F5)3)2] (HAB2),
5 (C^Npy-OMe^C)AuCl (39),6  
were synthesized according to literature procedures. 
1H, 1H PGSE, 19F, 13C{1H}, 1H NOESY, 1H, 13C HMQC and 1H, 13C HMBC NMR experiments 
were recorded on a Bruker DPX–300 spectrometer equipped with a 1H, BB smartprobe and 
Z-gradients. 1H NMR spectra are referenced to the residual protons of the deuterated solvent. 
13C NMR spectra are referenced to the D-coupled 13C signals of the solvent. 
Elemental analyses were carried out at London Metropolitan University with a Perkin-Elmer 
2400 CHNS/O microanalyzer. 
Mass spectrometry was carried out by the EPSRC UK National Mass Spectrometry Facility 
at Swansea University. 
6.2 Synthesis and characterisation 
6.2.1 Complexes in Chapter Two 
The general methods used in this chapter: 
Method 1: (C^Npz^C)AuCl (0.050 g, 0.087 mmol) and K2CO3 (0.024 g, 0.174 mmol) were 
dissolved in acetone (5 mL). The corresponding thiol (0.087 mmol) was added and the mixture 
was stirred at room temperature for 3 h. The acetone was removed in vacuo and the resulting 
solid was extracted into dichloromethane (5 mL). The suspension was filtered through celite 
and washed with dichloromethane (5 mL). The solvent was removed to give a solid. This was 
washed with cold hexane to give the desired product.  
Method 2: To a flask charged with (C^Npz^C)AuCl (0.040 g, 0.070 mmol) and potassium t-
butoxide (0.009 g, 0.084 mmol) under N2 was added dry toluene (5 mL), this was left to stir 
for 3 hours. Then the corresponding thiol (0.070 mmol) was added and reaction stirred for 
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further 3 hours. Solvent removed under vacuum, solid suspended in dichloromethane and 
passed through celite plug. The solution was evaporated to dryness to give the desired product. 
Method 3: Under a nitrogen atmosphere, a flask was charged with (C^Npz^C)AuCl (0.056 g, 
0.097 mmol), K2CO3 (0.027 g, 0.191 mmol) and degassed acetone (5 mL). The corresponding 
thiol (0.097 mmol) was added and the mixture was stirred at room temperature for 3 hours. 
The acetone was removed in vacuo and the resulting solid was extracted into dichloromethane 
(5 mL). The suspension was filtered through celite and washed with dichloromethane (5 mL). 
The solvent was removed. The solid residue was washed with cold hexane to give the desired 
product. 
(C^Npz^C)AuSPh (3) 
Synthesised using method 1 with thiophenol (0.013 
mL, 0.087 mmol) as the corresponding thiol. 3 was 
isolated as a yellow powder (0.054 g, 99% yield). 
Single crystals suitable for X-ray diffraction were 
obtained from slow evaporation of a solution in 
dichloromethane/isopropanol (9:1). Both red and 
yellow crystals were obtained under the same 
conditions.  
1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 8.85 (s, 2 H, H
2), 7.65 (m, 4 H, H5 + H11), 7.39 (d, 
4JH-H = 1.9 Hz, 2 H, H
8), 7.29 (dd, 3JH-H = 8.2 Hz, 
4JH-H = 1.9 Hz, 2 H, H
6), 7.21 (m, 3 H, H12 
+ H13), 1.17 (s, 18 H, tBu).  
13C{1H} NMR (CD2Cl2, 75.48 MHz, 298 K):  169.2 (s, C
9), 156.2 (s, C3/4), 156.1 (s, C3/4), 
145.0 (s, C7), 138.8 (s, C2), 137.6 (s, C10), 135.0 (s, C5/11), 131.5 (s, C8), 128.9 (s, C12), 126.7 
(s, C13), 125.7 (s, C5/11), 124.4 (s, C6), 35.6 (s, C(CH3)3), 31.1 (s, CH3). 
Elemental Microanalysis for C30H31N2AuS (648.2): C, 55.55; H, 4.82; N, 4.32. Found: C, 
55.47; H, 4.81; N, 4.38.  
(C^Npz^C)AuSC5H4N-2 (4) 
Synthesised using method 1 and 1-mercaptopyridine 
(0.010 g, 0.087 mmol) as the corresponding thiol. 4 was 
isolated as a yellow powder (0.041 g, 0.063 mmol, 72%). 
Single crystals suitable for X-ray diffraction were 
obtained from slow evaporation of a dichloromethane 
and isopropanol (4:1) solution.  
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1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 8.83 (s, 2 H, H
2), 8.25 (bd, 3JH-H = 4.9 Hz, 1 H, 
H14), 7.64 (m, 3 H, H5 + H11), 7.57 (d, 4JH-H = 1.9 Hz, 2 H, H
8), 7.40 (m, 1 H, H12), 7.29 (dd, 
3JH-H = 8.2 Hz, 
4JH-H = 1.9 Hz, 2 H, H
6), 6.96 (m, 1 H, H13), 1.19 (s, 18 H, tBu).  
13C{1H} NMR (CD2Cl2, 75.48 MHz, 298 K): δ 170.1 (s, C
9), 162.4 (s, C10), 156.7 (s, C3/4), 
156.4 (s, C3/4), 149.5 (s, C14), 144.8 (s, C7), 138.8 (s, C2), 135.8 (s, C12), 132.6 (s, C8), 127.8 
(s, C5), 125.8 (s, C6/11), 124.5 (s, C6/11), 119.9 (s, C13), 35.7 (s, C(CH3)3), 31.1 (s, CH3). 
Elemental Microanalysis C29H30AuN3S (649.61): C, 53.62%; H, 4.66%; N, 6.49%. Found: C, 
53.53%; H, 4.77%; N, 6.54%. 
(C^Npz^C)AuSNp-2 (5) 
Synthesised using method 1 and 2-naphthalenethiol 
(0.014 g, 0.087 mmol) to give 5 as an orange solid (0.051 
g, 0.073 mmol, 84%). Single crystals suitable for X-ray 
diffraction were obtained from slow evaporation of a 
dichloromethane and isopropanol (4:1) solution (yellow 
polymorph) and slow evaporation of a dichloromethane 
solution (red polymorph).  
1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 8.83 (s, 2 H, H
2), 8.22 (s, 1 H, H11), 7.79 (d, 3JH-H 
= 6.7 Hz, 1 H, H16), 7.72 (d, 3JH-H = 6.7 Hz, 1 H, H
13), 7.67 (m, 2 H, H18 + H19), 7.62 (d, 3JH-H 
= 8.2 Hz, 2 H, H5), 7.44 (m, 2 H, H14 + H15), 7.29 (d, 4JH-H = 1.9 Hz, 2 H, H
8), 7.24 (dd, 3JH-H 
= 8.2 Hz, 4JH-H = 1.9 Hz, 2 H, H
6), 1.00 (s, 18 H, tBu).  
13C{1H} NMR (CD2Cl2, 75.48 MHz, 298 K): δ 169.0 (s, C
9), 156.2 (s, C3 + C4), 145.1 (s, C7), 
138.8 (s, C2), 134.8 (s, C10/12/17), 134.3 (s, C10/12/17), 133.7 (s, C18/19), 133.3 (s, C11), 132.7 (s, 
C10/12/17), 131.3 (s, C8), 128.1 (s, C18/19), 127.9 (s, C16), 127.5 (s, C13), 126.7 (s, C14/15), 126.0 
(s, C14/15), 125.8 (s, C5), 124.4 (s, C6), 35.5 (s, C(CH3)3), 30.8 (s, CH3). 
Elemental Microanalysis: C34H33AuN2S (698.68): C, 58.45%; H, 4.76%; N, 4.01%. Found: C, 
58.34%; H, 4.62%; N, 4.12%. 
(C^Npz^C)AuSquinoline (6) 
Using method 1 and 2-quinolinethiol (0.014 g, 0.087 
mmol) to give 6 as an orange solid (0.042 g, 0.060 
mmol, 69%).  
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1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 8.86 (s, 2 H, H
2), 7.90-7.50 (bm, 4H, H13 + H16 + 
H18 + H19), 7.64 (d, 3JH-H = 8.1 Hz, 2 H, H
5), 7.52 (bs, 2 H, H8), 7.45-7.35 (bm, 2 H, H14 + H15), 
7.26 (dd, 3JH-H = 8.1 Hz, 
4JH-H = 1.6 Hz, 2 H, H
6), 1.04 (s, 18 H, tBu). 1H NMR (CD2Cl2, 300.13 
MHz, 223 K): δ 8.83 (s, 2 H, H2), 7.82 (d, 3JH-H = 8.6 Hz, 1 H, H
13/16/18/19), 7.78 (d, 3JH-H = 8.6 
Hz, 1 H, H13/16/18/19), 7.70 (d, 3JH-H = 7.4 Hz, 1 H, H
13/16/18/19), 7.60 (m, 3JH-H = 8.3 Hz, 4 H, H
5 
+ H14 + H15), 7.41 (d, 3JH-H = 8.0 Hz, 1 H, H
13/16/18/19), 7.37 (d, 4JH-H = 1.4 Hz, 2 H, H
8), 7.21 
(dd, 3JH-H = 8.2 Hz, 
4JH-H = 1.4 Hz, 2 H, H
6), 0.95 (s, 18 H, tBu).  
13C{1H} NMR (CD2Cl2, 75.48 MHz, 298 K): δ 170.1 (s, C
9), 156.8 (s, C3/4), 156.4 (s, C3/4), 
144.7 (s, C7), 138.9 (s, C2), 132.6 (s, C8), 127.7 (s, Cquinoline), 127.1 (s, Cquinoline), 125.9 (s, C5), 
124.4 (s, C6), 35.6 (s, C(CH3)3), 30.9 (s, CH3). 
Elemental Microanalysis C33H32AuN3S (699.67): C, 56.65%; H, 4.61%; N, 6.01%. Found: C, 
56.58%; H, 4.55%; N, 6.09%. 
(C^Npz^C)AuS-4-methylcoumarin (7) 
Synthesised using method 1 and 7-mercapto-4-
methylcoumarin (0.017 g, 0.087 mmol), however 
reaction time of 18 h was required. The product (7) was 
isolated as a yellow solid (0.022 g, 35%).  
Synthesised by method 2 and 7-mercapto-4-
methylcoumarin (0.013 g, 0.070 mmol) to give 7 as a 
yellow solid (0.043 g, 0.059 mmol, 84%). 
1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 8.84 (s, 2 H, H
2), 7.65 (d, 3JH-H = 8.2 Hz, 2 H, H
5), 
7.58 (d, 4JH-H = 1.7 Hz, 1 H, H
11), 7.55 (dd, 3JH-H = 8.3 Hz, 
4JH-H = 1.9 Hz, 1 H, H
19), 7.42 (d, 
4JH-H = 1.9 Hz, 2 H, H
8), 7.40 (d, 3JH-H = 8.3 Hz, 1 H, H
18), 7.34 (dd, 3JH-H = 8.2 Hz, 
4JH-H = 1.9 
Hz, 2 H, H6), 6.14 (bq, 4JH-H = 1.2 Hz, 1 H, H
15), 2.36  (bd, 4JH-H = 1.2 Hz, 3 H, H
20),  1.13 (s, 
18 H, tBu).  
13C{1H} NMR (CD2Cl2, 75.48 MHz, 298 K): δ 169.5 (s, C
9), 160.8 (s, C10/12/14/17), 156.4 (s, 
C3/4), 156.3 (s, C3/4), 153.4 (s, C10/12/14/17), 152.6 (s, C10/12/14/17), 144.9 (s, C7 + C10/12/14/17), 138.9 
(s, C2), 131.9 (s, C8), 130.3 (s, C19), 125.9 (s, C5), 124.6 (s, C6), 124.3 (s, C18), 121.8 (s, C11), 
118.1 (s, C16), 113.9 (s, C15), 35.7 (s, C(CH3)3), 30.9 (s, CH3), 18.7 (s, C
20). 
Elemental Microanalysis C34H33AuN2O2S (704.73): C, 55.89%; H, 4.55%; N, 3.83%. Found: 
C, 56.02%; H, 4.48%; N, 3.91%.  
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(C^Npz^C)AuSAd (8) 
Under an atmosphere of dinitrogen, a flask was charged 
with (C^Npz^C)AuCl (0.055 g, 0.097 mmol), K2CO3 
(0.027 g, 0.191 mmol) and 1-adamantanethiol (0.016 g, 
0.097 mmol). Degassed acetone (5 mL) was added and 
the mixture was stirred at room temperature for 24 hours 
(the reaction was incomplete after 6 h, so an excess 1-
adamantanethiol was added and the reaction was left overnight). The acetone was removed in 
vacuo and the resulting solid extracted into dichloromethane (5 mL). The suspension was 
filtered through celite and washed with dichloromethane (5 mL). Solvent was removed to give 
a red solid which was further purified by flash column chromatography (1:1 dichloromethane 
and petroleum ether) (0.022 g, 0.031 mmol, 36%). 
Synthesised with method 2 and 1-adamantanethiol (0.012 g, 0.070 mmol) gave 8 as a red solid 
(0.036 g, 0.051 mmol, 73%) 
1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 8.83 (s, 2 H, H
2), 8.44 (d, 4JH-H = 1.9 Hz, 2 H, H
8), 
7.63 (d, 3JH-H = 8.2 Hz, 2 H, H
5), 7.31 (dd, 3JH-H = 8.2 Hz, 
4JH-H = 1.9 Hz, 2 H, H
6), 2.13 (bd, 
3JH-H = 2.3 Hz, 6 H, H
11), 1.92 (brs, 3 H, H12), 1.61 (brs, 6 H, H13), 1.39 (s, 18 H, tBu).  
13C{1H} NMR (CD2Cl2, 75.48 MHz, 298 K): 172.8 (s, C
9), 156.7 (s, C3/4), 156.1 (s, C3/4), 
145.0 (s, C7), 138.7 (s, C2), 134.5 (s, C8), 125.5 (s, C5), 124.1 (s, C6), 50.1 (s, C11), 49.1 (s, 
C10), 36.6 (s, C13), 36.0 (s, C(CH3)3), 31.3 (s, CH3), 31.2 (s, C
12). 
Elemental Microanalysis C34H41AuN2S (706.74): C, 57.78%; H, 5.85%; N, 3.96%. Found: C, 
57.52%; H, 5.90%; N, 4.12%.  
(C^Npz^C)AuSC6H4
tBu-4 (9) 
Synthesised with method 3 and 4-tert-butylbenzenethiol 
(15 µl, 0.097 mmol) to give 9 as a yellow solid (0.057 g, 
0.081 mmol, 83%). Single crystals suitable for X-ray 
diffraction were obtained from slow evaporation of a 
dichloromethane and isopropanol (4:1) solution. 
1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 8.83 (s, 2 H, H
2), 7.64 (d, 3JH-H = 8.2 Hz, 2 H, H
5), 
7.56 (d, 3JH-H = 8.4 Hz, 2 H, H
11), 7.43 (d, 4JH-H = 1.9 Hz, 2 H, H
8), 7.26 (m, 4 H, H6 + H12), 
1.29 (s, 9 H, tBu(SPh-4-tBu)), 1.17 (s, 18 H, tBu(C^Npz^C)).  
13C{1H} NMR (CD2Cl2, 75.48 MHz, 298 K): δ 169.1 (s, C
9), 156.1 (s, C3/4), 156.0 (s, C3/4), 
149.7 (s, C13), 145.1 (s, C7), 138.8 (s, C2), 134.7 (s, C11), 133.8 (s, C10), 131.4 (s, C8), 126.1 (s, 
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C6/12), 125.7 (s, C5), 124.4 (s, C6/12), 35.7 (s, C(CH3)3(C^N
pz^C)), 34.7 (s, C(CH3)3(SPh-4-
tBu)), 31.4 (s, CH3(SPh-4-
tBu)), 31.2 (s, CH3(C^N
pz^C)). 
Elemental Microanalysis: Calc. C34H39AuN2S (704.73): C, 57.95%; H, 5.58%; N, 3.98%. 
Found: C, 57.80%; H, 5.65%; N, 4.12%. 
 (C^Npz^C)AuSNp-1 (10) 
Synthesised with method 3 and the following quantities: 
(C^Npz^C)AuCl (0.062 g, 0.108 mmol), K2CO3 (0.030 
mg, 0.216 mmol) and 1-naphthalenethiol (15 µL, 0.108 
mmol). 10 was isolated as an orange solid (0.060 g, 0.086 
mmol, 80%).  
 
1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 8.44 (s + d, 3 H, H
2 + H12), 8.05 (d, 3JH-H = 7.2 Hz, 
1 H, H17/19), 7.86 (m, 1 H, H15), 7.82 (d, 3JH-H = 8.4 Hz, 1 H, H
17/19), 7.63 (d, 3JH-H = 8.1 Hz, 2 
H, H5), 7.49 (m, 2 H, H13 + H14), 7.40 (dd, 3JH-H = 8.0 Hz, 1 H, H
18), 7.24 (dd, 3JH-H = 8.1 Hz, 
4JH-H = 1.8 Hz, 2 H, H
6), 7.18 (d, 4JH-H = 1.8 Hz, 2 H, H
8), 1.02 (s, 18 H, tBu).  
13C{1H} NMR (CD2Cl2, 75.48 MHz, 298 K): δ 168.5 (s, C
9), 156.0 (s, C3 + C4), 145.2 (s, C7), 
138.8 (s, C2), 136.4 (s, C10/11/16), 135.6 (s, C17/19), 134.7 (s, C10/11/16), 134.6 (s, C10/11/16), 130.7 
(s, C8), 128.9 (s, C15), 128.8 (s, C17/19),  127.6 (s, C12), 126.7 (s, C13/14), 126.4 (s, C13/14), 126.1 
(s, C18), 125.8 (s, C5), 124.3 (s, C6), 35.5 (s, C(CH3)3), 30.9 (s, CH3). 
Elemental Microanalysis C34H33AuN2S (698.68): C, 58.45%; H, 4.76%; N, 4.01%. Found: C, 
58.45%; H, 4.67%; N, 4.00%. 
(C^Npy^C)AuSNp-2 (11) 
Synthesised using method 1 with (C^Npy^C)AuCl (0.050 
g, 0.087 mmol) and 2-naphthalenethiol (0.014 g, 0.087 
mmol) to give 11 as a pure product (0.041 g, 0.058 mmol, 
67%). Single crystals suitable for X-ray diffraction were 
obtained from slow evaporation of a dichloromethane/ 
isopropanol (4:1) mixture.  
1H NMR (CD2Cl2, 300.13 MHz, 298 K): 8.20 (s, 1 H, H
11), 7.88 (t, 3JH-H = 8.0 Hz, 1 H, H
1), 
7.75 (d, 3JH-H = 7.4 Hz, 1 H, H
16), 7.70 (d, 3JH-H = 7.0 Hz, 1 H, H
13), 7.64 (m, 2 H, H18 + H19), 
7.55 (d, 3JH-H = 8.1 Hz, 2 H, H
5), 7.51 (d, 3JH-H = 8.0 Hz, 2 H, H
2),  7.43 (m, 2 H, H14 + H15), 
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7.38 (d, 4JH-H = 2.0 Hz, 2 H, H
8), 7.21 (dd, 3JH-H = 8.1 Hz, 
4JH-H = 2.0 Hz, 2 H, H
6), 1.00 (s, 18 
H, tBu).  
13C{1H} NMR (CD2Cl2, 75.48 MHz, 298 K): δ 168.0 (s, C
9), 163.6 (s, C3), 154.9 (s, C4), 147.3 
(s, C7), 142.4 (s, C1), 135.9 (s, C10/12/17), 134.3 (s, C10/12/17), 133.6 (s, C18/19), 132.6 (s, C11), 
132.4 (s, C10/12/17), 131.1 (s, C8), 127.9 (s, C18/19 + C16), 127.3 (s, C13), 126.6 (s, C14/15), 125.7 
(s, C14/15), 125.3 (s, C5), 124.1 (s, C6), 116.7 (s, C2), 35.3 (s, C(CH3)3), 30.9 (s, CH3). 
Elemental Microanalysis C35H34AuNS (697.69): C, 60.25%; H, 4.91%; N, 2.01%. Found: C, 
60.07%; H, 4.97%; N, 2.16%. 
6.2.2 Complexes in Chapter Three 
General methods used in this chapter: 
Method 4 (for the in situ reductive elimination reactions): Under a N2 atmosphere, a J-Young 
NMR tube was charged with the gold(III) complex (0.005 g) and the corresponding thiol in 
CD2Cl2 (0.6 mL). The tube was sealed, and the reaction monitored by 
1H NMR spectroscopy 
until the reaction was complete.  
Method 5: A J-Young’s NMR tube was charged with a gold complex (0.005 g), HAB2 (1 
molar equivalent) and CD2Cl2 (0.6 mL).
8 The reaction monitored by 1H NMR spectroscopy 
until no further changes were observed. 
HC^Npy^CSAd (12) 
Using method 4 and adamantyl thiol (0.004 g, 0.026 
mmol). The reaction was monitored for 3 hours until the 
reaction went to completion and the fading of the yellow 
colour of (C^Npy^C)AuCl was observed to give a clear 
solution. Over 2 days a white precipitate of the proposed 
[ClAuSAd]nHn compound was observed.  
1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 8.26 (t, 
3JH-H = 8.0 Hz, 1 H, H
1), 8.12 (d, 3JH-H = 8.6 
Hz, 2 H, H5’), 7.90 (dd, 3JH-H = 8.0 Hz,
 4JH-H = 0.8 Hz, 1 H, H
2’), 7.78 (d, 4JH-H = 1.9 Hz,
 1 H, 
H8), 7.70 (dd, 3JH-H = 8.0 Hz, 
4JH-H = 0.8 Hz, 1 H, H
2), 7.67 (d, 3JH-H = 8.1 Hz,
 1 H, H5), 7.65 
(d, 3JH-H = 8.6 Hz, 2 H, H
6’), 7.60 (dd, 3JH-H = 8.1 Hz, 
4JH-H = 1.9 Hz, 1 H, H
6), 1.88 (bs, 3 H, 
H12), 1.57 (d, 3JH-H = 2.3 Hz, 6 H, H
11), 1.50 (m, 6 H, H13), 1.41 (s, 9 H, tBu), 1.39 (s, 9 H, 
tBu’).  
13C{1H} NMR (CD2Cl2, 75.48 MHz, 298 K): δ 156.0 (s, C
7’), 155.4 (s, C3), 154.5 (s, C7), 153.7 
(s, C3’), 142.9 (s, C1), 137.5 (s, C8), 136.1 (s, C4), 131.5 (s, C5), 130.7 (s, C9), 130.0 (s, C5’), 
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128.8 (s, C4’), 127.6 (s, C2), 126.4 (s, C6+6’), 123.9 (s, C2’), 50.5 (s, C10), 44.0 (s, C11), 36.2 (s, 
C13), 35.4 (s, CMe3’), 35.2 (s, CMe3), 31.3 (s, CMe3 + CMe3’), 30.5 (s, C
12). 
Bulk synthesis: Under a N2 atmosphere, a Schlenk tube was charged with (C^N
py^C)AuCl 
(0.030 g, 0.052 mmol) and adamantyl thiol (0.018 g, 0.105 mmol), which were then dissolved 
in dichloromethane (5 mL). The reaction was stirred at room temperature for 4 hours until the 
solution turned from yellow to colourless. The solvent was removed under vacuum, petrol (5 
mL) was added and the suspension filtered. The solvent was removed to give 12 as a white 
solid (0.025 g, 94%).  
1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 7.98 (d,
 3JH-H = 8.4 Hz, 2 H, H
5’), 7.76 (t, 3JH-H = 
7.7 Hz, 1 H, H1), 7.68 (overlapped s, 1 H, H8), 7.67 (overlapped d, 1 H, H2’), 7.61 (d, 3JH-H = 
8.0 Hz, 1 H, H5), 7.5 (m, 4 H, H6+6’+2), 1.86 (br s, 3H, H12), 1.57 (br d, 3JH-H = 1.4 Hz, 6 H, 
H11), 1.51 (m, 6 H, H13), 1.39 (s, 9 H, tBu), 1.36 (s, 9 H, tBu’).  
13C{1H} NMR (CD2Cl2, 75.48 MHz, 298 K): δ 159.4, 156.5, 152.3, 151.3, 144.9, 137.2, 137.1, 
135.9, 130.7, 128.7, 127.0, 126.2, 125.9, 125.0, 118.4, 49.7, 44.0, 36.4, 34.9, 34.8, 31.4, 31.4, 
30.5. 
TOF MS ASAP+: m/z [12+H]+ 510.3194 (calc. 510.3195). Spectrum displays the expected 
isotopic pattern. 
(C^Npy^C)AuSAd (14) 
Synthesised by method 2 with (C^Npy^C)AuCl (0.040 g, 
0.070 mmol) and 1-adamantanethiol (0.012 g, 0.070 
mmol). 14 was isolated as a bright yellow solid (0.045 g, 
0.059 mmol, 91%).  
 
1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 8.46 (d, 
4JH-H = 2.0 Hz, 2 H, H
8), 7.83 (t, 3JH-H = 8.0 
Hz, 1 H, H1), 7.54 (d, 3JH-H = 8.1 Hz, 2 H, H
5), 7.47 (d, 3JH-H = 8.0 Hz,
 2 H, H2), 7.27 (dd, 3JH-
H = 8.1 Hz, 
4JH-H = 2.0 Hz, 2 H, H
6), 2.14 (bd, 3JH-H = 2.4 Hz, 6 H, H
11), 1.92 (bs, 3 H, H12), 
1.61 (s, 6 H, H13), 1.39 (s, 18 H, tBu).  
13C{1H} NMR (CD2Cl2, 75.48 MHz, 298 K): δ 171.6 (s, C
4), 164.0 (s, C3), 154.8 (s, C7), 147.4 
(s, C9), 142.6 (s, C1), 134.1 (s, C8), 125.0 (s, C5), 123.8 (s, C6), 116.6 (s, C2), 50.2 (s, C11), 48.5 
(s, C10), 36.7 (s, C13), 35.9 (s, C(CH3)3), 31.4 (s, C(CH3)3), 31.2 (s, C
12). 
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HC^Npz^CSAd (15) 
Using method 4 with (C^Npz^C)AuCl (0.005 g, 0.0087 
mmol) and adamantyl thiol (0.004 g, 0.026 mmol). The 
reaction monitored by 1H NMR over 3 hours until the 
reaction was complete forming 15 and [ClAuSAd]nHn. 
Over the course of the reaction the solution turned from 
bright yellow to colourless. Over the following 2 days a 
white precipitate of [ClAuSAd]nHn was observed.  
1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 8.91 (s, 1 H, H
2), 8.89 (s, 1 H, H2’), 8.12 (d, 3JH-H = 
8.6 Hz, 2 H, H5’), 7.81 (d, 3JH-H = 8.1 Hz,
 1 H, H5), 7.77 (d, 4JH-H = 1.8 Hz,
 1 H, H8), 7.65 
(partially overlapped dd, 3JH-H = 8.1 Hz, 
4JH-H = 1.8 Hz, 1 H, H
6), 7.63 (d, 3JH-H = 8.6 Hz,
 1 H, 
H6’), 1.86 (bs, 3 H, H12), 1.53 (d, 3JH-H = 1.8 Hz, 6 H, H
11), 1.47 (m, 6 H, H13), 1.41 (s, 9 H, 
tBu), 1.38 (s, 9 H, tBu’).  
13C{1H} NMR (CD2Cl2, 75.48 MHz, 298 K): δ 159.1 (s, C
3/3’), 156.2 (s, C3/3’/7’), 156.1 (s, 
C3/3’/7’), 154.7 (s, C7), 138.9 (s, C4), 137.7 (s, C8), 134.4 (s, C2), 131.5 (s, C4’), 131.1 (s, C5), 
128.9 (s, C9), 127.8 (s, C2’), 127.4 (s, C5’), 127.3 (s, C6), 127.0 (s, C6’), 51.2 (s, C10), 43.9 (s, 
C11), 36.2 (s, C13), 35.4 (s, CMe3’), 35.2 (s, CMe3), 31.2 (s, CMe3 + CMe3’), 30.5 (s, C
12). 
TOF MS ASAP+: m/z [15+H]+ 511.141 (calc. 511.3129). Spectrum displays the expected 
isotopic pattern. 
HC^Npy^CSMes (16) + HC^N^CH (L2) 
Synthesised with (C^Npy^C)AuCl (0.005 g, 0.0087 
mmol) and 2,4,6-trimethylthiophenol (4 μL, 0.026 
mmol). The reaction was monitored by 1H NMR over 4 
hours until the reaction was complete and the solution 
turned from yellow to a clear colourless solution. The 
reaction gave 16 and free ligand (L2) in a ratio of 1:3.3 
respectively. Over 2 days a white precipitate of an 
[ClAuSAr]H compound was observed. 
 
 
1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 8.26 (t, 
3JH-H = 8.0 Hz, 1 H, H
1), 8.25 (t, 3JH-H = 7.9 
Hz, 1 H, HL1), 8.07 (d, 3JH-H = 8.6 Hz, 2 H, H
5’), 8.03 (d, 3JH-H = 8.6 Hz, 4 H, H
L5), 7.90 (dd, 
3JH-H = 8.1 Hz,
 4JH-H = 0.9 Hz, 1 H, H
2’), 7.86 (dd, 3JH-H = 7.9 Hz, 
4JH-H = 0.9 Hz, 1 H, H
2), 7.83 
(d, 3JH-H = 8.0 Hz, 2 H, H
L2), 7.63 (d, 3JH-H = 8.3 Hz, 2 H + 4 H, H
6’+L6), 7.53 (d, 3JH-H = 8.0 
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Hz, 1 H, H5), 7.29 (dd, 3JH-H = 8.0 Hz,
 4JH-H = 1.8 Hz,
 1 H, H6), 6.98 (s, 2 H, H12), 6.83 (d, 4JH-
H = 1.8 Hz,
 1 H, H8), 2.33 (s, 6 H, o-Me), 2.26 (s, 3 H,p-Me), 1.39 (s, 9 H, tBu’ + LtBu), 1.1 7 
(s, 9 H, tBu). 
13C{1H} NMR (CD2Cl2, 75.48 MHz, 298 K): δ 155.9 (s, C
7’/L7), 155.7 (s, C7’/L7/L3), 155.4 (s, 
C7’/L7/L3), 154.9 (s, C7/3/3’), 154.8 (s, C7/3/3’), 154.7 (s, C7/3/3’), 143.7 (s, C13), 143.5 (s, CL1), 143.3 
(s, C1), 139.8 (s, C11), 137.8 (s, C10), 132.0 (s, C5), 129.9 (s, C12), 129.8 (s, C5’/L5), 129.7 (s, 
C5’/L5), 128.6 (s, C4), 127.0 (s, C10), 126.4 (s, C6 + C’L6), 126.2 (s, C2), 126.1 (s, C4 + CL4), 
124.2 (s, C8), 123.8 (s, C2’), 123.6 (s, CL2), 122.4 (s, C6), 35.4 (s, CMe3’ + L CMe3), 35.2 (s, 
CMe3), 31.3 (s, CMe3’ + LCMe3), 31.0 (s, CMe3), 22.1 (s, C
Me11), 30.5 (s, CMe13). 
Npy^CSAd (19) 
In a J Young NMR tube, (C^N)AuCl2 (0.005 g, 0.011 mmol) and 
adamantyl thiol (0.005 g, 0.031 mmol) were dissolved in CD2Cl2 
(0.6 mL). The reaction was monitored by 1H NMR for 5 days at 
room temperature. Further adamantyl thiol (0.015 g, 0.093) was 
added, then the NMR tube was heated to 50 °C for 4 months until 
no further changes were observed in the 1H NMR spectrum. Over 
the course of the reaction a white precipitate was observed. 19 (80%) and L18 (20%) were 
observed in the final 1H NMR spectrum.  
1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 8.90 (d,
 3JH-H = 5.6 Hz, 1 H, H
1), 8.34 (pseudo 
triplet, 3JH-H = 7.3 Hz, 1 H, H
3), 8.07 (d, 3JH-H = 8.2 Hz, 1 H, H
4), 7.83 (pseudo triplet, 3JH-H = 
6.6 Hz, 1 H, H2), 7.79 (d, 4JH-H = 1.8 Hz, 1 H, H
10), 7.76 (d, 3JH-H = 8.2 Hz,
 1 H, H7), 7.66 (dd, 
3JH-H = 8.2 Hz, 
4JH-H = 1.8 Hz, 1 H, H
8), 1.90 (overlapped with free thiol observed by NOE, 
H14), 1.51 (d + m , 3JH-H = 2.1 Hz, 13 H, H
13 + H15), 1.40 (s, 9 H, tBu).  
13C{1H} NMR (CD2Cl2, 75.48 MHz, 298 K): δ 155.1 (s, C
9), 153.7 (s, C5), 143.6 (s, C3), 141.5 
(s, C1), 138.3 (s, C10), 134.9 (s, C6), 131.4 (s, C7), 130.9 (s, C4), 129.7 (s, C11), 127.1 (s, C8), 
124.8 (s, C2), 51.0 (s, C12), 43.8 (s, C13), 36.2 (s, C15), 35.2 (s, CMe3), 31.1 (s, CMe3), 30.4 (s, 
C15). 
TOF MS ASAP+: m/z [19+H]+ 378.2257 (calc. 378.2256). Spectrum displays the expected 
isotopic pattern. 
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(C^Npz^C)AuC≡Cphenyl–OMe-m (21) 
A flask was charged with (C^Npy^C)AuCl (0.040 g, 0.070 
mmol), [AgC≡CC6H4-3-OMe]n
7 (0.050 g, 0.210 mmol) 
and dichloromethane (10 mL). The reaction was stirred in 
the dark for 21 days. The solution was filtered through 
celite and evaporated to dryness giving a solid which 
washed with petrol. The pure product 21 was isolated as 
a light yellow powder (0.024 g, 51%).  
1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 8.17 (d, 
3JH-H = 2.0 Hz, 2 H, H
8), 7.85 (t, 3JH-H = 8.0 
Hz, 1 H, H1), 7.54 (d, 3JH-H = 8.2 Hz, 2 H, H
5), 7.44 (d, 3JH-H = 8.0 Hz,
 2 H, H2), 7.32 (dd, 3JH-
H = 8.2 Hz, 
4JH-H = 2.0 Hz, 2 H, H
6), 7.26 (dd, 3JH-H = 8.0 Hz,
 1 H, H16), 7.19 (d psd t, 3JH-H = 
7.6 Hz, 4JH-H = 1.1 Hz, 1 H, H
17), 7.14 (brm, 1 H, H13), 6.87 (ddd, 3JH-H = 8.0 Hz, 
4JH-H = 2.4 
Hz, 4JH-H = 1.1 Hz, 1 H, H
15), 3.84 (s, 3 H, O-Me), 1.39 (s, 18 H, tBu).  
13C{1H} NMR (CD2Cl2, 75.48 MHz, 298 K): δ 167.3 (s, C
9), 165.2 (s, C3), 159.8 (s, C14), 
155.6 (s, C7), 147.0 (s, C4), 142.7 (s, C1), 133.7 (s, C8), 129.6 (s, C16), 128.1 (s, C12), 125.4 (s, 
C5), 124.7 (s, C17), 124.3 (s, C6), 116.8 (s, C13), 116.7 (s, C2), 114.0 (s, C15), 101.4 (s, C11), 
92.7 (s, C10), 55.5 (s, O-CH3) 35.7 (s, C(CH3)3), 31.3 (s, C(CH3)3). 
HC^Npy^CMe (22) 
Synthesised using method 4 with (C^Npy^C)Au-Me 
(0.005 g, 0.009 mmol) and adamantyl thiol (0.006 g, 
0.036 mmol). The reaction monitored by 1H NMR over 
24 days until the reaction was complete forming 22.  
1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 8.02 (d,
 3JH-H = 8.5 Hz, 2 H, H
5’), 7.81 (t, 3JH-H = 
7.8 Hz, 1 H, H1), 7.70 (dd, 3JH-H = 7.9 Hz, 
4JH-H = 0.9 Hz,1 H, H
2/2’), 7.50 (d, 3JH-H = 8.5 Hz, 2 
H, H6’), 7.40 (d, 3JH-H = 7.8 Hz, 1 H, H
5),7.33 (m, 3 H, H2/2’ + H6 + H8), 2.46 (s, 3 H, H10) , 
1.37 (s, 9 H, tBu/ tBu’), 1.36 (s, 9 H, tBu/tBu’). 
HC^Npy^CC6H4-p-F (23) 
Synthesised using method 4 with (C^Npy^C)Au-C6H4F 
(0.005 g, 0.008 mmol) and adamantyl thiol (0.005 g, 
0.032 mmol). The reaction monitored by 1H NMR over 6 
days until the reaction was complete forming 23.  
1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 7.79 (d,
 3JH-H = 8.4 Hz, 2 H, H
5’), 7.68 (d, 3JH-H = 
8.1 Hz,1 H, H5), 7.56 (m, 2 H, H1 + H2’), 7.53 (dd, 3JH-H = 8.1 Hz, 
4JH-H = 1.9 Hz, 1 H, H
6), 
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7.45 (m, 3 H, H6’ + H8), 7.45 (m, 2 H, H11), 6.96 (m, 3 H, H2 + H12), 1.40 (s, 9 H, tBu), 1.35 
(s, 9 H, tBu’).  
19F NMR (CD2Cl2, 282.36 MHz, 298K): δ -117.2 (br, p–F). 
HC^Npy^CC≡Cphenyl–OMe-m (24) 
Synthesised using method 4 with (C^Npy^C)Au- 
CC≡Cphenyl–OMe-m (0.005 g, 0.008 mmol) and 
adamantyl thiol (0.005 g, 0.030 mmol). The reaction 
monitored by 1H NMR over 6 days until 50 % conversion. 
Addition of further HSAd led to the formation of 24.  
1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 8.08 (d,
 3JH-H = 8.5 Hz, 2 H, H
5’), 7.85 (m, 3 H, H1 
+ H2 + H5), 7.75 (dd, 3JH-H = 7.5 Hz, 
4JH-H = 1.2 Hz, 1 H, H
2’), 7.72 (d, 4JH-H = 1.8 Hz, 1 H, H
8), 
7.54 (dd, 3JH-H = 8.4 Hz, 
4JH-H = 1.8 Hz, 1 H, H
6), 7.48 (d, 3JH-H = 8.5 Hz, 2 H, H
6’), 7.20 
(pseudo t, 3JH-H = 7.9 Hz, 1 H, H
16), 6.98 (d pseudo t, 3JH-H = 7.8 Hz, 
4JH-H = 1.1 Hz, 1 H, H
17), 
6.89 (brm, 1 H, H13), 6.85 (ddd, 3JH-H = 8.5 Hz, 
4JH-H = 2.5 Hz,
 4JH-H = 0.9 Hz, 1 H, H
15), 3.71 
(s, 3 H, O-Me), 1.40 (s, 9 H, tBu), 1.36 (s, 9 H, tBu’).  
13C{1H} NMR (CD2Cl2, 75.48 MHz, 298 K): δ 159.8 (s, C
14), 157.6 (s, C3/3’), 156.9 (s, C3/3’), 
152.5 (s, C7’), 151.8 (s, C7), 140.2 (s, C4), 136.9 (s, C4’), 136.8 (s, C1), 130.6 (s, C8), 130.0 (s, 
C5), 129.7 (s, C16), 126.9 (s, C5’), 126.5 (s, C6), 126.0 (s, C6’), 124.8 (s, C12), 124.2 (s, C17), 
122.5 (s, C2), 121.1 (s, C9), 118.7 (s, C2’), 116.4 (s, C13), 115.2 (s, C15), 92.0 (s, C11), 90.0 (s, 
C10), 55.5 (s, O-Me), 34.9 (s, CMe3’ + CMe3), 31.5 (s, CMe3), 31.3 (s, CMe3’) 
MS CI+: m/z [24 + H]+ 474.3 (calc. 473.3). 
(C^Npy^C)Au–carbazole (27) 
Under a N2 atmosphere a flask was charged with 
(C^Npy^C)AuCl (0.050 g, 0.087 mmol), carbazole (0.015 
g, 0.087 mmol) and potassium t-butoxide (0.029 g, 0.26 
mmol). Dry toluene (5 mL) was added and reaction was 
stirred at 60°C for 16 hours. The solution was filtered 
through celite and evaporated to dryness, then washed 
with petrol. The pure product 27 was isolated as a yellow powder (0.036 g, 59%).  
1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 8.18 (d, 
3JH-H = 7.4 Hz, 2 H, H
14), 7.94 (t, 3JH-H = 
8.0 Hz, 1 H, H1), 7.58 (d, 3JH-H = 8.2 Hz, 2 H, H
5), 7.53 (d, 3JH-H = 8.0 Hz,
 2 H, H2), 7.49 (d, 
3JH-H = 8.3 Hz,
 2 H, H11), 7.25 (m, 4 H, H6+12), 7.11 (pseudo triplet, 3JH-H = 7.4 Hz,
 2 H, H13), 
6.93 (d, 4JH-H = 1.8 Hz, 2 H, H
8), 0.96 (s, 18 H, tBu).  
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13C{1H} NMR (CD2Cl2, 75.48 MHz, 298 K): δ 168.5 (s, C
4), 165.6 (s, C3), 155.4 (s, C7), 146.2 
(s, C10), 146.2 (s, C9), 143.4 (s, C1), 133.1 (s, C8), 125.3 (s, C15), 125.2 (s, C5), 124.4 (s, C6/12), 
124.3 (s, C6/12), 120.0 (s, C14), 117.2 (s, C13), 116.8 (s, C2), 35.2 (s, C(CH3)3), 30.8 (s, C(CH3)3). 
[(C^Npy^CH)AuSAd]2 2[H2N{B(C6F5)3}2] (28) 
Synthesised using method 5 with 14 (0.005 g, 
0.0071 mmol), HAB2 (0.008 g, 0.0071 mmol). 
The reaction monitored by 1H NMR spectroscopy 
for 11 days until no further changes were 
observed. Crystals suitable for X-ray 
crystallography were obtained from a CD2Cl2 
solution.  
1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 8.33 (t, 
3JH-H = 7.7 Hz, 1 H, H
1), 8.05 (dd, 3JH-H = 
8.0 Hz, 4JH-H = 0.7 Hz, 1 H, H
2), 7.80-7.50 (br m, 4 H, H5’+6’+8’+9’),  7.79 (dd, 3JH-H = 7.7 Hz,
 
4JH-H = 0.9 Hz, 1 H, H
2’), 7.68 (d, 3JH-H = 8.3 Hz,
 1 H, H5), 7.57 (dd, 3JH-H = 8.2 Hz, 
4JH-H = 1.3 
Hz, 1 H, H6), 7.00 (d, 4JH-H = 1.2 Hz,
 1 H, H8), 2.34 (d, 2JH-H = 11.2 Hz, 3 H, H
11), 2.16 (br s, 3 
H, H12), 2.08 (d, 2JH-H = 11.4 Hz, 3 H, H
11),  1.78 (m, 3 H, H13), 1.58 (m, 3 H, H13), 1.40 (s, 9 
H, tBu), 1.18 (s, 9 H, tBu’).  
1H NMR (CD2Cl2, 300.13 MHz, 263 K): δ 8.33 (t, 
3JH-H = 8.0 Hz, 1 H, H
1), 8.04 (d, 3JH-H = 8.0 
Hz, 1 H, H2), 7.88 (d, 3JH-H = 7.8 Hz, 1 H, H
9’), 7.78 (d, 3JH-H = 7.7 Hz,
 1 H, H2’), 7.70 (d, 3JH-H 
= 8.2 Hz, 1 H, H8’),  7.67 (d, 3JH-H = 8.5 Hz,
 1 H, H5), 7.55 (d, 3JH-H = 8.1 Hz, 1 H, H
6), 7.47 
(br s, 2 H, H5’+ 6’),  6.94 (s, 1 H, H8), 2.31 (d, 2JH-H = 11.4 Hz, 3 H, H
11), 2.14 (br s, 3 H, H12), 
2.01 (d, 2JH-H = 10.9 Hz, 3 H, H
11), 1.74 (d, 2JH-H = 14.9 Hz, 3 H, H
13), 1.55 (d, 2JH-H = 14.9 
Hz, 3 H, H13), 1.36 (s, 9 H, tBu), 1.14 (s, 9 H, tBu’ +Et2O signal).  
13C{1H} NMR (CD2Cl2, 75.48 MHz, 298 K): δ 162.8 (s, C
3), 161.3 (s, C9), 160.5 (s, C3’), 157.8 
(s, C7’), 157.3 (s, C7), 148.2 (brd, 1JC-F = 243.8 Hz, o-C-F H2N[B(C6F5)3]2
-), 144.8 (s, C1), 
139.5 (brd, 1JC-F = 246.1 Hz, p-C-F H2N[B(C6F5)3]2
-), 139.3 (s, C4), 137.0 (brd, 1JC-F = 248.3 
Hz, m-C-F H2N[B(C6F5)3]2
-), 135.3 (br s, CAnion), 134.4 (s, C4’), 129.2 (s, C6), 128.7 (s, C5), 
128.3 (s, CAryl), 127.4 (s, CAryl), 127.0 (s, C2’), 125.9 (s, C8), 120.6 (s, C2), 69.9 (s, C2)  49.2 (s, 
C11), 37.0 (s, CMe3), 35.5 (s, CMe3’), 35.4 (s, C
13), 31.7 (s, C12), 31.3 (s, CMe3), 30.1 (s, 
CMe3’). 
To trigger reductive elimination from 28: Addition of dimethyl sulfide (4 μL, 0.0034 mmol) 
to a solution of 28 in a J-Young NMR tube gave 12. Over the course of the 4 hours the solution 
changed from yellow to colourless.  
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[(C^Npy^C)AuOEt2][H2N{B(C6F5)3}2] (29) 
Obtained as a transient species using 
method 5 with 26 (0.005g, 0.007 mmol) and 
HAB2 (0.009 g, 0.007 mmol).  
 
1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 7.96 (t,
 3JH-H = 8.0 Hz, 1 H, H
1), 7.56 (d, 3JH-H = 8.2 
Hz, 2 H, H5), 7.47 (d, 4JH-H = 1.6 Hz, 1 H, H
8), 7.44 (d, 3JH-H = 8.0 Hz,
 2 H, H2), 7.43 (dd, 3JH-
H = 8.1 Hz, 
4JH-H = 1.6 Hz, 2 H, H
6), 7.93 (pst, 3JH-F/H-H = 8.0 Hz, 2 H, phenol H), 6.78 (m, 2 
H, phenol H), 4.68 (q, 3JH-H = 7.0 Hz,
 4 H, Et), 4.68 (t, 3JH-H = 7.0 Hz,
 6 H, Et), 1.37 (s, 18 H, 
tBu).  
[(HC^Npy^C)Au(carbazole)(OEt2)][H2N{B(C6F5)3}2] (30) 
Synthesised using method 5 with 28 
(0.005 g, 0.007 mmol) and HAB2 (0.009 
g, 0.007 mmol), to give 30. The species 
decomposed over 3 hours.  
 
 
1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 8.21 (d, 
3JH-H = 7.5 Hz, 2 H, H
14), 7.98 (t, 3JH-H = 
8.0 Hz, 1 H, H1), 7.90 (d, 3JH-H = 7.9 Hz, 2 H, H
11), 7.76 (m, 3 H, H5+13), 7.60 (m, 5 H, H8+6+12+2), 
7.41 (m, 3 H, H2’+5’), 7.12 (dd, 3JH-H = 8.2 Hz, 
4JH-H = 1.8 Hz, 1 H, H
6’), 5.62 (d, 4JH-H = 1.0 Hz, 
1 H, H8’), 3.49 (brs, 12 H, CH2 (OEt2)), 1.17 (t, 
3JH-H = 7.1 Hz, 18 H, CH3 (OEt2)), 1.41 (s, 9 
H, tBu), 0.91 (s, 9 H, tBu’). 
6.2.3 Complexes in Chapter Four 
(C^Npy^C)Au–I (32) 
Under a N2 atmosphere (C^N
py^C)AuCl (0.050 g, 0.087 
mmol) was dissolved in dry THF (6 mL) to this solution, 
IZnC6H4-p-Me 0.5 M in THF (0.35, 0.174 mmol) was 
added and the reaction was stirred for 16 hours. In air, the 
solution was passed through a silica plug and the solvent was removed in vacuo to give a solid. 
This was washed with petrol to give 32 as a light yellow solid (0.030 g, 52%).  
Chapter Six 
 
145 
 
1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 8.52 (d,
 4JH-H = 1.9 Hz, 2 H, H
8), 7.87 (t, 3JH-H = 8.0 
Hz, 1 H, H1), 7.50 (d, 3JH-H = 8.2 Hz, 2 H, H
5), 7.40 (d, 3JH-H = 8.2 Hz, 2 H, H
2), 7.27 (dd, 3JH-
H = 8.2 Hz,
 4JH-H = 1.9 Hz, 2 H, H
6), 1.36 (s, 18 H, tBu).  
13C{1H} NMR (CD2Cl2, 75.48 MHz, 298 K): δ 168.7 (s, C
9), 165.2 (s, C3), 156.4 (s, C7), 146.9 
(s, C4), 142.8 (s, C1), 135.9 (s, C8), 125.6 (s, C5), 123.9 (s, C6), 116.7 (s, C2), 35.9 (s, C(CH3)3), 
31.3 (s, C(CH3)). 
Elemental Microanalysis: Calc. C25H27AuNI (665.37): C, 45.13%; H, 4.09%; N, 2.11%. 
Found: C, 45.22%; H, 4.01%; N, 2.15%. 
(C^Npy^C)AuC6H4-p-Me (33) 
Synthesised from (C^Npy^C)AuCl: Under a N2 
atmosphere (C^Npy^C)AuCl (0.030 g, 0.052 mmol) was 
suspended in dry toluene (6 mL) to this solution, 
IZnC6H4-p-Me 0.5 M in THF (0.21 mL, 0.104 mmol) was 
added and the reaction was stirred for 4 days. In air, the 
solution was passed through a silica plug and the solvent 
was removed in vacuo to give a solid. This was washed 
with petrol to give 33 as a light yellow solid (0.029 g, 88%).  
Synthesised from (C^Npy^C)AuSAd: Under a N2 atmosphere (C^N
py^C)AuSAd (0.050 g, 
0.071 mmol) was dissolved in dry toluene (6 mL) to this solution, IZnC6H4-p-Me 0.5 M in 
THF (0.28 mL, 0.142 mmol) was added and the reaction was stirred for 4 days. In air the 
solution was passed through a silica plug and the solvent was removed in vacuo to give a solid. 
This was washed with petrol to give 33 as a light yellow solid (0.031 g, 70%). 
NMR synthesis: In a J-Youngs NMR tube, (0.005 g) of 11 was dissolved in d8-toluene. 
IZnC6H4-p-Me 0.5 M in THF (2 molar equivalents) was added and the reaction was monitored 
by 1H NMR until completion.  
1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 7.83 (t, 
3JH-H = 8.1 Hz, 1 H, H
1), 7.59 (d, 3JH-H = 
8.2 Hz, 2 H, H5), 7.55 (d, 3JH-H = 7.9 Hz, 2 H, H
11), 7.50 (m, 4 H, H2 + H8), 7.26 (dd, 3JH-H = 
8.2 Hz 4JH-H = 2.0 Hz, 2 H, H
6), 7.15 (d, 3JH-H = 7.8 Hz, 2 H, H
12), 2.39 (s, 3 H, H14), 1.25 (s, 
18 H, tBu).  
13C{1H} NMR (CD2Cl2, 75.48 MHz, 298 K): δ 169.7 (s, C
9), 163.5 (s, C3), 154.6 (s, C7), 147.6 
(s, C4), 144.3 (s, C10), 142.0 (s, C1), 134.7 (s, C11), 134.2 (s, C13), 132.7 (s, C8), 129.7 (s, C12), 
125.1 (s, C5), 123.6 (s, C6), 116.4 (s, C2), 35.6 (s, C(CH3)3), 31.3 (s, C(CH3)), 21.3 (s, C
14). 
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Elemental Microanalysis: Calc. C32H34AuN (629.60): C, 61.05%; H, 5.44%; N, 2.22%. Found: 
C, 60.97%; H, 5.37%; N, 2.30%. 
(C^Npz^C)AuC6H4-p-Me (34) 
Under a N2 atmosphere (C^Npz^C)AuCl (0.050 g, 0.087 
mmol) was dissolved in dry toluene (6 mL) to this 
solution, IZnC6H4-p-Me 0.5 M in THF (0.35 mL, 0.174 
mmol) was added. The solution was stirred for 6 hours, 
filtered and transferred to a flask with 10 mL water: 
isopropanol mixture and the reaction stirred 16 hours, 
whilst the solution turned from red to yellow. The mixture 
was separated and the organic fraction was washed with water (3 x 15 mL). The organic layer 
was dried over MgSO4 and passed through a silica plug. Solvent was removed in vacuo to give 
34 as a yellow solid (0.050 g, 91%).  
NMR synthesis: In a J-Youngs NMR tube, (0.005 g) of 4 was dissolved in d8-toluene. 
IZnC6H4-p-Me 0.5 M in THF (2 molar equivalents) was added and the reaction was monitored 
by 1H NMR until completion.  
1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 8.86 (s, 2 H, H
2), 7.68 (d, 3JH-H = 8.2 Hz, 2 H, H
5), 
7.54 (m, 4 H, H8 + H11), 7.30 (dd, 3JH-H = 8.2 Hz
 4JH-H = 2.0 Hz, 2 H, H
6), 7.17 (d, 3JH-H = 7.7 
Hz, 2 H, H12), 2.38 (s, 3 H, H14), 1.26 (s, 18 H, tBu).  
13C{1H} NMR (CD2Cl2, 75.48 MHz, 298 K): δ 169.5 (s, C
9), 156.3 (s, C3), 155.8 (s, C7), 145.3 
(s, C4), 143.6 (s, C10), 138.4 (s, C2), 134.6 (s, C13), 134.4 (s, C11), 131.1 (s, C8), 129.8 (s, C12), 
125.6 (s, C5), 123.9 (s, C6), 35.7 (s, C(CH3)3), 31.2 (s, C(CH3)), 21.3 (s, C
14). 
(C^Npy^C)AuH (36) 
In an inert atmosphere in J-Youngs NMR tube, 
(C^Npy^C)Au-OH (0.010 g, 0.018 mmol) was dissolved 
in CD2Cl2, to this was added HBpin (1.9 uL, 0.018 mmol). 
The 1H NMR spectrum was recorded 40 minutes after 
addition of H-Bpin and the spectrum matched that 
previously reported for 36.9 
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(C^Npy^C)AuSiMePh2 (38) 
In a J-Youngs NMR tube charged with (C^Npy^C)AuCl 
(0.015 g, 0.026 mmol) and potassium tert-butoxide 
(0.005 g, 0.045 mmol) were suspended in dry d-8-toluene. 
The tube was heated to 60 ºC until all the gold was 
dissolved and a clear bright yellow solution was observed. 
In the 1H NMR spectrum the consumption of (C^Npy^C)AuCl could be observed. To this 
solution (dimethylphenylsilyl)boronic acid pinacol ester (7.8 µL, 0.029 mmol) was added and 
the reaction was monitored by 1H NMR for 24 hours until complete. Decomposition of this 
complex hindered further isolation.   
1H NMR (C7D8, 300.13 MHz, 298 K): δ 7.99 (d,
 4JH-H = 1.9 Hz, 2 H, H
8), 7.87 (m, 2 H, H11), 
7.30 (d, 3JH-H = 8.1 Hz, 2 H, H
5), 7.17 (m, 3 H, H12 + H13) (H13 indirectly observed), 7.13 (dd, 
3JH-H = 8.1 Hz,
 4JH-H = 1.9 Hz, 2 H, H
6), 6.94 (overlapped with solvent, 1 H, H1), 6.80 (d, 3JH-H 
= 7.8 Hz, 2 H, H2), 1.21 (s, 18 H, tBu), 1.02 (s, 6 H, H14).  
13C{1H} NMR (C7D8, 75.48 MHz, 298 K): δ 167.4 (s, C
9), 161.9 (s, C3), 153.7 (s, C7), 149.6 
(s, C4), 143.3 (s, C10), 140.5 (s, C1), 137.0 (s, C8), 135.6 (s, C11), 128.7 (s, C13), 127.9 
(overlapped with solvent signal, observed by HMQC, C12), 125.3 (s, C5), 122.6 (s, C6), 115.4 
(s, C2), 35.2 (s, C(CH3)3), 31.4 (s, C(CH3)), 3.5 (s, C
14). 
6.2.4 Complexes in Chapter Five 
General methods used in this chapter: 
Method 6: A flask was charged with 1,3-dimethylimidazolium iodide (0.030 g, 0.131 mmol) 
and silver(I) oxide (0.012 g, 0.087 mmol) to which acetonitrile (20 mL) was added and stirred 
in the dark at room temperature for 6 h. To this solution, (C^N^C)AuCl (0.087 mmol) and 
KPF6 (0.080 g, 0.434 mmol) were added and reaction stirred for X h. The solvent was removed 
in vacuo, the solid was dissolved in dichloromethane and washed with water (3 x 20 mL). The 
dichloromethane solution was dried over MgSO4 and filtered through celite. The solvent was 
removed in vacuo to give the product as a powder. 
Method 7: A flask was charged with 1,3-dimethylbenzimidazolium iodide (0.024 mg, 0.087 
mmol) and silver(I) oxide (0.012 g, 0.087 mmol) to which dichloromethane (10 mL) was 
added and stirred in the dark at room temperature for 6 h. (C^N^C)AuCl (0.087 mmol) and 
KPF6 (0.080 g, 0.434 mmol) were added and reaction stirred for X h. The solution was filtered 
through celite and the solvent was removed in vacuo to give the product as a powder. 
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Method 8: Under an N2 atmosphere using standard Shlenk line techniques using a modified 
literature protocol; (C^N^C)AuCl (0.050 g) and potassium tert-butoxide were dissolved in dry 
degassed toluene (10 mL) and the reaction stirred for 3 hours. [1,3-dimethylcaffeine][BF4]
10 
was added and reaction was heated to 80 °C for 16 hours. The solvent was removed in vacuuo 
to give a solid. This was extracted into dichloromethane, filtered over celite and evaporated to 
dryness to give the pure product. 
[(C^Npz^C)Auimidazole]PF6 (40) 
Prepared using method 6 using the following 
amounts: (C^Npz^C)AuCl (0.050 g, 0.087 mmol). 
For 40 the reaction time is 16 hours.  40 was isolated 
as a yellow powder (0.064 g, 0.082 mmol, 94%).  
 
1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 8.95 (s, 2 H, H
2), 7.76 (d, 3JH-H = 8.3 Hz, 2 H, H
5), 
7.53 (s, 2 H, H11), 7.44 (dd, 3JH-H = 8.2 Hz, 
4JH-H = 1.8 Hz, 2 H, H
6), 7.02 (d, 4JH-H = 1.8 Hz, 2 
H, H8), 3.91 (s, 6 H, N-CH3), 1.26 (s, 18 H, 
tBu).  
13C{1H} NMR (CD2Cl2, 75.48 MHz, 298 K): δ 165.4 (s, C
9), 158.3 (s, C7), 157.3(s, C3), 153.1 
(s, C10 observed in the HMBC), 144.9 (s, C4), 139.7(s, C2), 133.4 (s, C8), 127.2 (s, C5), 125.9 
(s, C6), 125.1 (s, C11), 39.0 (s, N-Me), 35.6 (s, C(CH3)3), 31.0 (s, C(CH3)3). 
[(C^Npz^C)Aubenzimidazole]PF6 (41) 
Prepared using method 7 using the following 
amounts: (C^Npz^C)AuCl (0.050 g, 0.087 mmol). 
For 41 the reaction time is 16 hours. 41 was 
isolated as a yellow powder (0.065 g, 0.078 mmol, 
90%).  
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[(C^Npz^C)Aucaffeine]BF4 (42) 
Prepared using method 8 using the following 
amounts: (C^Npz^C)AuCl (0.050 g, 0.087 mmol), 
potassium tert-butoxide (0.012 g, 0.107 mmol), 
[1,3-dimethylcaffeine][BF4] (0.026 g, 0.087 
mmol). 42 was isolated as a yellow powder (0.050 
g, 0.060 mmol, 69%).  
 
[(C^Npy^C)Auimidazole]PF6 (43) 
Prepared using method 6 using the following 
amounts: (C^Npy^C)AuCl (0.050 g, 0.087 mmol). 
The reaction time for 43 is 16 hours. The product 
was isolated as a yellow powder (0.062 g, 0.079 
mmol, 91%).  
1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 8.02 (t,
 3JH-H = 8.0 Hz, 1 H, H
1), 7.65 (d, 3JH-H = 8.2 
Hz, 2 H, H5), 7.58 (d, 3JH-H = 8.0 Hz,
 2 H, H2), 7.50 (s, 2 H, H11), 7.39 (dd, 3JH-H = 8.2 Hz, 
4JH-
H = 1.7 Hz, 2 H, H
6), 6.97 (d, 4JH-H = 1.7 Hz, 2 H, H
8), 3.91 (s, 6 H, N-CH3), 1.25 (s, 18 H, 
tBu).  
13C{1H} NMR (CD2Cl2, 75.48 MHz, 298 K): δ 164.9 (s, C
3), 164.4 (s, C9), 156.8 (s, C7), 154.5 
(s, C10), 147.1 (s, C4), 144.3 (s, C1), 132.8 (s, C8), 126.6 (s, C5), 125.5 (s, C6), 124.9 (s, C11),  
117.7 (s, C2), 38.9 (s, N-Me), 35.4 (s, C(CH3)3), 31.1 (s, C(CH3)3). 
Elemental Microanalysis: Calc. C30H35AuN3PF6 (779.21): C, 46.22%; H, 4.53%; N, 5.39%. 
Found: C, 46.07%; H, 4.66%; N, 5.27%. 
[(C^Npy^C)Aubenzimidazole]PF6 (44) 
Prepared using method 7 using the following 
amounts: 1,3-dimethylbenzimidazolium iodide 
(0.024 g, 0.131 mmol), (C^Npy^C)AuCl (0.050 g, 
0.087 mmol). For 44 the reaction time is 16 hours. 
44 was isolated as a yellow powder (0.069 g, 
0.084 mmol, 96%).  
1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 8.06 (t,
 3JH-H = 8.0 Hz, 1 H, H
1), 7.81 (m, 2 H, H12), 
7.72 (m, 2 H, H13), 7.68 (d, 3JH-H = 8.3 Hz, 2 H, H
5), 7.61 (d, 3JH-H = 8.0 Hz,
 2 H, H2), 7.40 (dd, 
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3JH-H = 8.3 Hz, 
4JH-H = 1.8 Hz, 2 H, H
6), 6.93 (d, 4JH-H = 1.8 Hz, 2 H, H
8), 4.13 (s, 6 H, N-CH3), 
1.17 (s, 18 H, tBu).  
13C{1H} NMR (CD2Cl2, 75.48 MHz, 298 K): δ 164.9 (s, C
3), 164.2 (s, C9), 163.8 (s, C10, 
observed in HMBC), 156.8 (s, C7), 147.1 (s, C4), 144.6 (s, C1), 134.7 (s, C11), 132.7 (s, C8), 
126.8 (s, C5/13), 126.5 (s, C5/13), 125.7 (s, C6), 117.9 (s, C2), 112.4 (s, C12), 36.2 (s, N-Me), 35.4 
(s, C(CH3)3), 31.0 (s, C(CH3)3). 
Elemental Microanalysis: Calc. C34H37AuN3PF6 (829.23): C, 49.22%; H, 4.50%; N, 5.07%. 
Found: C, 49.41%; H, 4.46%; N, 4.98%. 
[(C^Npy^C)Aucaffeine]BF4 (45) 
Prepared using method 8 using the following 
amounts: (C^Npz^C)AuCl (0.050 g, 0.087 mmol), 
potassium tert-butoxide (0.012 g, 0.105 mmol), 
[1,3-dimethylcaffeine][BF4] (0.026 g, 0.087 
mmol). 45 was isolated as a yellow powder (0.042 
g, 0.051 mmol, 58%).  
 
1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 8.02 (t,
 3JH-H = 8.0 Hz, 1 H, H
1), 7.66 (d, 3JH-H = 8.2 
Hz, 2 H, H5), 7.58 (d, 3JH-H = 8.0 Hz,
 2 H, H2), 7.39 (dd, 3JH-H = 8.2 Hz, 
4JH-H = 1.5 Hz, 2 H, 
H6), 7.13 (d, 4JH-H = 1.5 Hz, 2 H, H
8), 4.29 (s, 3 H, H11), 4.19 (s, 3 H, H18), 3.94 (s, 3 H, H13), 
3.45 (s, 3 H, H15), 1.26 (s, 18 H, tBu).  
13C{1H} NMR (CD2Cl2, 75.48 MHz, 298 K): δ 165.0 (s, C
3/9), 164.3 (s, C3/9), 160.4 (s, C10), 
157.1 (s, C7), 154.0 (s, C16), 151.0 (s, C14),  147.0 (s, C4), 144.5 (s, C1), 141.6 (s, C12), 133.1 
(s, C8), 126.7 (s, C5), 125.6 (s, C6), 117.8 (s, C2), 110.8 (s, C17), 40.2 (s, C11), 38.6 (s, C18), 
35.5 (s, C(CH3)3), 32.6 (s, C
13), 31.1 (s, C(CH3)3), 29.0 (s, C
15). 
Elemental Microanalysis: Calc. C34H39AuN5O2BF4 (833.28): C, 49.00%; H, 4.72%; N, 8.40%. 
Found: C, 49.21%; H, 4.60%; N, 8.31%. 
[(C^Npy-OMe^C)Auimidazole]PF6 (46) 
Prepared using method 6 using the following 
amounts: (C^NpyO-Me^C)AuCl (0.055 g, 0.087 
mmol). The reaction time for 46 is 8 days. 46 was 
isolated as a cream coloured powder (0.062 g, 
0.077 mmol, 88%).  
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1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 7.63 (d,
 3JH-H = 8.2 Hz, 2 H, H
5), 7.49 (s, 2 H, H11), 
7.38 (dd, 3JH-H = 8.2 Hz, 
4JH-H = 1.8 Hz, 2 H, H
6), 7.04 (s, 2 H, H2), 6.97 (d, 4JH-H = 1.8 Hz, 2 
H, H8), 4.1 (s, 3 H, O-CH3), 3.90 (s, 6 H, N-CH3), 1.25 (s, 18 H, 
tBu).  
13C{1H} NMR (CD2Cl2, 75.48 MHz, 298 K): δ 172.1 (s, C
1), 166.4 (s, C3), 164.3 (s, C9), 156.7 
(s, C7), 155.3 (brs, C10, located using HMBC), 147.1 (s, C4), 132.7 (s, C8), 126.2 (s, C5), 125.4 
(s, C6), 124.8 (s, C11), 103.6 (s, C2), 57.3 (s, O-Me), 38.9 (s, N-Me), 35.4 (s, C(CH3)3), 31.1 (s, 
C(CH3)3).  
Elemental Microanalysis: Calc. C31H37AuN3OPF6 (809.22): C, 45.99%; H, 4.61%; N, 5.19%. 
Found: C, 46.12%; H, 4.72%; N, 5.13%. 
[(C^Npy-OMe^C)Aubenzimidazole]PF6 (47) 
Prepared using method 7 using the following 
amounts: (C^Npy-O-Me^C)AuCl (0.055 g, 0.087 
mmol). The reaction time for 47 is 8 days. 47 was 
isolated as a cream coloured powder (0.062 g, 
0.072 mmol, 83%).  
 
1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 7.80 (m,
 2 H, H12), 7.71 (m, 2 H, H13), 7.66 (d, 3JH-
H = 8.2 Hz, 2 H, H
5), 7.39 (dd, 3JH-H = 8.2 Hz, 
4JH-H = 1.8 Hz, 2 H, H
6), 7.07 (s, 2 H, H2), 6.94 
(d, 4JH-H = 1.8 Hz, 2 H, H
8), 4.12 (s, 3 H, O-CH3), 4.12 (s, 6 H, N-CH3), 1.16 (s, 18 H, 
tBu).  
13C{1H} NMR (CD2Cl2, 75.48 MHz, 298 K): δ 172.3 (s, C
1), 166.4 (s, C3), 164.5 (s, C10), 
164.0 (s, C9), 156.7 (s, C7), 147.1 (s, C4), 134.7 (s, C11), 132.6 (s, C8), 126.5 (s, C5/13), 126.4 
(s, C5/13), 125.5 (s, C6), 112.3 (s, C12), 103.8 (s, C2), 57.4 (s, O-Me), 36.1 (s, N-Me), 35.4 (s, 
C(CH3)3), 31.0 (s, C(CH3)3). 
Elemental Microanalysis: Calc. C31H37AuN3OPF6 (859.24): C, 48.90%; H, 4.57%; N, 4.89%. 
Found: C, 48.91%; H, 4.56%; N, 4.98%. 
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[(C^Npy-OMe^C)Aucaffeine]BF4 (48) 
Prepared using method 8 using the following 
amounts: (C^Npy-O-Me^C)AuCl (0.050 g, 0.083 
mmol), potassium tert-butoxide (0.011 g, 0.098 
mmol), [1,3-dimethylcaffeine][BF4] (0.025 g, 
0.083 mmol). 48 was isolated as a cream coloured 
powder (0.035 g, 0.041 mmol, 49%).  
 
1H NMR (CD2Cl2, 300.13 MHz, 298 K): δ 7.64 (d,
 3JH-H = 8.2 Hz, 2 H, H
5), 7.39 (dd, 3JH-H = 
8.2 Hz, 4JH-H = 1.8 Hz, 2 H, H
6), 7.12 (d, 4JH-H = 1.8 Hz, 2 H, H
8), 7.04 (s, 2 H, H2), 4.27 (s, 3 
H, H11), 4.19 (s, 3 H, H18), 4.11 (s, 3 H, O-CH3), 3.93 (s, 3 H, H
13), 3.46 (s, 3 H, H15), 1.26 (s, 
18 H, tBu).  
13C{1H} NMR (CD2Cl2, 75.48 MHz, 298 K): δ 172.2 (s, C
1), 166.4 (s, C3), 164.1 (s, C9), 161.2 
(s, C10), 156.9 (s, C7), 153.9 (s, C16), 151.0 (s, C14), 146.9 (s, C4), 141.6 (s, C12), 132.9 (s, C8), 
126.3 (s, C5), 125.5 (s, C6), 110.8 (s, C17), 103.7 (s, C2), 57.4 (s, O-Me), 40.1 (s, C11), 38.6 (s, 
C18), 35.5 (s, C(CH3)3), 32.6 (s, C
13), 31.1 (s, C(CH3)3), 29.1 (s, C
15). 
Elemental Microanalysis: Calc. C35H41AuN5O3BF4 (863.29): C, 48.68%; H, 4.79%; N, 8.11%. 
Found: C, 48.70%; H, 4.77%; N, 8.06%. 
6.3 X-ray crystallography 
The work in the section was done by Dr Julio Fernandez-Cestau (4, 5, 7, 9 and 11) and Dr 
David Hughes (3, 28 and 46) 
Crystals of each sample were mounted on a MiTeGen MicroMesh and fixed in the cold 
nitrogen stream on a diffractometer. Diffraction intensities were recorded at the specified 
temperature on an Oxford Diffraction Xcalibur-3/Sapphire3-CCD diffractometer, equipped 
with Mo-Kα radiation and graphite monochromator or Rigaku HG Saturn724+ (2×2 bin 
mode). Data were processed using the CrystAlisPro-CCD and –RED software or CrystalClear-
SM Expert 3.1 b27, with the absorption correction done at this stage.11 
The structures of all samples were determined by the direct methods routines with SHELXS 
or SHELXT programs and refined by full-matrix least-squares methods on F2 in SHELXL.12 
Non-hydrogen atoms were generally refined with anisotropic thermal parameters. Hydrogen 
atoms were included in idealised positions. No missed symmetry was reported by PLATON.13 
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Refinement results are included in Table 6.1. Computer programs used in this analysis were 
run through WinGX.14 Scattering factors for neutral atoms were taken from reference 15. 
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 (C^Npz^C)AuSPh (3) (C^Npz^C)AuSC6H4
tBu-4 (9) (C^Npz^C)AuSC5H4N-2 (4) 
 Red polymorph Yellow polymorph   
Empirical formula C30H31AuN2S C30H31AuN2S C34H35AuN2S C29H30AuN3S 
Crystal dimensions (mm), colour 0.065×0.14×0.35, red 0.35×0.09×0.08, pale yellow 0.048×0.033×0.019, yellow 0.6×0.04×0.03, yellow 
Fw 648.59 648.59 700.66 649.58 
T (K) 140(2) 140(2) 140(2) 100(2) 
crystal system, space group triclinic; P-1 monoclinic; P 21/m Monoclinic; P21/c Monoclinic, P21/c 
a(Å) 12.2846(2) 12.5213(8) 14.4504(6) 8.8501(2) 
b(Å)  14.7009(3) 6.9443(2) 16.8527(4) 15.3636(3) 
c(Å) 15.3192(2) 15.8652(6) 13.2971(4) 18.8486(3) 
(deg) 98.283(2) 90 90 90 
(deg) 109.863(2) 110.495(5) 114.412(4) 100.107(2) 
(deg) 93.835(2) 90 90 90 
volume (A3) 2554.81(8) 1292.19(11) 2948.71(19) 2523.06(9) 
Z 4 2 4 4 
Dcalcd (Mg/m
3) 1.686 1.667 1.578 1.71 
absorption coefficient (mm-1) 5.861 5.794 5.085 5.936 
F(000) 1280 640 1392 1280 
 range for data collection (º) 3.143 to 29.999 3.238 to 27.496 2.129 to 27.482 2.338 to 29.557 
data // restraints // params 14889 // 0 // 613 3213 // 0 // 193 6719 // 0 // 352 6272 // 0 // 313 
goodness-of-fit on F2[a]  1.044 1.153 1.031 0.888 
final R indexes [I2(I)][a] R1 = 0.0304, wR2 = 0.0651 R1 = 0.0372, wR2 = 0.0798 R1 = 0.0276, wR2 = 0.0531 R1 = 0.0296, wR2 = 0.1048 
R indexes (all data)[a] R1 = 0.0484, wR2 = 0.0701 R1 = 0.0456, wR2 = 0.0819 R1 = 0.0379, wR2 = 0.0563 R1 = 0.0354, wR2 = 0.1202 
largest diff peak and hole (e.Å –3) 1.661 and -1.297 2.630 and -0.993 0.746 and -1.277 1.67 and -1.753 
[a] R1 = (Fo - Fc)/Fo; wR2 = [w(Fo2 – Fc2)2/wFo2] 1/2; goodness of fit = {[w(Fo2 – Fc2)2]/(Nobs – Nparam)}1/2; w = [2(Fo) + (g1P)2 + g2P]-1; P = [max(Fo2;0 + 2Fc2]/3. 
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 (C^Npz^C)AuSNp-2 (5) (C^Npz^C)AuSCoum (7) 
(C^N^C)AuSNp-2 · CH2Cl2 
(11 · CH2Cl2) 
 Red polymorph Yellow polymorph   
Empirical formula C34H33AuN2S C34H33AuN2S C34H33Au N2O2S C36H36AuCl2NS 
Crystal dimensions (mm), colour 0.074×0.032×0.012, red 0.235×0.049 × 0.014, yellow 0.2×0.2×0.014, orange 0.15×0.02×0.02, yellow 
Fw 698.65 698.65 730.65 782.58 
T (K) 100(2) 140(2) 140(2) 100(2) 
crystal system, space group monoclinic; P 21/n monoclinic; P 21/n monoclinic; P 21/n triclinic; P-1 
a(Å) 15.2707(4) 6.36960(10) 9.9308(2) 9.7612(7) 
b(Å)  6.3728(2) 17.2085(3) 17.6575(4) 11.4058(8) 
c(Å) 29.0818(8) 25.1788(5) 16.8512(4) 16.1645(11) 
(deg) 90 90 90 89.924(5) 
(deg) 101.425(3) 91.386(2) 103.620(2) 74.521(4) 
(deg) 90 90 90 65.656(4) 
volume (A3) 2774.08(14) 2759.07(8) 2871.81(11) 1568.0(2) 
Z 4 4 4 2 
Dcalcd (Mg/m
3) 1.673 1.682 1.69 1.658 
absorption coefficient (mm-1) 5.405 5.434 5.23 4.955 
F(000) 1384 1384 1448 776 
 range for data collection (º) 2.3 to 29.572 2.502 to 27.482 3.127 to 29.801 2.635 to 27.538 
data // restraints // params 7378 // 0 // 349 6269 // 0 // 343 7041 // 0 // 368 7141 // 0 // 376 
goodness-of-fit on F2[a]  1.052 1.055 1.001 1.025 
final R indexes [I2(I)][a] R1 = 0.0527, wR2 = 0.1045 R1 = 0.0237, wR2 = 0.0504 R1 = 0.0241, wR2 = 0.0405 R1 = 0.0453, wR2 = 0.1147 
R indexes (all data)[a] R1 = 0.0635, wR2 = 0.1103 R1 = 0.0282, wR2 = 0.052 R1 = 0.0375, wR2 = 0.0429 R1 = 0.0488, wR2 = 0.1179 
largest diff peak and hole (e.Å –3) 3.026 and -4.187 1.344 and -0.716 1.02 and -0.727 3.213 and -2.257 
[a] R1 = (Fo - Fc)/Fo; wR2 = [w(Fo2 – Fc2)2/wFo2] 1/2; goodness of fit = {[w(Fo2 – Fc2)2]/(Nobs – Nparam)}1/2; w = [2(Fo) + (g1P)2 + g2P]-1; P = [max(Fo2;0 + 
2Fc2]/3. 
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 (CNCAuSAd)2HAB2
 (28) CNpy-OMeCAu–imidazole (46) 
Empirical formula C142H90Au2N4S2B4F60 C31H37AuN3OPF6, ca C1.55 
Crystal dimensions (mm), colour 0.19×0.10×0.07, colourless 0.055×0.065×0.35, colourless 
Fw 3525.47 828.19 
T (K) 295(1) 140(1) 
crystal system, space group triclinic; P-1 Orthorhombic, P n a 21 
a(Å) 15.0100(8) 23.0946(7) 
b(Å)  15.8427(8) 22.5721(7) 
c(Å) 16.5234(7) 13.9068(5) 
(deg) 70.367(4) 90 
(deg) 84.345(4) 90 
(deg) 70.653(5) 90 
volume (A3) 3491.5(3) 7249.5(4) 
Z 2 8 
Dcalcd (Mg/m
3) 1.677 1.518 
absorption coefficient (mm-1) 2.263 4.161 
F(000) 1736 3274 
 range for data collection (º) 3.515 to 22.500 3.523 to 26.000 
data // restraints // params 9083 // 0 // 983 14224 // 1 // 815 
goodness-of-fit on F2[a]  1.044 1.038 
final R indexes [I2(I)][a] R1 = 0.065, wR2 = 0.121 R1 = 0.039, wR2 = 0.079 
R indexes (all data)[a] R1 = 0.093, wR2 = 0.132 R1 = 0.056, wR2 = 0.084 
largest diff peak and hole (e.Å –3) 1.23 and -0.96 0.80 and -0.48 
[a] R1 = (Fo - Fc)/Fo; wR2 = [w(Fo2 – Fc2)2/wFo2] 1/2; goodness of fit = {[w(Fo2 – Fc2)2]/(Nobs 
– Nparam)}1/2; w = [2(Fo) + (g1P)2 + g2P]-1; P = [max(Fo2;0 + 2Fc2]/3. 
Table 6.1. Selected crystal data and structure refinement details. 
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6.4 Photophysical Properties  
UV−visible absorption spectra were recorded using a Perkin-Elmer Lambda 35 UV/vis 
spectrometer. Excitation and emission spectra were measured using a (TCSPC) FluoroLog 
Horiba Jobin Yvon spectrofluorometer. Lifetime measurements were conducted with a 
Datastation HUB-B with a nanoLED controller and software DAS6. The nanoLEDs employed 
for lifetime measurements were of 370 nm with pulse lengths of 0.8−1.4 ns. Quantum yields 
in the solid state were measured upon excitation at 370-400 nm using an F-3018 integrating 
sphere mounted on a Fluorolog 3-11 Tau-3 spectrofluorimeter, at the Universidad de La Rioja 
by Dr Julio Fernandez-Cestau. In solution, relative quantum yields were determined with 
reference to [Ru(bpy)3]
2+ in H2O (stn = 2.8 %) in accordance with reference 16. 
Complex Absorbance [nm] (103 /M-1 cm-1) 
(C^Npz^C)AuSPh 3 320 (9.1), 344 (6.2), 365 (4.3), 421 (4.3), 441 (4.3), 470(1.4), long 
tail up to 530. 
(C^Npz^C)AuSC5H4N-2 
4 
321 (11.5), 349 (8.9), 425 (5.1), 443 (5.0), 470 (1.1), tail up to 500. 
(C^Npz^C)AuSNp-2 5 323 (15.9), 348 (11.0), 420 (7.3), 440 (7.3), 469 (2.1), long tail up 
to 530. 
(C^Npz^C)AuSQuin-2 6 322 (13.6), 351 (11.9), 424 (5.9), 445 (5.2), 470 (1.8), tail up to 515. 
(C^Npz^C)AuSCoum 7 324 (23.2), 373 (17.3), 423 (7.8), 442 (7.5), 471 (2.3), long tail up 
to 530. 
(C^Npz^C)AuSAd 8 322 (7.2), 348 (4.4), 395 (2.4), 423 (2.9), 445 (3.1), 469 (0.8), tail 
up to 530. 
(C^Npz^C)AuSC6H4
tBu-
4 9 
321 (10.0), 348 (6.0), 421 (4.1), 440 (5.0), 471 (1.7), long tail up to 
530. 
(C^Npz^C)AuSNp-1 10 320 (10.3) broad shoulder, 419 (3.4), 439 (3.4), 470 (0.8), long tail 
up to 530. 
(C^Npy^C)AuSNp-2 11 319 (13.8), 368 (8.0), 384 (7.6), 405 (6.1), 470 (0.3). 
Table 6.2. Absorption data for complexes in CH2Cl2 (5 × 10
-5 M). 
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 λem / nm (λex / nm) 
Complex 298 K 77 K 
(C^Npz^C)AuSPh 3 574 (350-500) 558max, 593sh (360-500) 
(C^Npz^C)AuSC5H4N-2 4 492 (300-450) 534max, 579sh (300-480, 
360max, 430sh, 460sh) 
(C^Npz^C)AuSNp-2 5 650 (350-600, 370max, 
480sh) 
650 (360-550) 
(C^Npz^C)AuSQuin-2 6 [a] 519sh, 532max, 553sh (350-
470) 
(C^Npz^C)AuSCoum 7 [a] 540, 577, 621 (360-550) 
(C^Npz^C)AuSAd 8 633 (370-470) 630 (360, 470, 500-570br) 
(C^Npz^C)AuSC6H4
tBu-4 9 600 (350-500) 548max, 593sh (350-500) 
(C^Npz^C)AuSNp-1 10 618 (360br-510max) 547sh, 630 (350-460, 518) 
(C^Npy^C)AuSNp-2 11 [a] 514max, 544sh (400-450) 
Table 6.3. PL properties of the complexes in the solid state. [a] Non-emissive. 
 
Complex λem / nm (λex / nm) τ / ns 
[a]  / % (λex 
/ nm) [b] 
3  530sh, 616max (320-390); 616 (500) 355.2±4.4(95%), 
44.5±2.0(5%) 
< 1 
4  540max, 573sh, 614sh (320-350, 400, 
420)[c] 
342.2±5.7(96%), 
25.0±2.1(5%) 
< 1 
5  611 (320-560, 380sh, 470max) 366.9±6.9(94%), 
51.8±2.5(6%) 
3.7 (480) 
6  508 (340-450, 390max) 369.5±4.8(95%), 
46.4±1.7(5%) 
4.7 (390) 
7  595 (330-450) 376.0±1.2(94%), 
56.7±4.8(6%) 
< 1 
8  642 (350-600, 320sh, 470sh, 550max) 374.3±5.7(95%), 
46.1±2.3(5%) 
< 1 
9  622 (340-580, 370sh, 510max) 345.6±3.9(96%), 
38.2±3.9(5%) 
3.4 (510) 
10  516sh, 615max (350-580, 515max) 368.8±3.0(95%), 
47.7±1.2(5%) 
1.8 (515) 
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11  ~480[b]   
Table 6.4. PL properties of complexes 3-11 in 10% PMMA matrix at 298 K. [a] Measured 
at  𝜆𝑚𝑎𝑥
𝑒𝑚  [b] Determined by absolute methods using an integrating sphere. [c] Weak 
emission. 
Matrix λem / nm (λex / nm) τav / ns 
[a]  / % (λex / nm) 
[b] 
1% in PMMA 600 (350-540, 375max, 450sh, 490sh) 
weak 
82.2 < 1 
5% in PMMA 611 (320-560, 380sh, 470max) 186 1.9 (480) 
10% in PMMA 619 (350-575, 380sh, 500max) 204 3.7 (480) 
20% in PMMA 628 (350-580, 505max) 194 4.1 (480) 
30% in PMMA 630 (350-590, 380sh, 505max) 204 5.0 (480) 
40% in PMMA 644 (350-600, 540max) 198 6.6 (480) 
50% in PMMA 649 (350-650, 520max) 267 11.2 (480) 
10% in PS 626 (350-580, 380sh, 515max) 223 4.4 (480) 
10% in PVK 632 (350-580, 380sh, 505max) 226 3.3 (480) 
Table 6.5. Steady State properties of complex (C^Npz^C)AuSNp-2 5 at 298 K in different 
polymeric matrix [a] Measured at 𝜆𝑚𝑎𝑥
𝑒𝑚 . Fit to tri-exponential decay functions in all cases. 
Only the average lifetime is given and used to calculate the radiative and non-radiative 
constants. [b] Determined by absolute methods using an integrating sphere. 
Matrix λem / nm (λex / nm) τav / ns 
[a]  / % (λex / nm) 
[b] 
10% in PMMA 508 (340-450, 390max) 28 4.7 (390) 
30% in PMMA 508 (340-450, 390max) 30 1.2 (390) 
50% in PMMA 517br (350-450) 94 < 1 (390) 
Table 6.6. Steady State properties of complex (C^Npz^C)AuSQuin-2 6 at 298 K in different 
polymeric matrix. [a] Measured at 𝜆𝑚𝑎𝑥
𝑒𝑚 . Fit to tri-exponential decay functions in all cases. 
Only the average lifetime is given and used to calculate the radiative and non-radiative 
constants. [b] Determined by absolute methods using an integrating sphere. 
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Com
plex 
T / 
K 
λem / nm (λex / nm) τ [λ / nm]  / % (λex 
/ nm) [a] 
3 298 [b]   
 77 540sh, 600max (370-480) (10
-4 M) [c] 28.7±1.1 μs [600]  
4 298 516max, 546sh (320-350, 400, 420) (10
-
4 M) [c] 
11.0±0.1(40), 
156.4±5.8(60) ns [516] 
 
 77 540max, 580sh (350-600, 370max, 480sh) 
(10-4 M) [c] 
84.3±1.5 μs (10-4 M) 
[540] 
 
5 298 680 (300-480) (10-4 M) // 683 (300-
600, 540max) (10
-2 M) 
17.3±0.1 ns [680] 2.62×10-3 
(436)[e] 
 77 605 (360-460) (10-4 M) // 614 (540max) 
(10-2 M) 
35.3±0.4 μs [614]  
6 298 508 (340-420) (10-2 M) [d] 10.6±0.2(14), 
211.2±6.4(86) ns [508] 
 
 77 544max, 579sh (300-470) (10
-4 M) [c] 118.4±3.7 μs [540]  
7 298 621 (350-570, 370sh, 520max) (10
-2 
M)[d] 
 2.34×10-3 
(436) 
 77 587max (320-470, 514max) (10
-2 M) // 
541max, 574sh (320-420) (10
-4 M) 
63.8±1.0 μs [541]  
8 298 670 (350-470) (10-4M) // 665 (360-600, 
500max) (10
-2 M) 
16.2±0.07 ns [670] 1.45×10-2 
(436) 
 77 540sh, 609 (320-480, 365, 430, 450) 
(10-4 M) // 629 (320-570, 370, 460) (10-
2 M) 
12.6±0.2 μs [629]  
9 298 680 (350-500, 360max, 430sh) (10
-4 M) 
[c] 
17.1±0.1 ns [680] 1.94×10-4 
(436) 
 77 539sh, 555sh, 616max (320-480) (10
-4 
M) // 616 nm (340-500) (10-2 M) 
106.8±2.6 μs [540], 
30.2±1.9 μs [616] 
 
10 298 685 (400-600, 530max) (10
-4 M) [c] 8.7±0.1 ns [689] 5.58×10-3 
(436) 
 77 516sh, 529max, 565sh (320-420) (10
-5 
M) // 516sh, 529sh, 599max (320-550) 
(10-4 M) // 529sh, 617 (320-550) (10-2 
M) [c] 
43.8±1.0 μs (10-2 M) 
[617] 
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11 298 [b]   
 77 517max, 552sh (300-460, 370max, 410sh, 
440sh) (10-4 M) [c] 
50.2±0.1 μs [517]  
Table 6.7. PL properties of complexes 3-11 in CH2Cl2. [a] Relative to standard.
S7 [b] Non-
emissive. [c] Same at 10-2 M. [d] Very weak at 10-4 M [e] 2.30×10-3 (372), 2.47×10-3 (419), 
2.62×10-3 (436), 9.59×10-3 (472), 1.70×10-2 (495). 
  λem / nm (λex / nm) 
Solvent Conc. 298 K 77 K 
CH2Cl2 10
-4 M 680 (350-500, 360max, 430sh) 515, 535sh, 605 (320-550, 365max, 440sh) 
 10-2 M 680 (350-600, 540max) 622 (500) 
THFMe-
2 
10-4 M weak 520, 591max (380-470) 
 10-2 M 660 (360-450, 540) 522, 542sh, 584 (380-470) 
Table 6.8. Steady State emission of (C^Npz^C)AuSC6H4
tBu-4 9 in different solvents. 
  λem / nm (λex / nm) 
Solvent Conc. 298 K 77 K 
CH2Cl2 10
-4 M 680 (300-480) 605 (360-460) 
 10-2 M 683 (300-600, 540max) 614 (540max) 
THFMe-2 10-4 M 663 (300-500, 365max, 440sh) 520, 591max (360-450) 
 10-2 M 664 (350-600, 540max) 520, 585max (360-460) 
Toluene 10-4 M 642 (300-500, 370max, 430sh) 604 (350-450) 
 10-2 M 642 (350-600, 540max) 600 (540max) 
Table 6.9. Steady State emission of (C^Npz^C)AuSNp-2 5 in different solvents. 
6.5 Diffusion NMR 
Diffusion NMR was used in 2.7 to determine the proportion of aggregates in solution and in 
3.13 to determine the hydrodynamic dimensions of the species obtained after C–C reductive 
elimination from 20.  
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6.5.1 Investigating aggregation tendency Dr Luca Rocchigiani  
1H PGSE NMR measurements were performed by using a double stimulated echo sequence 
with longitudinal eddy current delay on a Bruker DRX 300 spectrometer equipped with a 
smartprobe and Z-gradient coil, at 297K without spinning. In the typical PGSE experiment, 
the dependence of the resonance intensity (I) on a constant waiting time and on a varied 
gradient strength G is described by Equation 1. 
ln
I
I0
= (gd 2 )Dt d -
D
3
æ
è
ç
ö
ø
÷G
2
 
Equation 6.1 
where I is the intensity of the observed spin echo, I0 the intensity of the spin echo in the absence 
of gradient, Dt the self-diffusion coefficient, Δ the delay between the midpoints of the 
gradients, δ the length of the gradient pulse, and γ the magnetogyric ratio. The shape of the 
gradients was rectangular, their length δ was 4–5 ms, and their strength G was varied during 
the experiments. All spectra were acquired for 64K points and a spectral width of 6200 Hz 
and processed with a line broadening of 1.0. The semi-logarithmic plots of ln(I/I0) versus G
2
 
were fitted by using a standard linear regression algorithm. Different values of G and number 
of transients were used for different samples.  
The self-diffusion coefficient Dt, which is directly proportional to the slope of the regression 
line obtained by plotting ln(I/I0) versus G
2, was estimated by evaluating the proportionality 
constant for a sample of HDO (5%) in D2O (known diffusion coefficients in the range 274–
318 K)17 under the exact same conditions as the sample of interest. The solvent was taken as 
internal standard. The actual concentration of the samples was measured by relative 
integration to an external standard. 
The relationship between Dt and hydrodynamic dimensions is expressed by the modified 
Stokes-Einstein equation: 
Dt =
kT
ph fc abd3
 
Equation 6.2. The modified Stokes-Einstein equation 
where k is the Boltzmann constant, T is the temperature,  is the solution viscosity, c is the 
“size factor”, which depends on the solute-solvent radius ratio and f is the “shape factor”, 
which takes into account the deviation from sphericity of the diffusing molecule. a, b and d 
are the semi-axes of the ellipsoid that better approximates the shape of the diffusing 
molecule.18  
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Structural parameter values (P= fc abd3 = kT /phDt ) were derived from the measured Dt 
values at different concentration in CD2Cl2 and the data are collected in Table 6.2. 
Assuming a monomer/dimer equilibrium, the observed P values can be treated as the average 
between the parameters of both monomer (PM) and dimer (PD), according to the following 
relationship: 
Pi = PM xM +PDxD 
where xM and xD are the molar fractions of monomer and dimer at a given concentration.  
PM and PD parameters are depending on the dimensions of monomer (aM, bM, dM), dimer (aD, 
bD, dD) and solvent (rsolv, approximated at the van der Waals radius of CD2Cl2). PM parameters 
can be derived from X-ray structures of monomers, by approximating their shape to ellipsoids. 
PD parameters have been calculated by using packing data derived by X ray diffraction (see 
below). 
c (mM) 10
10
Dt (m
2
 s
–1
) P (Å) mol-% dimer 
1 (C^NPz^C)AuCl PM=27.9 Å; PD=39.6 Å 
0.8 11.0 27.8 <1 
4.3 11.0 27.8 <1 
11.8 10.9 28.0 1.5 
23.9 10.6 28.8 13 
3 (C^NPz^C)AuSPh   PM=29.3 Å; PD=39.8 Å 
2.9 10.4 29.5 2 
8.8 10.2 29.9 5 
17.5 10.1 30.3 9 
22.3 10.1 30.4 10 
23.5 10.0 30.5 11 
53.8 9.8 31.3 19 
55.5 9.7 31.5 21 
5 (C^NPz^C)AuSNp-2   PM=30.4 Å; PD=44.0 Å 
0.6 10.0 30.7 2 
1.3 9.8 31.1 5 
1.9 9.8 31.2 6 
4.1 9.7 31.5 8 
19.3 9.5 32.3 14 
42.6 9.3 32.8 18 
72.5 9.0 34.0 26 
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Table 6.10. Diffusion coefficient (Dt), structural parameters (P) and estimated percentage of 
dimers (%D) for 1, 3 and 5 as a function of concentration in CD2Cl2 at 297 K. 
The amount of dimers was quantified by using standard equations for monomer-dimer 
equilibrium:19   
di =dM fM +dD fD =
[A]
[A]0
dM +
2[A2 ]
[A]0
dD
 
di =dM + (dD -dM )
(1+8K[A]0 )
1/2 -1
(1+8K[A]0 )
1/2 +1  
where fm and fd are the molar fractions of monomers and dimers, M and D are the limit 
chemical shift values of monomer and dimer, respectively, K is the association constant. After 
fitting chemical shift versus concentration trends, the molar fractions of dimers were obtained 
as: 
fD = –1+
2[A]0
[A]0 +
1+8K[A]0 -1
4K
 
C (mM) fD (%) 
(C^NPz^C)AuCl K=3.6 M–1 
0.8 <1 
4.3 3 
11.8 7 
23.9 13 
(C^NPz^C)AuSPh  K=1.0 M–1 
2.9 <1 
8.8 2 
17.5 3 
22.3 4 
23.5 4 
53.8 9 
55.5 9 
(C^NPz^C)AuSNp-2  K=1.8 M–1 
0.6 <1 
1.3 <1 
1.9 <1 
4.1 1 
19.3 6 
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42.6 12 
72.5 18 
Table 6.11. Table Molar fraction of dimers derived by fitting chemical shift vs. 
concentration trends for (C^NPz^C)AuCl (1), (C^NPz^C)AuSPh (3) and (C^NPz^C)AuSNp-2 
(5) (CD2Cl2, 297 K). 
6.5.2 Hydrodynamic dimensions of [ClAuSAd]nHn in collaboration with Dr Luca 
Rocchigiani 
Diffusion NMR was used to investigate the hydrodynamic dimensions of the species obtained 
after C–C reductive elimination of 20 in the presence of adamantly thiol. As described in 
section 3.13, at the end of the reaction, the mixture is composed by free adamantly thiol, 23 
and an additional adamantly species, reasonably assigned to the Au(I) complex formed upon 
elimination of the ligand.  
1H PGSE NMR experiments were again performed by using a double stimulated echo 
sequence with longitudinal eddy delay on a Bruker DRX 300 spectrometer equipped with a 
smartprobe and Z-gradient coil, at 297K without spinning. The decay of the signals (I) as a 
function of the applied gradient (G, Figure 6.1) were used with Equation 6.118a to obtain the 
diffusion coefficient. The modified Stokes-Einstein equation (Equation 6.2) was used to 
calculate the hydrodynamic data values, under the spherical approximation, these are shown 
in Table 6.12. The CD2Cl2 solvent was used as internal standard. 
 
Chapter Six 
 
166 
 
 
Figure 6.1. Trends of ln(I/I0) versus G
2 for the components of the mixture obtained after the 
reaction of 20 with AdSH.  
Species Hydrodynamic 
Radius  
Hydrodynamic 
Volume 
AuSAd 7.1 Å  1500 Å3 
HSAd 3.53 Å  184 Å3 
23 5.58 Å  727 Å3 
 
Table 6.12. The hydrodynamic radii and volumes of species measured by PGSE NMR 
experiments. 
The hydrodynamic volume values of 184 and 727 Å3 for adamantly thiol and 23, respectively. 
The Au(I) complex showed a hydrodynamic volume of 1500 Å3, which is about 8 times larger 
than free thiol. Therefore, it can be reasonably assumed that the Au(I) product exists as a small 
[ClAuSAd]nHn cluster, with an average n close to 7.  
6.6 Kinetic Investigations  
1/2 (0.005 g, 0.0087 mmol) was dissolved in dry CD2Cl2 (0.6 mL) in a J-Young NMR tube 
and an initial 1H NMR spectra was recorded to lock and shim the sample. In open air, 
adamantly thiol (at varying concentrations) was added to the NMR tube and the reaction was 
followed in situ by 1H NMR spectroscopy. Different intervals between the spectra were used 
according to the thiol concentration. 
23 
23 
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Absolute concentration values were evaluated by comparing the relative integration to an 
external standard (4,4’-diiodobiphenyl in CDCl3 at 3.6 mM) at a known concentration using 
identical NMR parameters. The spectra were processed and the normalized concentration of 
1/2 was monitored over the course of the reaction by comparing the intensity of t-butyl signal 
with the spectrum at t = 0. 
6.7 Biological testing 
6.7.1 Antiproliferation assay (Dr Benoit Bertrand)20 
Human A549 cancer cell lines (from ECACC) were cultured in RPMI 1640 medium with 10% 
fetal calf serum, 2 mM L-glutamine, 100 units/mL penicillin, and 100 μg/mL streptomycin 
(Invitrogen). Cells were maintained in a humidified atmosphere at 37 °C and 5% CO2. 
Inhibition of cancer cell proliferation was measured by the 3-(4,5- dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)- 2H-tetrazolium (MTS) assay using the CellTiter 
96 Aqueous One Solution Cell Proliferation Assay (Promega) and following the 
manufacturer’s instructions. Briefly, A549 cells (8 × 103 /100 μL) were seeded in 96-well 
plates and left untreated or treated with 1 μL of DMSO (vehicle control) or 1 μL of complex 
diluted in DMSO at different concentrations in triplicate for 72 h at 37 °C with 5% CO2. 
Following this, the MTS assay reagent was added for 4 h, and the absorbance measured at 490 
nm using a Polarstar Optima microplate reader (BMG Labtech). IC50 values were calculated 
using GraphPad Prism version 5.0 software.  
6.7.2 FRET assay21 
The experiments for 5.9 were carried under the supervision of Dr Zoe Waller and Dr Elise 
Wright. 
The initial FRET melting screen was performed using a FRET DNA-melting-based assay. The 
oligonucleotides are labelled with a donor fluorophore, FAM (6- carboxyfluorescein) and an 
acceptor TAMRA (6- carboxytetramethylrhodamine).  
Name DNA sequence Transitional pH 
hTeloCFRET 5′-FAM-[TAA-CCC-TAA-CCC-TAA-CCC-TAA-
CCC]-TAMRA-3′ 
6.0 
c-MycCFRET 5′-FAM-[TCC-CCA-CCT-TCC-CCA-CCC-TCC-
CCA-CCC-TCC-CCA]-TAMRA-3′ 
6.6 
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hif-1αFRET 5′-FAM-[CGC-GCT-CCC-GCC−CCCTCT-CCC-
CTC−CCC-GCG-C]-TAMRA-3′ 
7.2 
hTeloGFRET 5′-FAM-[GGG-TTA-GGG-TTA-GGG-TTA-GGG]-
TAMRA-3′ 
7.2 
DSFRET 5′-FAM-[TAT-AGC-TAT-A-HEG(18)-TAT-AGC-
TAT-A]-TAMRA-3′ 
7.2 
Table 6.13. FRET labled DNA sequences used in Section 5.9 and corresponding transitional 
pH values. 
The solutions of the oligonucleotides were prepared as 0.2 μM solutions, with 10 mM sodium 
cacodylate and 100 mM sodium chloride buffer at the specified pH. This was thermally 
annealed by heating the prepared samples for 5 minutes at 95 °C, then allowing them to cool 
to room temperature over 16 hours. Strip tubes (QIAgen) were prepared by aliquoting 20 μL 
of the annealed DNA followed by 0.5 μL of 2 mM solutions of the complexes 40 – 48 
dissolved in DMSO to deliver a final concentration of 50 μM of complex. Control samples for 
each run were prepared with the same quantity of DMSO with the DNA in buffer. 
Fluorescence melting curves were determined in a QIAgen RotorGene Q-series PCR machine. 
Measurements of fluorescence were made with excitation at 470 nm and detection at 510 nm. 
Final analysis of the data to determine melting temperatures for each secondary structure when 
exposed to complexes 40 – 48 was carried out using QIAgen RotorGene Q-series software 
and Excel.  
The dose response FRET assays were completed using the same method. A serial dilution of 
complexes 44 and 47 gave a series of solutions at the following concentrations: 2 mM, 1.2 
mM, 800 μM, 400 μM, 200 μM, 80 μM, 40 μM, 20 μM and 10 μM. The preparation of the 
samples was the same, using strip tubes (QIAgen) contining 20 μL of the annealed DNA 
followed by 0.5 μL of solutions of the prepared solutions of 44 and 47 dissolved in DMSO to 
deliver the final concentrations of 50 μM, 30 μM, 20 μM, 10 μM, 5 μM, 2 μM, 1 μM, 0.5 μM 
and 0.25 μM of complex. 
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